<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>KCTD16 - AI Gene Review</title>
    <style>
        :root {
            --color-accept: #22c55e;
            --color-remove: #ef4444;
            --color-modify: #f97316;
            --color-keep-non-core: #3b82f6;
            --color-undecided: #6b7280;
            --color-new: #8b5cf6;
            --color-mark-over: #eab308;
            --bg-light: #f9fafb;
            --border-color: #e5e7eb;
            --text-muted: #6b7280;
            --text-primary: #111827;
        }

        * {
            margin: 0;
            padding: 0;
            box-sizing: border-box;
        }

        body {
            font-family: -apple-system, BlinkMacSystemFont, "Segoe UI", Roboto, "Helvetica Neue", Arial, sans-serif;
            line-height: 1.6;
            color: var(--text-primary);
            background-color: #ffffff;
            padding: 2rem;
            max-width: 1400px;
            margin: 0 auto;
        }

        .header {
            border-bottom: 2px solid var(--border-color);
            padding-bottom: 1.5rem;
            margin-bottom: 2rem;
        }

        h1 {
            font-size: 2.5rem;
            font-weight: 700;
            margin-bottom: 0.5rem;
            color: #1f2937;
        }

        .gene-info {
            display: flex;
            gap: 2rem;
            flex-wrap: wrap;
            margin-top: 1rem;
        }

        .info-item {
            display: flex;
            gap: 0.5rem;
        }

        .info-label {
            font-weight: 600;
            color: var(--text-muted);
        }

        .aliases {
            display: flex;
            gap: 0.5rem;
            flex-wrap: wrap;
        }

        .badge {
            padding: 0.25rem 0.75rem;
            border-radius: 9999px;
            font-size: 0.875rem;
            font-weight: 500;
            background-color: var(--bg-light);
            border: 1px solid var(--border-color);
        }

        .status-badge {
            padding: 0.375rem 0.875rem;
            border-radius: 0.375rem;
            font-size: 0.875rem;
            font-weight: 600;
            text-transform: uppercase;
            letter-spacing: 0.025em;
        }

        .status-initialized {
            background-color: #fef3c7;
            color: #92400e;
            border: 1px solid #fde68a;
        }

        .status-in-progress {
            background-color: #dbeafe;
            color: #1e40af;
            border: 1px solid #bfdbfe;
        }

        .status-draft {
            background-color: #fce7f3;
            color: #831843;
            border: 1px solid #fbcfe8;
        }

        .status-complete {
            background-color: #d1fae5;
            color: #065f46;
            border: 1px solid #a7f3d0;
        }

        .description-card {
            background-color: var(--bg-light);
            border: 1px solid var(--border-color);
            border-radius: 0.5rem;
            padding: 1.5rem;
            margin-bottom: 2rem;
        }

        .description-card h2 {
            font-size: 1.25rem;
            margin-bottom: 1rem;
            color: #374151;
        }

        .section {
            margin-bottom: 2.5rem;
        }

        .section-title {
            font-size: 1.5rem;
            font-weight: 600;
            margin-bottom: 1.5rem;
            color: #1f2937;
            border-bottom: 1px solid var(--border-color);
            padding-bottom: 0.5rem;
        }

        .annotations-table {
            width: 100%;
            border-collapse: collapse;
            border: 1px solid var(--border-color);
            border-radius: 0.5rem;
            overflow: hidden;
        }

        .annotations-table thead {
            background-color: var(--bg-light);
        }

        .annotations-table th {
            text-align: left;
            padding: 1rem;
            font-weight: 600;
            border-bottom: 2px solid var(--border-color);
            font-size: 0.875rem;
            text-transform: uppercase;
            letter-spacing: 0.05em;
            color: var(--text-muted);
        }

        .annotations-table td {
            padding: 1rem;
            border-bottom: 1px solid var(--border-color);
        }

        .annotations-table tbody tr:hover {
            background-color: #f9fafb;
        }

        .action-badge {
            display: inline-block;
            padding: 0.375rem 0.75rem;
            border-radius: 0.375rem;
            font-size: 0.875rem;
            font-weight: 600;
            text-transform: uppercase;
            letter-spacing: 0.025em;
        }

        .action-accept {
            background-color: var(--color-accept);
            color: white;
        }

        .action-remove {
            background-color: var(--color-remove);
            color: white;
        }

        .action-modify {
            background-color: var(--color-modify);
            color: white;
        }

        .action-keep_as_non_core {
            background-color: var(--color-keep-non-core);
            color: white;
        }

        .action-undecided {
            background-color: var(--color-undecided);
            color: white;
        }

        .action-new {
            background-color: var(--color-new);
            color: white;
        }

        .action-mark_as_over_annotated {
            background-color: var(--color-mark-over);
            color: white;
        }

        .term-info {
            display: flex;
            flex-direction: column;
            gap: 0.25rem;
        }

        .term-id {
            font-family: monospace;
            font-size: 0.875rem;
            color: var(--text-muted);
        }

        .term-label {
            font-weight: 500;
        }

        .evidence-code {
            font-family: monospace;
            background-color: var(--bg-light);
            padding: 0.125rem 0.375rem;
            border-radius: 0.25rem;
            font-size: 0.875rem;
        }

        .not-badge {
            display: inline-block;
            background-color: #fef2f2;
            color: #991b1b;
            border: 1px solid #fecaca;
            padding: 0.125rem 0.375rem;
            border-radius: 0.25rem;
            font-size: 0.75rem;
            font-weight: 600;
            margin-left: 0.25rem;
        }

        .isoform-badge {
            display: inline-block;
            background-color: #eff6ff;
            color: #1e40af;
            border: 1px solid #bfdbfe;
            padding: 0.125rem 0.375rem;
            border-radius: 0.25rem;
            font-size: 0.75rem;
            margin-top: 0.25rem;
        }

        .core-function-card {
            background-color: white;
            border: 1px solid var(--border-color);
            border-radius: 0.5rem;
            padding: 1.5rem;
            margin-bottom: 1rem;
        }

        .core-function-card h3 {
            font-size: 1.125rem;
            margin-bottom: 1rem;
            color: #1f2937;
        }

        .core-function-statement {
            margin-bottom: 1rem;
            padding: 0.75rem;
            background-color: var(--bg-light);
            border-left: 4px solid var(--color-accept);
            border-radius: 0.25rem;
        }

        .function-annotations {
            display: flex;
            flex-wrap: wrap;
            gap: 0.5rem;
            margin-top: 1rem;
        }

        .reference-item {
            border: 1px solid var(--border-color);
            border-radius: 0.5rem;
            padding: 1rem;
            margin-bottom: 1rem;
        }

        .reference-header {
            display: flex;
            justify-content: space-between;
            align-items: start;
            margin-bottom: 0.75rem;
        }

        .reference-id {
            font-family: monospace;
            font-weight: 600;
            color: #2563eb;
        }

        .supported-by {
            margin-top: 0.5rem;
            padding: 0.5rem;
            background-color: #f3f4f6;
            border-left: 3px solid #3b82f6;
            border-radius: 0.25rem;
            font-size: 0.875rem;
        }

        .supported-by-title {
            font-weight: 600;
            color: #4b5563;
            margin-bottom: 0.25rem;
        }

        .support-item {
            margin-bottom: 0.5rem;
        }

        .support-ref {
            font-weight: 500;
            color: #2563eb;
        }

        .support-text {
            color: #6b7280;
            font-style: italic;
            margin-left: 1rem;
        }

        a.term-link {
            color: #2563eb;
            text-decoration: none;
        }

        a.term-link:hover {
            text-decoration: underline;
        }

        .core-function-terms {
            margin-top: 1rem;
        }

        .function-term-group {
            margin-bottom: 1rem;
        }

        .function-term-label {
            font-weight: 600;
            color: #4b5563;
            margin-bottom: 0.25rem;
        }

        .reference-title {
            font-weight: 500;
            margin-bottom: 0.5rem;
        }

        .findings-list {
            margin-top: 1rem;
            padding-left: 1.5rem;
        }

        .finding-item {
            margin-bottom: 0.75rem;
        }

        .finding-statement {
            font-weight: 500;
            margin-bottom: 0.25rem;
        }

        .finding-text {
            color: var(--text-muted);
            font-size: 0.95rem;
            font-style: italic;
        }

        .proposed-term {
            border: 1px solid var(--border-color);
            border-radius: 0.5rem;
            padding: 1rem;
            margin-bottom: 1rem;
            background-color: #fef3c7;
        }

        .question-card {
            border: 1px solid var(--border-color);
            border-radius: 0.5rem;
            padding: 1rem;
            margin-bottom: 1rem;
            background-color: #dbeafe;
        }

        .experiment-card {
            border: 1px solid var(--border-color);
            border-radius: 0.5rem;
            padding: 1rem;
            margin-bottom: 1rem;
            background-color: #f3e8ff;
        }

        .isoforms-grid {
            display: grid;
            grid-template-columns: repeat(auto-fill, minmax(400px, 1fr));
            gap: 1rem;
        }

        .isoform-card {
            border: 1px solid var(--border-color);
            border-radius: 0.5rem;
            padding: 1rem;
            background-color: white;
            transition: box-shadow 0.2s;
        }

        .isoform-card:hover {
            box-shadow: 0 2px 8px rgba(0, 0, 0, 0.1);
        }

        .functional-isoform-type {
            display: inline-block;
            padding: 0.2rem 0.5rem;
            border-radius: 0.25rem;
            font-size: 0.7rem;
            font-weight: 600;
            text-transform: uppercase;
            letter-spacing: 0.03em;
        }

        .type-SPLICE_VARIANT, .type-SPLICE_CLASS {
            background-color: #dbeafe;
            color: #1e40af;
            border: 1px solid #93c5fd;
        }

        .type-CLEAVAGE_PRODUCT {
            background-color: #fef3c7;
            color: #92400e;
            border: 1px solid #fcd34d;
        }

        .type-MODIFICATION_STATE {
            background-color: #f3e8ff;
            color: #6b21a8;
            border: 1px solid #c4b5fd;
        }

        .type-CONFORMATIONAL_STATE {
            background-color: #dcfce7;
            color: #166534;
            border: 1px solid #86efac;
        }

        .functional-isoform-mappings {
            margin-top: 0.5rem;
            padding: 0.5rem;
            background-color: var(--bg-light);
            border-radius: 0.25rem;
            font-size: 0.85rem;
        }

        .functional-isoform-mappings .mapping-type {
            font-weight: 600;
            color: var(--text-muted);
            font-size: 0.75rem;
        }

        .functional-isoform-go {
            margin-top: 0.5rem;
            display: flex;
            flex-wrap: wrap;
            gap: 0.25rem;
        }

        .go-chip {
            display: inline-block;
            padding: 0.15rem 0.4rem;
            background-color: #ecfdf5;
            color: #047857;
            border: 1px solid #a7f3d0;
            border-radius: 0.25rem;
            font-size: 0.75rem;
            font-family: monospace;
        }

        .isoform-header {
            display: flex;
            justify-content: space-between;
            align-items: center;
            margin-bottom: 0.75rem;
            padding-bottom: 0.5rem;
            border-bottom: 1px solid var(--border-color);
        }

        .isoform-name {
            font-weight: 600;
            font-size: 1.1rem;
            color: #1f2937;
        }

        .isoform-id {
            font-family: monospace;
            font-size: 0.875rem;
            color: var(--text-muted);
        }

        .isoform-sequence-note {
            font-size: 0.875rem;
            color: var(--text-muted);
            margin-bottom: 0.5rem;
            padding: 0.5rem;
            background-color: var(--bg-light);
            border-radius: 0.25rem;
        }

        .isoform-description {
            font-size: 0.95rem;
            line-height: 1.5;
        }

        .collapsible {
            cursor: pointer;
            user-select: none;
        }

        .collapsible:after {
            content: ' ‚ñº';
            font-size: 0.75rem;
        }

        .collapsible.collapsed:after {
            content: ' ‚ñ∫';
        }

        .collapse-content {
            transition: max-height 0.3s ease;
            overflow: hidden;
        }

        .collapsed + .collapse-content {
            max-height: 0;
        }

        .no-data {
            color: var(--text-muted);
            font-style: italic;
            padding: 1rem;
            text-align: center;
            background-color: var(--bg-light);
            border-radius: 0.5rem;
        }

        /* Styling for markdown section summaries with voting */
        .markdown-section summary {
            padding: 0.75rem;
            background: var(--bg-light);
            border-radius: 0.5rem;
            margin-bottom: 0.5rem;
        }

        .markdown-section summary:hover {
            background: #e5e7eb;
        }

        .markdown-section summary .vote-buttons {
            margin-left: auto;
        }

        @media print {
            body {
                padding: 1rem;
            }

            .collapsible:after {
                display: none;
            }

            .collapsed + .collapse-content {
                max-height: none !important;
            }
        }

        @media (max-width: 768px) {
            body {
                padding: 1rem;
            }

            h1 {
                font-size: 2rem;
            }

            .annotations-table {
                font-size: 0.875rem;
            }

            .annotations-table th,
            .annotations-table td {
                padding: 0.5rem;
            }
        }
    </style>
</head>
<body>
    <div class="header">
        <h1>KCTD16</h1>
        <div class="gene-info">
            
            <div class="info-item">
                
                <span class="info-label">UniProt ID:</span>
                <span>
                    <a href="https://www.uniprot.org/uniprotkb/Q68DU8" target="_blank" class="term-link">
                        Q68DU8
                    </a>
                </span>
                
            </div>
            
            
            <div class="info-item">
                <span class="info-label">Organism:</span>
                <span>Homo sapiens</span>
            </div>
            
            
            <div class="info-item">
                <span class="info-label">Review Status:</span>
                <span class="status-badge status-complete">
                    COMPLETE
                </span>
            </div>
            
            
        </div>
        <div style="margin-top: 1rem; text-align: center;">
            <a id="feedback-form-link"
               href="#"
               target="_blank"
               style="display: inline-block; padding: 10px 20px; background-color: #4CAF50; color: white; text-decoration: none; border-radius: 5px; font-weight: 600;">
                üìù Provide Detailed Feedback
            </a>
            <script>
                // Construct the form URL with proper encoding
                // Extract organism code from the current page path (e.g., /genes/ARATH/APO1/ -> ARATH)
                const pathParts = window.location.pathname.split('/');
                const genesIndex = pathParts.indexOf('genes');
                let organism = '';
                if (genesIndex !== -1 && pathParts[genesIndex + 1]) {
                    organism = pathParts[genesIndex + 1].toUpperCase();
                }
                const geneSymbol = "KCTD16";
                const speciesGene = organism + ' ' + geneSymbol;
                const formBaseUrl = 'https://docs.google.com/forms/d/e/1FAIpQLSdTot9L6GVkkZYgLQT0E8ZdAJv8RiN5ZgOVkgWNcKSbYvxxzQ/viewform';
                const entryId = '1226477767'; // Correct entry ID for Species/Gene field
                const formUrl = formBaseUrl + '?entry.' + entryId + '=' + encodeURIComponent(speciesGene);
                const feedbackLink = document.getElementById('feedback-form-link');
                feedbackLink.href = formUrl;
                // Add tooltip showing the pre-filled value
                feedbackLink.title = 'Opens form with pre-filled: ' + speciesGene;
            </script>
        </div>
    </div>

    
    <div class="description-card">
        <div style="display: flex; justify-content: space-between; align-items: center;">
            <h2>Gene Description</h2>
            <span class="vote-buttons" data-g="Q68DU8" data-a="DESCRIPTION: KCTD16 is an auxiliary subunit of GABA-B receptors..." data-r="" data-act="DESCRIPTION">
                <button class="vote-btn" data-v="up" title="Agree with this description">üëç</button>
                <button class="vote-btn" data-v="down" title="Disagree with this description">üëé</button>
            </span>
        </div>
        <p>KCTD16 is an auxiliary subunit of GABA-B receptors that modulates the pharmacology and kinetics of receptor signaling. It contains an N-terminal BTB/POZ domain that forms an open pentamer and binds to the GABAB2 C-terminal tail in a 1:5 stoichiometry. Unlike KCTD12 which promotes rapid desensitization, KCTD16 generally confers sustained, non-desensitizing GABA-B receptor responses. KCTD16 is enriched in brain regions including thalamus, hippocampus, and amygdala, where it shapes postsynaptic inhibitory currents through GIRK channels. Notably, KCTD16 does not function as a Cullin3 E3 ligase adaptor, distinguishing it from other KCTD family members.</p>
    </div>
    

    

    

    
    <div class="section">
        <h2 class="section-title">Existing Annotations Review</h2>
        <table class="annotations-table">
            <thead>
                <tr>
                    <th>GO Term</th>
                    <th>Evidence</th>
                    <th>Action</th>
                    <th>Reason</th>
                </tr>
            </thead>
            <tbody>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0042734" target="_blank" class="term-link">
                                    GO:0042734
                                </a>
                            </span>
                            <span class="term-label">presynaptic membrane</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IBA</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000033
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q68DU8" data-a="GO:0042734" data-r="GO_REF:0000033" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> KCTD16 localizes to presynaptic membranes as part of GABA-B receptor complexes. Mouse brain studies show KCTD16 expression in regions with both presynaptic and postsynaptic localization (Metz et al. 2011). UniProt confirms presynaptic cell membrane localization.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> IBA annotation is well-supported. KCTD16 functions as an auxiliary subunit of GABA-B receptors which are present at presynaptic terminals where they modulate neurotransmitter release via Gbetagamma signaling to voltage-gated calcium channels. This is consistent with the established role of GABA-B receptors in presynaptic inhibition.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    file:human/KCTD16/KCTD16-deep-research-falcon.md
                                    
                                </span>
                                
                                <div class="support-text">In mouse brain KCTD16 shows high expression across thalamic nuclei and is enriched in hippocampal CA1, amygdala (lateral/basolateral nuclei) and dentate regions</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0045211" target="_blank" class="term-link">
                                    GO:0045211
                                </a>
                            </span>
                            <span class="term-label">postsynaptic membrane</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IBA</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000033
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q68DU8" data-a="GO:0045211" data-r="GO_REF:0000033" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> KCTD16 is a component of postsynaptic GABA-B receptor complexes where it modulates GIRK channel-mediated inhibitory currents. Immunolocalization studies show KCTD16 at neuronal somata and neuropil (Metz et al. 2011).
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> IBA annotation is well-supported. KCTD16 tethers to GABAB2 C-terminus and shapes Gbetagamma-GIRK signaling kinetics at postsynaptic sites. Structural studies confirm the KCTD16-GABAB2 interaction (Zuo et al. 2019, PNAS). UniProt also confirms postsynaptic cell membrane localization.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    file:human/KCTD16/KCTD16-deep-research-falcon.md
                                    
                                </span>
                                
                                <div class="support-text">By tethering to GABAB2 and shaping Gbetagamma availability and GIRK channel interactions, KCTD16 contributes to the amplitude and temporal profile of postsynaptic inhibitory currents</div>
                                
                            </div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    file:human/KCTD16/KCTD16-deep-research-falcon.md
                                    
                                </span>
                                
                                <div class="support-text">Immunolocalization shows KCTD16 at granule cell somata and neuropil in dentate gyrus and colocalization with GABAB2 in specific layers, supporting a postsynaptic role</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0043235" target="_blank" class="term-link">
                                    GO:0043235
                                </a>
                            </span>
                            <span class="term-label">receptor complex</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IBA</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000033
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-modify">
                            MODIFY
                        </span>
                        <span class="vote-buttons" data-g="Q68DU8" data-a="GO:0043235" data-r="GO_REF:0000033" data-act="MODIFY">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> KCTD16 is an integral auxiliary subunit of the GABA-B receptor complex. Multiple structural studies have demonstrated that KCTD16 pentamers bind the GABAB2 C-terminal tail.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> While GO:0043235 (receptor complex) is correct, a more specific term exists. KCTD16 specifically forms part of the G protein-coupled GABA receptor complex (GABA-B receptor). The term GO:1902712 (G protein-coupled GABA receptor complex) is the appropriate specific term for GABA-B receptors.
                        </div>
                        
                        
                        <div style="margin-top: 0.5rem;">
                            <strong>Proposed replacements:</strong>
                            
                            <span class="badge">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:1902712" target="_blank" class="term-link">
                                    G protein-coupled GABA receptor complex
                                </a>
                            </span>
                            
                        </div>
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    file:human/KCTD16/KCTD16-deep-research-falcon.md
                                    
                                </span>
                                
                                <div class="support-text">Native GBR complexes comprise principal subunits GABAB1 and GABAB2 plus auxiliary KCTDs (notably KCTD8, KCTD12/12b, KCTD16)</div>
                                
                            </div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    file:human/KCTD16/KCTD16-deep-research-falcon.md
                                    
                                </span>
                                
                                <div class="support-text">Human KCTD16 is a BTB/POZ-domain auxiliary protein that constitutively associates with the GABAB2 C-terminus in a 1:5 pentameric arrangement</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0008277" target="_blank" class="term-link">
                                    GO:0008277
                                </a>
                            </span>
                            <span class="term-label">regulation of G protein-coupled receptor signaling pathway</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IBA</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000033
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q68DU8" data-a="GO:0008277" data-r="GO_REF:0000033" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> KCTD16 modulates GABA-B receptor signaling kinetics, particularly the amplitude and temporal profile of GIRK-mediated responses. Unlike KCTD12, KCTD16 generally produces sustained, non-desensitizing responses.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> This annotation accurately captures the core biological process function of KCTD16. The protein regulates GABA-B receptor (a GPCR) signaling by modulating the kinetics and amplitude of downstream effector responses. Structural and electrophysiological studies demonstrate this regulatory function.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    file:human/KCTD16/KCTD16-deep-research-falcon.md
                                    
                                </span>
                                
                                <div class="support-text">KCTD16 modulates GBR signaling kinetics and amplitude, particularly in coupling to G protein-gated inwardly rectifying K+ channels (GIRK)</div>
                                
                            </div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    file:human/KCTD16/KCTD16-deep-research-falcon.md
                                    
                                </span>
                                
                                <div class="support-text">KCTD8 and KCTD16 generally confer primarily non-desensitizing/sustained responses</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0042734" target="_blank" class="term-link">
                                    GO:0042734
                                </a>
                            </span>
                            <span class="term-label">presynaptic membrane</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IEA</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000120
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q68DU8" data-a="GO:0042734" data-r="GO_REF:0000120" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> IEA annotation consistent with IBA and UniProt localization data for presynaptic membrane.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> This IEA annotation is consistent with the experimentally-supported IBA annotation and UniProt subcellular localization data. GABA-B receptors with KCTD16 auxiliary subunits are present at presynaptic terminals.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    UniProtKB:Q68DU8
                                    
                                </span>
                                
                                <div class="support-text">Presynaptic cell membrane</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0042802" target="_blank" class="term-link">
                                    GO:0042802
                                </a>
                            </span>
                            <span class="term-label">identical protein binding</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IEA</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000117
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q68DU8" data-a="GO:0042802" data-r="GO_REF:0000117" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> KCTD16 forms homopentamers via its BTB/POZ domain. Crystal structures confirm the pentameric assembly.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> This annotation is well-supported by structural evidence. KCTD16 forms an open pentamer through its BTB/T1 domain, as demonstrated by X-ray crystallography (PDB 6OCP, 5A15). UniProt confirms homopentamer formation.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    file:human/KCTD16/KCTD16-deep-research-falcon.md
                                    
                                </span>
                                
                                <div class="support-text">The KCTD16 BTB/T1 domain forms an open pentamer that wraps around one copy of the GABAB2 C-terminal peptide</div>
                                
                            </div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    file:human/KCTD16/KCTD16-deep-research-falcon.md
                                    
                                </span>
                                
                                <div class="support-text">The KCTD16 T1/BTB domain forms an open pentamer that binds one GABAB2 C-terminal peptide (1:5 stoichiometry; structure deposited PDB 6OCP)</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0045211" target="_blank" class="term-link">
                                    GO:0045211
                                </a>
                            </span>
                            <span class="term-label">postsynaptic membrane</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IEA</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000120
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q68DU8" data-a="GO:0045211" data-r="GO_REF:0000120" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> IEA annotation consistent with IBA and UniProt localization data for postsynaptic membrane.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> This IEA annotation is consistent with the experimentally-supported IBA annotation and UniProt subcellular localization data showing postsynaptic cell membrane localization.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    UniProtKB:Q68DU8
                                    
                                </span>
                                
                                <div class="support-text">Postsynaptic cell membrane</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0051260" target="_blank" class="term-link">
                                    GO:0051260
                                </a>
                            </span>
                            <span class="term-label">protein homooligomerization</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IEA</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000002
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q68DU8" data-a="GO:0051260" data-r="GO_REF:0000002" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> KCTD16 forms homopentamers through its BTB/POZ domain. This pentamerization is essential for its function as a GABA-B receptor auxiliary subunit.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> This annotation is strongly supported by structural evidence. Crystal structures show KCTD16 forms an open pentamer via its BTB/T1 domain (Zuo et al. 2019, Pinkas et al. 2017). The pentamerization is functionally important for receptor complex assembly.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    file:human/KCTD16/KCTD16-deep-research-falcon.md
                                    
                                </span>
                                
                                <div class="support-text">The KCTD16 T1/BTB domain forms an open pentamer that binds one GABAB2 C-terminal peptide (1:5 stoichiometry; structure deposited PDB 6OCP)</div>
                                
                            </div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    file:human/KCTD16/KCTD16-deep-research-falcon.md
                                    
                                </span>
                                
                                <div class="support-text">the T1/BTB mediates pentamer formation</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005515" target="_blank" class="term-link">
                                    GO:0005515
                                </a>
                            </span>
                            <span class="term-label">protein binding</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IPI</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/26960425" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:26960425
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    Yeast Two-Hybrid Screening for Proteins that Interact with t...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-remove">
                            REMOVE
                        </span>
                        <span class="vote-buttons" data-g="Q68DU8" data-a="GO:0005515" data-r="PMID:26960425" data-act="REMOVE">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> This annotation derives from a yeast two-hybrid study that identified KCTD16 as an interactor of APP (amyloid precursor protein) extracellular domain. The interaction was confirmed in mammalian cells.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> GO:0005515 (protein binding) is an uninformative annotation that should be avoided. The referenced study (Yu et al. 2016) is a high-throughput yeast two-hybrid screen for APP interactors. While the interaction was confirmed, there is no clear physiological relevance established for a KCTD16-APP interaction, and this does not represent the core function of KCTD16. More informative molecular function terms should be used instead, such as the GABA-B receptor binding function.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/26960425" target="_blank" class="term-link">
                                        PMID:26960425
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">After confirming the interactions in the mammalian system, mutated PLP1, members of the FLRT protein family, and KCTD16 were shown to interact with APP</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0043235" target="_blank" class="term-link">
                                    GO:0043235
                                </a>
                            </span>
                            <span class="term-label">receptor complex</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IEA</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000107
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-modify">
                            MODIFY
                        </span>
                        <span class="vote-buttons" data-g="Q68DU8" data-a="GO:0043235" data-r="GO_REF:0000107" data-act="MODIFY">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> IEA annotation for receptor complex membership, consistent with KCTD16 role as GABA-B receptor auxiliary subunit.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> While correct that KCTD16 is part of a receptor complex, the more specific term GO:1902712 (G protein-coupled GABA receptor complex) should be used since KCTD16 specifically associates with GABA-B receptors.
                        </div>
                        
                        
                        <div style="margin-top: 0.5rem;">
                            <strong>Proposed replacements:</strong>
                            
                            <span class="badge">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:1902712" target="_blank" class="term-link">
                                    G protein-coupled GABA receptor complex
                                </a>
                            </span>
                            
                        </div>
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    file:human/KCTD16/KCTD16-deep-research-falcon.md
                                    
                                </span>
                                
                                <div class="support-text">Functions as an auxiliary subunit of neuronal GABAB receptors</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0031795" target="_blank" class="term-link">
                                    GO:0031795
                                </a>
                            </span>
                            <span class="term-label">G protein-coupled GABA receptor binding</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IDA</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            file:human/KCTD16/KCTD16-deep-research-falcon.md
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-new">
                            NEW
                        </span>
                        <span class="vote-buttons" data-g="Q68DU8" data-a="GO:0031795" data-r="file:human/KCTD16/KCTD16-deep-research-falcon.md" data-act="NEW">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> KCTD16 directly binds to the GABAB2 subunit of the G protein-coupled GABA-B receptor via its BTB/T1 domain. Structural studies have mapped the binding interface.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> This molecular function annotation captures the core activity of KCTD16 as a GABA-B receptor auxiliary subunit. The BTB/T1 domain of KCTD16 directly binds the C-terminal tail of GABAB2 with characterized interfacial residues (Q34, F80, P101, E102 on KCTD16; I898, Y903, L904 on GABAB2).
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    file:human/KCTD16/KCTD16-deep-research-falcon.md
                                    
                                </span>
                                
                                <div class="support-text">The KCTD16 BTB/T1 domain forms an open pentamer that wraps around one copy of the GABAB2 C-terminal peptide, establishing a 1:5 GB2 peptide:KCTD16 stoichiometry. Key interfacial residues include KCTD16 Q34, F80, P101, E102 and GABAB2 I898, Y903, L904</div>
                                
                            </div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    file:human/KCTD16/KCTD16-deep-research-falcon.md
                                    
                                </span>
                                
                                <div class="support-text">KCTD family H1 domains can oligomerize to bind multiple Gbetagamma heterodimers cooperatively in a 5:5 complex</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0031683" target="_blank" class="term-link">
                                    GO:0031683
                                </a>
                            </span>
                            <span class="term-label">G-protein beta/gamma-subunit complex binding</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">ISS</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            file:human/KCTD16/KCTD16-deep-research-falcon.md
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-new">
                            NEW
                        </span>
                        <span class="vote-buttons" data-g="Q68DU8" data-a="GO:0031683" data-r="file:human/KCTD16/KCTD16-deep-research-falcon.md" data-act="NEW">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> KCTD16 H1 domain binds Gbetagamma subunits, analogous to KCTD12. This interaction shapes GABA-B receptor signaling kinetics.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> KCTD16, like other GABA-B associated KCTDs, possesses an H1 domain that engages Gbetagamma subunits. While the detailed kinetic effects differ from KCTD12 (which causes desensitization), the structural architecture for Gbetagamma binding is conserved. This is a key molecular function enabling KCTD16 to modulate GPCR signaling.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    file:human/KCTD16/KCTD16-deep-research-falcon.md
                                    
                                </span>
                                
                                <div class="support-text">KCTD family H1 domains can oligomerize to bind multiple Gbetagamma heterodimers cooperatively in a 5:5 complex, enabling rapid desensitization of GBR-GIRK signaling by stripping Gbetagamma from GIRK after initial activation</div>
                                
                            </div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    file:human/KCTD16/KCTD16-deep-research-falcon.md
                                    
                                </span>
                                
                                <div class="support-text">KCTD8/16 possess additional C-terminal features (including H2) that oppose desensitization</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0099602" target="_blank" class="term-link">
                                    GO:0099602
                                </a>
                            </span>
                            <span class="term-label">neurotransmitter receptor regulator activity</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">ISS</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            file:human/KCTD16/KCTD16-deep-research-falcon.md
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-new">
                            NEW
                        </span>
                        <span class="vote-buttons" data-g="Q68DU8" data-a="GO:0099602" data-r="file:human/KCTD16/KCTD16-deep-research-falcon.md" data-act="NEW">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> KCTD16 functions as a neurotransmitter receptor regulator by modulating GABA-B receptor activity, kinetics, and desensitization properties.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> This molecular function term accurately describes KCTD16 function. It directly modulates GABA-B receptor activity by binding to GABAB2 and influencing the kinetics of downstream GIRK channel responses. UniProt states it increases agonist potency and alters G-protein signaling kinetics.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    file:human/KCTD16/KCTD16-deep-research-falcon.md
                                    
                                </span>
                                
                                <div class="support-text">Functions as an auxiliary subunit of neuronal GABAB receptors, modulating receptor expression and the amplitude/kinetics of GIRK-mediated K+ currents</div>
                                
                            </div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    file:human/KCTD16/KCTD16-deep-research-falcon.md
                                    
                                </span>
                                
                                <div class="support-text">KCTD16 modulates GBR signaling kinetics and amplitude, particularly in coupling to G protein-gated inwardly rectifying K+ channels (GIRK)</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
            </tbody>
        </table>
    </div>
    

    
    <div class="section">
        <h2 class="section-title">Core Functions</h2>
        
        <div class="core-function-card">
            
            <div style="display: flex; justify-content: space-between; align-items: center;">
                <h3>KCTD16 directly binds to the GABAB2 subunit C-terminal tail through its BTB/T1 domain, forming a 1:5 stoichiometric complex that is essential for GABA-B receptor function and signaling modulation</h3>
                <span class="vote-buttons" data-g="Q68DU8" data-a="FUNCTION: KCTD16 directly binds to the GABAB2 subunit C-term..." data-r="" data-act="CORE_FUNCTION">
                    <button class="vote-btn" data-v="up" title="Agree with this core function">üëç</button>
                    <button class="vote-btn" data-v="down" title="Disagree with this core function">üëé</button>
                </span>
            </div>
            

            <div class="core-function-terms">
                
                <div class="function-term-group">
                    <div class="function-term-label">Molecular Function:</div>
                    <span class="badge">
                        <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0031795" target="_blank" class="term-link">
                            G protein-coupled GABA receptor binding
                        </a>
                    </span>
                </div>
                

                

                

                

                
            </div>

            
            <div style="margin-top: 1rem; padding-top: 1rem; border-top: 1px solid var(--border-color);">
                <strong>Supporting Evidence:</strong>
                <ul class="findings-list">
                    
                    <li class="finding-item">
                        <span class="reference-id">
                            
                            file:human/KCTD16/KCTD16-deep-research-falcon.md
                            
                        </span>
                        
                        <div class="finding-text">The KCTD16 BTB/T1 domain forms an open pentamer that wraps around one copy of the GABAB2 C-terminal peptide</div>
                        
                    </li>
                    
                </ul>
            </div>
            
        </div>
        
        <div class="core-function-card">
            
            <div style="display: flex; justify-content: space-between; align-items: center;">
                <h3>KCTD16 forms homopentamers via its BTB/POZ domain, a structural prerequisite for GABA-B receptor complex assembly</h3>
                <span class="vote-buttons" data-g="Q68DU8" data-a="FUNCTION: KCTD16 forms homopentamers via its BTB/POZ domain,..." data-r="" data-act="CORE_FUNCTION">
                    <button class="vote-btn" data-v="up" title="Agree with this core function">üëç</button>
                    <button class="vote-btn" data-v="down" title="Disagree with this core function">üëé</button>
                </span>
            </div>
            

            <div class="core-function-terms">
                
                <div class="function-term-group">
                    <div class="function-term-label">Molecular Function:</div>
                    <span class="badge">
                        <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0042802" target="_blank" class="term-link">
                            identical protein binding
                        </a>
                    </span>
                </div>
                

                

                

                

                
            </div>

            
            <div style="margin-top: 1rem; padding-top: 1rem; border-top: 1px solid var(--border-color);">
                <strong>Supporting Evidence:</strong>
                <ul class="findings-list">
                    
                    <li class="finding-item">
                        <span class="reference-id">
                            
                            file:human/KCTD16/KCTD16-deep-research-falcon.md
                            
                        </span>
                        
                        <div class="finding-text">The KCTD16 T1/BTB domain forms an open pentamer that binds one GABAB2 C-terminal peptide (1:5 stoichiometry; structure deposited PDB 6OCP)</div>
                        
                    </li>
                    
                </ul>
            </div>
            
        </div>
        
        <div class="core-function-card">
            
            <div style="display: flex; justify-content: space-between; align-items: center;">
                <h3>KCTD16 modulates GABA-B receptor pharmacology and signaling kinetics, conferring sustained non-desensitizing responses unlike KCTD12</h3>
                <span class="vote-buttons" data-g="Q68DU8" data-a="FUNCTION: KCTD16 modulates GABA-B receptor pharmacology and ..." data-r="" data-act="CORE_FUNCTION">
                    <button class="vote-btn" data-v="up" title="Agree with this core function">üëç</button>
                    <button class="vote-btn" data-v="down" title="Disagree with this core function">üëé</button>
                </span>
            </div>
            

            <div class="core-function-terms">
                
                <div class="function-term-group">
                    <div class="function-term-label">Molecular Function:</div>
                    <span class="badge">
                        <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0099602" target="_blank" class="term-link">
                            neurotransmitter receptor regulator activity
                        </a>
                    </span>
                </div>
                

                

                

                

                
            </div>

            
            <div style="margin-top: 1rem; padding-top: 1rem; border-top: 1px solid var(--border-color);">
                <strong>Supporting Evidence:</strong>
                <ul class="findings-list">
                    
                    <li class="finding-item">
                        <span class="reference-id">
                            
                            file:human/KCTD16/KCTD16-deep-research-falcon.md
                            
                        </span>
                        
                        <div class="finding-text">KCTD8 and KCTD16 generally confer primarily non-desensitizing/sustained responses</div>
                        
                    </li>
                    
                </ul>
            </div>
            
        </div>
        
    </div>
    

    
    <div class="section">
        <h2 class="section-title collapsible">References</h2>
        <div class="collapse-content">
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://github.com/geneontology/go-site/blob/master/metadata/gorefs/goref-0000002.md" target="_blank" class="term-link">
                            GO_REF:0000002
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">Gene Ontology annotation through association of InterPro records with GO terms</div>
                
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://github.com/geneontology/go-site/blob/master/metadata/gorefs/goref-0000033.md" target="_blank" class="term-link">
                            GO_REF:0000033
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">Annotation inferences using phylogenetic trees</div>
                
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://github.com/geneontology/go-site/blob/master/metadata/gorefs/goref-0000107.md" target="_blank" class="term-link">
                            GO_REF:0000107
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">Automatic transfer of experimentally verified manual GO annotation data to orthologs using Ensembl Compara</div>
                
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://github.com/geneontology/go-site/blob/master/metadata/gorefs/goref-0000117.md" target="_blank" class="term-link">
                            GO_REF:0000117
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">Electronic Gene Ontology annotations created by ARBA machine learning models</div>
                
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://github.com/geneontology/go-site/blob/master/metadata/gorefs/goref-0000120.md" target="_blank" class="term-link">
                            GO_REF:0000120
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">Combined Automated Annotation using Multiple IEA Methods</div>
                
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://pubmed.ncbi.nlm.nih.gov/26960425" target="_blank" class="term-link">
                            PMID:26960425
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">Yeast Two-Hybrid Screening for Proteins that Interact with the Extracellular Domain of Amyloid Precursor Protein</div>
                
                
                <ul class="findings-list">
                    
                    <li class="finding-item">
                        <div class="finding-statement">KCTD16 identified as APP interactor via yeast two-hybrid screen and confirmed in mammalian cells</div>
                        
                        <div class="finding-text">"After confirming the interactions in the mammalian system, mutated PLP1, members of the FLRT protein family, and KCTD16 were shown to interact with APP"</div>
                        
                    </li>
                    
                </ul>
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        file:human/KCTD16/KCTD16-deep-research-falcon.md
                        
                    </span>
                </div>
                
                <div class="reference-title">Deep research on KCTD16 function</div>
                
                
                <ul class="findings-list">
                    
                    <li class="finding-item">
                        <div class="finding-statement">KCTD16 is a BTB/POZ-domain auxiliary protein of GABA-B receptors forming pentameric complexes with GABAB2</div>
                        
                        <div class="finding-text">"Human KCTD16 is a BTB/POZ-domain auxiliary protein that constitutively associates with the GABAB2 C-terminus in a 1:5 pentameric arrangement"</div>
                        
                    </li>
                    
                    <li class="finding-item">
                        <div class="finding-statement">KCTD16 modulates GABA-B receptor signaling kinetics conferring sustained non-desensitizing responses</div>
                        
                        <div class="finding-text">"KCTD8 and KCTD16 generally confer primarily non-desensitizing/sustained responses"</div>
                        
                    </li>
                    
                    <li class="finding-item">
                        <div class="finding-statement">KCTD16 does not function as a Cullin3 E3 ligase adaptor</div>
                        
                        <div class="finding-text">"KCTD subcluster harboring GABAB-binding proteins (including KCTD16) shows no structural propensity for Cul3 binding via BTB"</div>
                        
                    </li>
                    
                </ul>
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        file:human/KCTD16/KCTD16-deep-research-cyberian.md
                        
                    </span>
                </div>
                
                <div class="reference-title">Cyberian deep research on KCTD16 function</div>
                
                
            </div>
            
        </div>
    </div>
    


    

    

    

    <!-- Additional Documentation Sections -->
    
    <div class="section">
        <h2 class="section-title">üìö Additional Documentation</h2>
        
        <details class="markdown-section">
            <summary style="display: flex; justify-content: space-between; align-items: center; cursor: pointer;">
                <div style="flex: 1;">
                    <h3 style="display: inline;">Deep Research Cyberian</h3>
                    <span style="font-size: 0.8rem; color: #666; margin-left: 1rem;">(KCTD16-deep-research-cyberian.md)</span>
                </div>
                <div class="vote-buttons" data-g="Q68DU8" data-a="DOC: Deep Research Cyberian" data-r="" data-act="DOCUMENTATION" style="display: flex; gap: 0.25rem;">
                    <button class="vote-btn" data-v="up" title="This documentation is helpful">üëç</button>
                    <button class="vote-btn" data-v="down" title="This documentation needs improvement">üëé</button>
                </div>
            </summary>
            <div class="markdown-content">
                <hr />
<p>provider: cyberian<br />
model: deep-research<br />
cached: false<br />
start_time: '2026-01-22T20:01:21.405224'<br />
end_time: '2026-01-22T20:20:57.876455'<br />
duration_seconds: 1176.47<br />
template_file: templates/gene_research_go_focused.md<br />
template_variables:<br />
  organism: human<br />
  gene_id: KCTD16<br />
  gene_symbol: KCTD16<br />
  uniprot_accession: Q68DU8<br />
  protein_description: 'RecName: Full=BTB/POZ domain-containing protein KCTD16; AltName:<br />
    Full=Potassium channel tetramerization domain-containing protein 16;'<br />
  gene_info: Name=KCTD16; Synonyms=KIAA1317;<br />
  organism_full: Homo sapiens (Human).<br />
  protein_family: Not specified in UniProt<br />
  protein_domains: BTB/POZ_dom. (IPR000210); H1_KCTD16. (IPR049903); SKP1/BTB/POZ_sf.<br />
    (IPR011333); T1-type_BTB. (IPR003131); BTB_2 (PF02214)<br />
provider_config:<br />
  timeout: 1800<br />
  max_retries: 3<br />
  parameters:<br />
    allowed_domains: []<br />
    agent_type: claude<br />
    port: 3284<br />
    skip_permissions: true<br />
citation_count: 17</p>
<hr />
<h2 id="question">Question</h2>
<h1 id="gene-research-for-functional-annotation">Gene Research for Functional Annotation</h1>
<h2 id="critical-geneprotein-identification-context">‚ö†Ô∏è CRITICAL: Gene/Protein Identification Context</h2>
<p><strong>BEFORE YOU BEGIN RESEARCH:</strong> You MUST verify you are researching the CORRECT gene/protein. Gene symbols can be ambiguous, especially for less well-characterized genes from non-model organisms.</p>
<h3 id="target-geneprotein-identity-from-uniprot">Target Gene/Protein Identity (from UniProt):</h3>
<ul>
<li><strong>UniProt Accession:</strong> Q68DU8</li>
<li><strong>Protein Description:</strong> RecName: Full=BTB/POZ domain-containing protein KCTD16; AltName: Full=Potassium channel tetramerization domain-containing protein 16;</li>
<li><strong>Gene Information:</strong> Name=KCTD16; Synonyms=KIAA1317;</li>
<li><strong>Organism (full):</strong> Homo sapiens (Human).</li>
<li><strong>Protein Family:</strong> Not specified in UniProt</li>
<li><strong>Key Domains:</strong> BTB/POZ_dom. (IPR000210); H1_KCTD16. (IPR049903); SKP1/BTB/POZ_sf. (IPR011333); T1-type_BTB. (IPR003131); BTB_2 (PF02214)</li>
</ul>
<h3 id="mandatory-verification-steps">MANDATORY VERIFICATION STEPS:</h3>
<ol>
<li><strong>Check if the gene symbol "KCTD16" matches the protein description above</strong></li>
<li><strong>Verify the organism is correct:</strong> Homo sapiens (Human).</li>
<li><strong>Check if protein family/domains align with what you find in literature</strong></li>
<li><strong>If you find literature for a DIFFERENT gene with the same or similar symbol, STOP</strong></li>
</ol>
<h3 id="if-gene-symbol-is-ambiguous-or-you-cannot-find-relevant-literature">If Gene Symbol is Ambiguous or You Cannot Find Relevant Literature:</h3>
<p><strong>DO NOT PROCEED WITH RESEARCH ON A DIFFERENT GENE.</strong> Instead:<br />
- State clearly: "The gene symbol 'KCTD16' is ambiguous or literature is limited for this specific protein"<br />
- Explain what you found (e.g., "Found extensive literature on a different gene with the same symbol in a different organism")<br />
- Describe the protein based ONLY on the UniProt information provided above<br />
- Suggest that the protein function can be inferred from domain/family information</p>
<h3 id="research-target">Research Target:</h3>
<p>Please provide a comprehensive research report on the gene <strong>KCTD16</strong> (gene ID: KCTD16, UniProt: Q68DU8) in human.</p>
<p>The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.</p>
<p>You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement<br />
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.</p>
<p>We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.</p>
<p>We are interested in where in or outside the cell the gene product carries out its function.</p>
<p>We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.</p>
<p>Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.</p>
<h2 id="output">Output</h2>
<h1 id="kctd16-an-auxiliary-subunit-of-gaba_b-receptors">KCTD16: An Auxiliary Subunit of GABA_B Receptors</h1>
<h2 id="introduction">Introduction</h2>
<p>KCTD16 (potassium channel tetramerization domain-containing protein 16; UniProt Q68DU8) is a BTB/POZ domain-containing protein that functions as an auxiliary subunit of metabotropic GABA_B receptors in the mammalian nervous system. The protein was initially identified through its sequence homology to the tetramerization domain of voltage-gated potassium channels, though KCTD16 itself does not form ion channels[schwenk-2010-gabab-kctd-discovery-abstract]. Rather, KCTD16 serves as a critical modulator of inhibitory neurotransmission by determining the pharmacology and kinetics of GABA_B receptor-mediated G-protein signaling[schwenk-2010-gabab-kctd-discovery-abstract]. The protein is highly expressed in brain regions including the cerebral cortex, hippocampus, and amygdala, where it plays essential roles in shaping the temporal dynamics of GABAergic inhibition.</p>
<p>The discovery of KCTD proteins as GABA_B receptor auxiliary subunits in 2010 fundamentally transformed understanding of this receptor system[schwenk-2010-gabab-kctd-discovery-abstract]. Prior to this work, GABA_B receptors were believed to function as simple heterodimers of GABA_B1 and GABA_B2 subunits. Proteomic analysis revealed that native receptors are actually high-molecular-weight complexes containing the principal subunits plus auxiliary KCTD proteins, explaining functional diversity that could not be reproduced with cloned receptors alone[schwenk-2010-gabab-kctd-discovery-abstract]. KCTD16, along with the related proteins KCTD8, KCTD12, and KCTD12b, defines molecularly and functionally distinct GABA_B receptor subtypes throughout the brain.</p>
<h2 id="protein-structure-and-domain-architecture">Protein Structure and Domain Architecture</h2>
<p>KCTD16 belongs to clade F of the KCTD protein family and contains three major structural domains: a conserved N-terminal T1/BTB domain, an H1 homology domain, and a C-terminal H2 domain[liu-2013-kctd-family-review-abstract][seddik-2012-h1h2-domains-abstract]. The T1/BTB domain mediates oligomerization and receptor binding, while the H1 and H2 domains regulate desensitization kinetics. Among the GABA_B receptor-associated KCTDs, only KCTD8 and KCTD16 possess both H1 and H2 domains; KCTD12 and KCTD12b lack the H2 domain entirely[seddik-2012-h1h2-domains-abstract].</p>
<p>Crystallographic studies have determined the high-resolution structure of human KCTD16's T1 domain at 2.3 √Öngstr√∂m resolution, revealing that it forms an open pentameric ring structure with an inner diameter of approximately 25 √Öngstr√∂ms[zuo-2019-kctd16-structure-abstract]. This open pentamer architecture is stabilized by extensive salt bridges at subunit interfaces, particularly involving charged residues along an alpha-3 helix. The pentameric structure of KCTD16 contrasts with the tetrameric organization of the homologous T1 domains in voltage-gated potassium channels, though both share the same fold[liu-2013-kctd-family-review-abstract]. Notably, unlike many other BTB domain-containing proteins, KCTD16 does not interact with the Cullin3 ubiquitin ligase, indicating that its function is specialized for receptor modulation rather than protein degradation[zuo-2019-kctd16-structure-abstract].</p>
<p>The binding interface between KCTD16 and the GABA_B2 receptor has been mapped in atomic detail. A single GABA_B2 C-terminal peptide binds to the interior of the open pentamer formed by five KCTD16 subunits, establishing a 1:5 stoichiometry[zuo-2019-kctd16-structure-abstract]. The phenylalanine residue at position 80 (F80) from each of the first four KCTD16 subunits creates hydrophobic grooves that accommodate the receptor peptide through hydrogen bonding, aromatic stacking, and hydrophobic contacts[zuo-2019-kctd16-structure-abstract]. Mutagenesis studies confirmed the functional importance of this interface: the F80A mutation in KCTD16 and corresponding Y903S/L904D mutations in GABA_B2 significantly reduced both coimmunoprecipitation efficiency and the ability of KCTD16 to modulate GIRK channel activation kinetics[zuo-2019-kctd16-structure-abstract].</p>
<h2 id="molecular-function-modulation-of-gaba_b-receptor-signaling">Molecular Function: Modulation of GABA_B Receptor Signaling</h2>
<p>The primary molecular function of KCTD16 is to modulate GABA_B receptor-mediated G-protein signaling and the subsequent activation of effector ion channels[schwenk-2010-gabab-kctd-discovery-abstract]. GABA_B receptors are metabotropic receptors for gamma-aminobutyric acid (GABA), the principal inhibitory neurotransmitter in the brain. Upon agonist binding, these receptors activate heterotrimeric G-proteins (primarily G_i/o), leading to release of GŒ≤Œ≥ subunits that directly gate G-protein-coupled inwardly rectifying potassium (GIRK) channels to produce slow inhibitory postsynaptic currents (IPSCs)[turecek-2014-gprotein-uncoupling-abstract].</p>
<p>KCTD16 increases agonist potency at GABA_B receptors and accelerates the onset of GIRK channel activation[schwenk-2010-gabab-kctd-discovery-abstract]. The mechanism involves the KCTD16 T1 domain recognizing the GABA_B2 C-terminus to tether the H1 domain near the receptor's distal tail, positioning it for interaction with released GŒ≤Œ≥ subunits[zheng-2019-desensitization-nature-abstract]. Structural and biochemical studies have demonstrated that the H1 domain engages in a symmetric interaction with five copies of GŒ≤Œ≥, with the G-protein subunits also interacting directly with one another[zheng-2019-desensitization-nature-abstract]. This cooperative binding allows KCTD proteins to efficiently regulate the availability of GŒ≤Œ≥ for effector channel activation.</p>
<p>Beyond its role in G-protein modulation, KCTD16 performs critical scaffolding functions by anchoring multiple effector channels to GABA_B receptors. Recent research has demonstrated that KCTD16 associates GABA_B receptors with HCN channels containing HCN2 and HCN3 subunits, forming a multiprotein signaling complex[perezgarci-2025-hcn-anxiety-abstract]. This interaction has profound functional consequences: during inhibitory postsynaptic potentials (IPSPs), the hyperpolarization produced by GABA_B receptor-activated potassium currents simultaneously activates the tethered HCN channels, generating an inward hyperpolarization-activated current (I_h) that counteracts and limits the duration of the IPSP[perezgarci-2025-hcn-anxiety-abstract]. This negative feedback mechanism, mediated specifically by KCTD16, provides rapid desensitization of inhibitory responses through a mechanism distinct from the GŒ≤Œ≥ sequestration employed by KCTD12[perezgarci-2025-hcn-anxiety-abstract].</p>
<p>In addition to HCN channels, KCTD16 acts as a scaffold protein that links GABA_B receptors to voltage-gated N-type calcium channels (Cav2.2)[trovo-2024-synaptotagmin11-abstract]. A 2024 study revealed that synaptotagmin-11 (Syt11), a vesicular protein, binds simultaneously to both KCTD16 and Cav2.2 channels, facilitating the assembly of GABA_B receptor/Cav2.2 signaling complexes in post-Golgi transport vesicles[trovo-2024-synaptotagmin11-abstract]. This mechanism ensures that pre-assembled receptor-channel signaling complexes are transported together to their functional sites at synapses. Syt11 also stabilizes GABA_B receptors and Cav2.2 channels at the neuronal plasma membrane by inhibiting constitutive internalization[trovo-2024-synaptotagmin11-abstract]. Neurons lacking Syt11 exhibit reduced presynaptic Cav2.2 channels and GABA_B receptors, diminished neurotransmitter release, and weakened GABA_B receptor-mediated inhibition of release[trovo-2024-synaptotagmin11-abstract]. These findings reveal that KCTD16 serves as a central hub for organizing presynaptic signaling machinery, coordinating the spatial coupling of GABA_B receptors with their primary effector channels for synaptic modulation.</p>
<p>A distinguishing feature of KCTD16, compared to KCTD12 and KCTD12b, is that it generates primarily non-desensitizing receptor responses[seddik-2012-h1h2-domains-abstract]. While KCTD12 promotes rapid desensitization of GABA_B receptor-induced GIRK currents by sequestering GŒ≤Œ≥ subunits away from effector channels, KCTD16 produces sustained, slowly deactivating responses[turecek-2014-gprotein-uncoupling-abstract][fritzius-2017-heterooligomers-abstract]. This functional difference is attributable to the presence of the H2 domain in KCTD16, which inhibits the desensitization-promoting activity of the H1 domain through a steric mechanism[seddik-2012-h1h2-domains-abstract].</p>
<p>The molecular basis for the opposing effects of H1 and H2 domains has been characterized through domain-swapping experiments[seddik-2012-h1h2-domains-abstract]. The H1 domains of KCTD12 and KCTD12b contain a critical T/NFLEQ sequence motif that mediates desensitization; this motif is not present in the H1 domains of KCTD8 or KCTD16[seddik-2012-h1h2-domains-abstract]. When the H2 domain of KCTD16 is attached to the C-terminus of KCTD12, the resulting chimera loses desensitizing properties, demonstrating the dominant inhibitory effect of H2[seddik-2012-h1h2-domains-abstract]. However, removal of the H2 domain from KCTD16 does not convert it into a desensitizing protein, indicating that the KCTD16 H1 domain itself lacks the capacity to promote desensitization[seddik-2012-h1h2-domains-abstract]. Evolutionary analysis suggests that KCTD12 and KCTD12b acquired desensitizing properties by disposing of their inhibitory H2 domains while selecting for the T/NFLEQ motif in their H1 domains[seddik-2012-h1h2-domains-abstract].</p>
<h2 id="hetero-oligomerization-and-functional-diversity">Hetero-oligomerization and Functional Diversity</h2>
<p>While KCTD proteins were initially assumed to function as homo-oligomers, subsequent research demonstrated that they can also assemble into hetero-oligomers in all possible dual combinations[fritzius-2017-heterooligomers-abstract]. This finding significantly expands the molecular and functional repertoire of native GABA_B receptors. Coimmunoprecipitation experiments using adult mouse brain tissue revealed that approximately two-thirds of KCTD16 in the hippocampus associates with KCTD12, forming KCTD12/KCTD16 hetero-oligomers[fritzius-2017-heterooligomers-abstract]. These hetero-oligomers form at least tetramers and directly interact with both the receptor and associated G-proteins through their self-associating T1 and H1 domains[fritzius-2017-heterooligomers-abstract].</p>
<p>KCTD12/KCTD16 hetero-oligomers confer unique kinetic properties to GABA_B receptor-induced potassium currents that differ from either homo-oligomer[fritzius-2017-heterooligomers-abstract]. During prolonged receptor activation (approximately one minute), KCTD12/KCTD16 hetero-oligomers produce moderately desensitizing, fast-deactivating currents. In contrast, KCTD12 homo-oligomers generate strongly desensitizing, fast-deactivating currents, while KCTD16 homo-oligomers produce non-desensitizing, slowly deactivating currents[fritzius-2017-heterooligomers-abstract]. During brief activation periods (approximately two seconds), hetero-oligomers produce non-desensitizing, slowly deactivating responses similar to KCTD16 homo-oligomers[fritzius-2017-heterooligomers-abstract].</p>
<p>The physiological significance of hetero-oligomer formation was demonstrated through electrophysiological recordings in hippocampal neurons from knockout mice[fritzius-2017-heterooligomers-abstract]. These experiments indicated that KCTD12/KCTD16 hetero-oligomers increase the duration of slow IPSCs in pyramidal cells, providing a molecular mechanism for fine-tuning the temporal properties of GABAergic inhibition in hippocampal circuits[fritzius-2017-heterooligomers-abstract].</p>
<h2 id="subcellular-localization-and-tissue-expression">Subcellular Localization and Tissue Expression</h2>
<p>KCTD16 exhibits a primarily cytoplasmic localization with enrichment in the central nervous system[vancoevorden-2019-encephalitis-abstract]. The protein associates with GABA_B receptors at the plasma membrane through its interaction with the GABA_B2 C-terminus; an F80A mutation abolishes this GABA_B-mediated membrane localization in cultured cells[zuo-2019-kctd16-structure-abstract]. Additional subcellular localization studies have detected KCTD16 at the centrosome and in vesicular structures, though the functional significance of these non-membrane locations remains to be determined.</p>
<p>Expression profiling data from the Human Protein Atlas indicates that KCTD16 is most highly expressed in the cerebral cortex (7.1 nTPM), with substantial expression also in the hippocampal formation (2.8 nTPM) and amygdala (2.2 nTPM). Outside the brain, enhanced expression is detected in the retina (1.8 nTPM) and pancreas (1.4 nTPM), while most other tissues show minimal expression. At the single-cell level, KCTD16 is most abundant in brain excitatory neurons (645.1 nCPM), brain inhibitory neurons (589.1 nCPM), oligodendrocyte progenitor cells (491.9 nCPM), and adrenal medulla cells (436.1 nCPM), consistent with its role in regulating inhibitory neurotransmission in neural circuits.</p>
<h2 id="biological-processes-and-physiological-functions">Biological Processes and Physiological Functions</h2>
<p>KCTD16 functions within the broader context of GABA_B receptor-mediated inhibitory neurotransmission, which controls neuronal excitability through regulation of potassium and calcium channels[schwenk-2010-gabab-kctd-discovery-abstract]. The protein influences the duration and kinetics of slow IPSCs, thereby shaping the temporal dynamics of synaptic inhibition in neural circuits[fritzius-2017-heterooligomers-abstract]. Through its non-desensitizing properties, KCTD16-containing GABA_B receptors are suited for sustained inhibitory responses that may be important during prolonged or repeated GABAergic input.</p>
<p>Behavioral studies in KCTD16 knockout mice have revealed specific roles in fear memory processing[cathomas-2017-knockout-behavior-abstract]. While initial fear conditioning is normal in these animals, KCTD16 knockout mice display reduced extinction of auditory fear memory and enhanced contextual fear retention compared to wild-type littermates[cathomas-2017-knockout-behavior-abstract]. Circadian activity patterns remain unaffected. These findings suggest that KCTD16 influences fear-related behaviors that may serve as endophenotypes for hyper-reactivity to aversive stimuli, with potential relevance to anxiety disorders and post-traumatic stress disorder[cathomas-2017-knockout-behavior-abstract].</p>
<p>A particularly important physiological role for KCTD16 has been identified in dopamine neurons of the ventral tegmental area (VTA)[perezgarci-2025-hcn-anxiety-abstract]. Aversive stimuli inhibit these DA_VTA neurons, and this inhibition is prolonged by GABA_B receptor-activated potassium currents. The KCTD16-mediated tethering of HCN channels to GABA_B receptors provides a negative feedback mechanism that limits the duration of this inhibition[perezgarci-2025-hcn-anxiety-abstract]. When KCTD16 is genetically ablated, either globally or specifically in DA_VTA neurons using CRISPR/Cas9, the result is prolonged optogenetic inhibition of DA_VTA neuron firing and increased anxiety-like behavior in response to stress[perezgarci-2025-hcn-anxiety-abstract]. This phenotype can be replicated by intra-VTA infusion of HCN antagonists in wild-type mice, confirming that the HCN channel anchoring function of KCTD16 is mechanistically responsible for the behavioral effect[perezgarci-2025-hcn-anxiety-abstract]. These findings establish that the GABA_B receptor/HCN channel complex organized by KCTD16 serves as a protective mechanism against anxiety development by restricting IPSP duration in the VTA reward circuitry.</p>
<p>The formation of KCTD12/KCTD16 hetero-oligomers in the hippocampus has implications for learning and memory circuits. By prolonging the duration of slow IPSCs in pyramidal cells, these hetero-oligomers may influence the temporal integration of inhibitory inputs and the balance between excitation and inhibition that underlies hippocampal function[fritzius-2017-heterooligomers-abstract]. GWAS studies have linked KCTD proteins more broadly to various neuropsychiatric conditions including autism spectrum disorder, bipolar disorder, major depression, and substance use disorders, though specific associations for KCTD16 require further investigation.</p>
<p>Notably, KCTD16 exhibits brain region-specific expression and function. While abundant in the cortex, hippocampus, and VTA, KCTD16 mRNA levels are very low in the medial habenula according to the Allen Brain Atlas[ren-2022-habenula-axonal-abstract]. In habenula cholinergic neurons, the related proteins KCTD8 and KCTD12, rather than KCTD16, play the dominant role in facilitating axonal GABA_B receptor expression and presynaptic modulation[ren-2022-habenula-axonal-abstract]. This regional specialization highlights that different KCTD isoforms have evolved to serve distinct functions in specific neural circuits.</p>
<h2 id="clinical-relevance-and-disease-associations">Clinical Relevance and Disease Associations</h2>
<p>The most well-characterized disease association for KCTD16 involves autoimmune encephalitis. Anti-GABA_B receptor encephalitis is an autoimmune condition mediated by antibodies targeting the GABA_B receptor complex, typically presenting with severe seizures, cognitive and behavioral changes, and limbic system involvement[vancoevorden-2019-encephalitis-abstract]. Research has identified KCTD16 as a novel autoantibody target in this condition, with KCTD16 antibodies detected in 72% (23/32) of patients with anti-GABA_B receptor encephalitis[vancoevorden-2019-encephalitis-abstract].</p>
<p>Importantly, the presence of KCTD16 autoantibodies marks a paraneoplastic origin and correlates strongly with underlying malignancy[vancoevorden-2019-encephalitis-abstract]. Among adequately screened patients, 95% of those with KCTD16 antibodies had tumors (primarily small cell lung carcinoma) compared to only 33% of anti-GABA_B receptor encephalitis patients without KCTD16 antibodies (P=0.001)[vancoevorden-2019-encephalitis-abstract]. This association suggests that tumor cells may express GABA_B receptor components including KCTD16, triggering antibody production through molecular mimicry. The addition of KCTD16 to diagnostic cell-based assays improves sensitivity for detecting GABA_B receptor antibodies without compromising specificity[vancoevorden-2019-encephalitis-abstract].</p>
<p>Clinical features of anti-GABA_B receptor encephalitis include cognitive or behavioral changes (97%), prominent seizures (90%), and status epilepticus requiring intensive care unit admission (42%)[vancoevorden-2019-encephalitis-abstract]. A notable finding was that 4/32 patients presented with rapidly progressive dementia as a clinical feature. Most patients (22/26) showed improvement with immunotherapy or chemotherapy[vancoevorden-2019-encephalitis-abstract]. These findings establish KCTD16 as a clinically relevant biomarker and therapeutic target in autoimmune neurology.</p>
<p>Cancer profiling has identified KCTD16 as a prognostic marker in kidney renal papillary cell carcinoma, though the mechanistic basis for this association remains unexplored. The highest expression in cancer cell lines is observed in neuroblastoma, consistent with the protein's neuronal expression pattern.</p>
<h2 id="therapeutic-development">Therapeutic Development</h2>
<p>The structural characterization of KCTD16 and its interaction with GABA_B receptors has enabled initial drug discovery efforts. In a pioneering study, researchers developed a peptide-based inhibitor targeting the KCTD-GABA_B receptor protein-protein interaction[sereikaite-2019-drug-discovery-abstract]. Using ŒºSPOT technology to map the receptor's binding region for KCTD proteins, they designed a highly potent peptide inhibitor capable of efficiently isolating endogenous KCTD proteins from mouse brain lysates[sereikaite-2019-drug-discovery-abstract]. Crystallographic and SEC-MALS analysis revealed that this inhibitor induces KCTD16 to adopt a distinct hexameric structure, different from its native pentameric form[sereikaite-2019-drug-discovery-abstract]. This work establishes proof-of-concept for targeting receptor-associated protein complexes as an alternative to direct receptor modulation, representing a fundamentally novel approach for developing therapeutics for GABA_B receptor-associated neuropsychiatric disorders[sereikaite-2019-drug-discovery-abstract].</p>
<p>The rationale for targeting the KCTD-GABA_B interaction is compelling because it offers the potential for more selective modulation than direct receptor agonists or antagonists. Since different KCTD isoforms confer distinct functional properties and are expressed in specific brain regions, targeting individual KCTD-receptor interactions could allow circuit-specific manipulation of GABA_B signaling. The identification of KCTD16's role in VTA dopamine neuron inhibition and anxiety[perezgarci-2025-hcn-anxiety-abstract] suggests that modulators of KCTD16 function could have therapeutic potential for anxiety disorders, while the association with autoimmune encephalitis[vancoevorden-2019-encephalitis-abstract] points to possible applications in autoimmune neurology.</p>
<h2 id="evolutionary-and-comparative-biology">Evolutionary and Comparative Biology</h2>
<p>The KCTD protein family comprises 26 members in humans with varying degrees of functional characterization[liu-2013-kctd-family-review-abstract]. KCTD16 is classified in clade F alongside KCTD8, sharing the distinctive feature of possessing both H1 and H2 domains[liu-2013-kctd-family-review-abstract]. Evolutionary analysis suggests that the functional diversification of GABA_B receptor-associated KCTD proteins occurred through domain loss and sequence evolution[seddik-2012-h1h2-domains-abstract]. The desensitizing KCTD12 and KCTD12b variants evolved by disposing of their inhibitory H2 domains while acquiring the T/NFLEQ motif necessary for GŒ≤Œ≥ sequestration[seddik-2012-h1h2-domains-abstract]. This evolutionary elaboration of KCTD-mediated GABA_B receptor regulation appears to be a vertebrate innovation, as invertebrate organisms lack these specialized auxiliary subunits[seddik-2012-h1h2-domains-abstract].</p>
<p>The conserved binding interface between KCTD16 and GABA_B2, with critical residues F80 and the corresponding receptor residues Y903/L904 maintained across species, suggests strong selective pressure to preserve this interaction[zuo-2019-kctd16-structure-abstract]. The structural studies reveal that this conserved interaction mechanism applies broadly across the GABA_B receptor-associated KCTD proteins (8, 12, 12b, and 16), indicating an ancestral binding mode that has been maintained through evolution while the functional properties encoded by other domains have diversified[zuo-2019-kctd16-structure-abstract].</p>
<h2 id="open-questions">Open Questions</h2>
<p>Several important questions remain regarding KCTD16 biology and function. First, while the structure of KCTD16's T1 domain bound to GABA_B2 has been determined, the structural basis of H2 domain-mediated inhibition of desensitization remains unclear. How does the H2 domain sterically interfere with the desensitization-promoting activity of H1, and what conformational changes occur upon receptor activation? Second, the precise stoichiometry and composition of native KCTD complexes in different brain regions and cell types requires further investigation. What factors determine whether homo-oligomers or hetero-oligomers form at a given synapse, and how is this regulated during development and plasticity?</p>
<p>Third, the structural basis of KCTD16's scaffolding function for HCN channels requires elucidation. Which domains of KCTD16 mediate interaction with HCN2/HCN3 subunits, and is this interaction direct or mediated through intermediate proteins? Understanding this would enable more precise targeting of this interaction therapeutically. Fourth, the relationship between KCTD16 function and fear memory processing warrants deeper mechanistic investigation. While VTA dopamine neurons have been implicated, which specific hippocampal and amygdala circuits depend on KCTD16 for normal fear extinction?</p>
<p>Fifth, the mechanism by which KCTD16 autoantibodies contribute to encephalitis pathogenesis needs elucidation. Do these antibodies directly impair GABA_B receptor function, or do they promote receptor internalization or complement-mediated cell damage? The intracellular location of KCTD16 raises questions about how extracellular antibodies access their target. Sixth, the discovery of peptide inhibitors that induce KCTD16 hexamerization opens questions about whether this alternative oligomeric state has any physiological relevance or could be exploited therapeutically.</p>
<p>Finally, given the distinct expression patterns of KCTD isoforms across brain regions, a comprehensive map of KCTD16 distribution at cellular resolution would inform understanding of where KCTD16-specific functions are most relevant. The low expression in habenula but high expression in VTA suggests that KCTD16 may play specialized roles in reward and motivation circuits that deserve further investigation.</p>
<h2 id="references">References</h2>
<ol>
<li>
<p><strong>[schwenk-2010-gabab-kctd-discovery-abstract]</strong> Schwenk J, Metz M, Zolles G, et al. Native GABA(B) receptors are heteromultimers with a family of auxiliary subunits. Nature. 2010;465(7295):231-235. doi:10.1038/nature08964. PMID: 20400944. URL: https://www.nature.com/articles/nature08964</p>
</li>
<li>
<p><strong>[zuo-2019-kctd16-structure-abstract]</strong> Zuo H, Glaaser IW, Zhao Y, et al. Structural basis for auxiliary subunit KCTD16 regulation of the GABAB receptor. Proc Natl Acad Sci U S A. 2019;116(17):8370-8379. doi:10.1073/pnas.1903024116. PMID: 30971491; PMCID: PMC6486783. URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC6486783/</p>
</li>
<li>
<p><strong>[zheng-2019-desensitization-nature-abstract]</strong> Zheng S, Abreu N, Levitz J, Kruse AC. Structural basis for KCTD-mediated rapid desensitization of GABAB signalling. Nature. 2019;567(7746):127-131. doi:10.1038/s41586-019-0990-0. PMID: 30814734; PMCID: PMC6405316. URL: https://www.nature.com/articles/s41586-019-0990-0</p>
</li>
<li>
<p><strong>[seddik-2012-h1h2-domains-abstract]</strong> Seddik R, Jungblut SP, Silander OK, et al. Opposite effects of KCTD subunit domains on GABA(B) receptor-mediated desensitization. J Biol Chem. 2012;287(47):39869-39877. doi:10.1074/jbc.M112.412767. PMID: 23035119; PMCID: PMC3501043. URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC3501043/</p>
</li>
<li>
<p><strong>[turecek-2014-gprotein-uncoupling-abstract]</strong> Turecek R, Schwenk J, Fritzius T, et al. Auxiliary GABAB receptor subunits uncouple G protein Œ≤Œ≥ subunits from effector channels to induce desensitization. Neuron. 2014;82(5):1032-1044. doi:10.1016/j.neuron.2014.04.015. PMID: 24836506. URL: https://www.sciencedirect.com/science/article/pii/S0896627314003055</p>
</li>
<li>
<p><strong>[fritzius-2017-heterooligomers-abstract]</strong> Fritzius T, Turecek R, Seddik R, et al. KCTD Hetero-oligomers Confer Unique Kinetic Properties on Hippocampal GABAB Receptor-Induced K+ Currents. J Neurosci. 2017;37(5):1162-1175. doi:10.1523/JNEUROSCI.2181-16.2016. PMID: 28003345; PMCID: PMC6596860. URL: https://www.jneurosci.org/content/37/5/1162</p>
</li>
<li>
<p><strong>[cathomas-2017-knockout-behavior-abstract]</strong> Cathomas F, Sigrist H, Schmid L, Seifritz E, Gassmann M, Bettler B, Pryce CR. Behavioural endophenotypes in mice lacking the auxiliary GABAB receptor subunit KCTD16. Behav Brain Res. 2017;317:393-400. doi:10.1016/j.bbr.2016.10.006. PMID: 27717812. URL: https://www.sciencedirect.com/science/article/abs/pii/S0166432816307653</p>
</li>
<li>
<p><strong>[vancoevorden-2019-encephalitis-abstract]</strong> van Coevorden-Hameete MH, de Bruijn MAAM, de Graaff E, et al. The expanded clinical spectrum of anti-GABABR encephalitis and added value of KCTD16 autoantibodies. Brain. 2019;142(6):1631-1643. doi:10.1093/brain/awz094. PMID: 31009048; PMCID: PMC6536844. URL: https://academic.oup.com/brain/article/142/6/1631/5476117</p>
</li>
<li>
<p><strong>[liu-2013-kctd-family-review-abstract]</strong> Liu Z, Xiang Y, Sun G. The KCTD family of proteins: structure, function, disease relevance. Cell Biosci. 2013;3(1):45. doi:10.1186/2045-3701-3-45. PMID: 24268103; PMCID: PMC3882106. URL: https://cellandbioscience.biomedcentral.com/articles/10.1186/2045-3701-3-45</p>
</li>
<li>
<p><strong>[perezgarci-2025-hcn-anxiety-abstract]</strong> P√©rez-Garci E, Pysanenko K, Rizzi G, et al. Binding of HCN channels to GABAB receptors in dopamine neurons of the VTA limits synaptic inhibition and prevents the development of anxiety. Neurobiol Dis. 2025;206:106831. doi:10.1016/j.nbd.2025.106831. PMID: 39914775. URL: https://www.sciencedirect.com/science/article/pii/S0969996125000476</p>
</li>
<li>
<p><strong>[sereikaite-2019-drug-discovery-abstract]</strong> Sereikaite V, Fritzius T, Kasaragod VB, et al. Targeting the Œ≥-Aminobutyric Acid Type B (GABAB) Receptor Complex: Development of Inhibitors Targeting the K+ Channel Tetramerization Domain (KCTD) Containing Proteins/GABAB Receptor Protein-Protein Interaction. J Med Chem. 2019;62(19):8819-8830. doi:10.1021/acs.jmedchem.9b01087. PMID: 31509708. URL: https://pubs.acs.org/doi/abs/10.1021/acs.jmedchem.9b01087</p>
</li>
<li>
<p><strong>[ren-2022-habenula-axonal-abstract]</strong> Ren Y, Liu Y, Zheng S, Luo M. KCTD8 and KCTD12 Facilitate Axonal Expression of GABAB Receptors in Habenula Cholinergic Neurons. J Neurosci. 2022;42(9):1648-1665. doi:10.1523/JNEUROSCI.1676-21.2021. PMID: 35017224; PMCID: PMC8896537. URL: https://www.jneurosci.org/content/42/9/1648</p>
</li>
<li>
<p><strong>[trovo-2024-synaptotagmin11-abstract]</strong> Trov√≤ L, Kouvaros S, Schwenk J, et al. Synaptotagmin-11 facilitates assembly of a presynaptic signaling complex in post-Golgi cargo vesicles. EMBO Rep. 2024;25(6):2610-2634. doi:10.1038/s44319-024-00147-0. PMID: 38698221; PMCID: PMC11169412. URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC11169412/</p>
</li>
</ol>
<h2 id="citations">Citations</h2>
<ol>
<li>cathomas-2017-knockout-behavior-abstract.md</li>
<li>fritzius-2017-heterooligomers-abstract.md</li>
<li>fritzius-2017-heterooligomers-summary.md</li>
<li>liu-2013-kctd-family-review-abstract.md</li>
<li>perezgarci-2025-hcn-anxiety-abstract.md</li>
<li>ren-2022-habenula-axonal-abstract.md</li>
<li>schwenk-2010-gabab-kctd-discovery-abstract.md</li>
<li>schwenk-2010-gabab-kctd-discovery-summary.md</li>
<li>seddik-2012-h1h2-domains-abstract.md</li>
<li>seddik-2012-h1h2-domains-summary.md</li>
<li>sereikaite-2019-drug-discovery-abstract.md</li>
<li>trovo-2024-synaptotagmin11-abstract.md</li>
<li>turecek-2014-gprotein-uncoupling-abstract.md</li>
<li>vancoevorden-2019-encephalitis-abstract.md</li>
<li>zheng-2019-desensitization-nature-abstract.md</li>
<li>zuo-2019-kctd16-structure-abstract.md</li>
<li>zuo-2019-kctd16-structure-summary.md</li>
</ol>
            </div>
        </details>
        
        <details class="markdown-section">
            <summary style="display: flex; justify-content: space-between; align-items: center; cursor: pointer;">
                <div style="flex: 1;">
                    <h3 style="display: inline;">Deep Research Falcon</h3>
                    <span style="font-size: 0.8rem; color: #666; margin-left: 1rem;">(KCTD16-deep-research-falcon.md)</span>
                </div>
                <div class="vote-buttons" data-g="Q68DU8" data-a="DOC: Deep Research Falcon" data-r="" data-act="DOCUMENTATION" style="display: flex; gap: 0.25rem;">
                    <button class="vote-btn" data-v="up" title="This documentation is helpful">üëç</button>
                    <button class="vote-btn" data-v="down" title="This documentation needs improvement">üëé</button>
                </div>
            </summary>
            <div class="markdown-content">
                <hr />
<p>provider: falcon<br />
model: Edison Scientific Literature<br />
cached: false<br />
start_time: '2025-12-27T10:39:14.983869'<br />
end_time: '2025-12-27T10:48:23.413484'<br />
duration_seconds: 548.43<br />
template_file: templates/gene_research_go_focused.md<br />
template_variables:<br />
  organism: human<br />
  gene_id: KCTD16<br />
  gene_symbol: KCTD16<br />
  uniprot_accession: Q68DU8<br />
  protein_description: 'RecName: Full=BTB/POZ domain-containing protein KCTD16; AltName:<br />
    Full=Potassium channel tetramerization domain-containing protein 16;'<br />
  gene_info: Name=KCTD16; Synonyms=KIAA1317;<br />
  organism_full: Homo sapiens (Human).<br />
  protein_family: Not specified in UniProt<br />
  protein_domains: BTB/POZ_dom. (IPR000210); H1_KCTD16. (IPR049903); SKP1/BTB/POZ_sf.<br />
    (IPR011333); T1-type_BTB. (IPR003131); BTB_2 (PF02214)<br />
provider_config:<br />
  timeout: 600<br />
  max_retries: 3<br />
  parameters:<br />
    allowed_domains: []<br />
    temperature: 0.1<br />
citation_count: 39</p>
<hr />
<h2 id="question">Question</h2>
<h1 id="gene-research-for-functional-annotation">Gene Research for Functional Annotation</h1>
<h2 id="critical-geneprotein-identification-context">‚ö†Ô∏è CRITICAL: Gene/Protein Identification Context</h2>
<p><strong>BEFORE YOU BEGIN RESEARCH:</strong> You MUST verify you are researching the CORRECT gene/protein. Gene symbols can be ambiguous, especially for less well-characterized genes from non-model organisms.</p>
<h3 id="target-geneprotein-identity-from-uniprot">Target Gene/Protein Identity (from UniProt):</h3>
<ul>
<li><strong>UniProt Accession:</strong> Q68DU8</li>
<li><strong>Protein Description:</strong> RecName: Full=BTB/POZ domain-containing protein KCTD16; AltName: Full=Potassium channel tetramerization domain-containing protein 16;</li>
<li><strong>Gene Information:</strong> Name=KCTD16; Synonyms=KIAA1317;</li>
<li><strong>Organism (full):</strong> Homo sapiens (Human).</li>
<li><strong>Protein Family:</strong> Not specified in UniProt</li>
<li><strong>Key Domains:</strong> BTB/POZ_dom. (IPR000210); H1_KCTD16. (IPR049903); SKP1/BTB/POZ_sf. (IPR011333); T1-type_BTB. (IPR003131); BTB_2 (PF02214)</li>
</ul>
<h3 id="mandatory-verification-steps">MANDATORY VERIFICATION STEPS:</h3>
<ol>
<li><strong>Check if the gene symbol "KCTD16" matches the protein description above</strong></li>
<li><strong>Verify the organism is correct:</strong> Homo sapiens (Human).</li>
<li><strong>Check if protein family/domains align with what you find in literature</strong></li>
<li><strong>If you find literature for a DIFFERENT gene with the same or similar symbol, STOP</strong></li>
</ol>
<h3 id="if-gene-symbol-is-ambiguous-or-you-cannot-find-relevant-literature">If Gene Symbol is Ambiguous or You Cannot Find Relevant Literature:</h3>
<p><strong>DO NOT PROCEED WITH RESEARCH ON A DIFFERENT GENE.</strong> Instead:<br />
- State clearly: "The gene symbol 'KCTD16' is ambiguous or literature is limited for this specific protein"<br />
- Explain what you found (e.g., "Found extensive literature on a different gene with the same symbol in a different organism")<br />
- Describe the protein based ONLY on the UniProt information provided above<br />
- Suggest that the protein function can be inferred from domain/family information</p>
<h3 id="research-target">Research Target:</h3>
<p>Please provide a comprehensive research report on the gene <strong>KCTD16</strong> (gene ID: KCTD16, UniProt: Q68DU8) in human.</p>
<p>The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.</p>
<p>You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement<br />
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.</p>
<p>We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.</p>
<p>We are interested in where in or outside the cell the gene product carries out its function.</p>
<p>We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.</p>
<p>Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.</p>
<h2 id="output">Output</h2>
<p>Question: You are an expert researcher providing comprehensive, well-cited information.</p>
<p>Provide detailed information focusing on:<br />
1. Key concepts and definitions with current understanding<br />
2. Recent developments and latest research (prioritize 2023-2024 sources)<br />
3. Current applications and real-world implementations<br />
4. Expert opinions and analysis from authoritative sources<br />
5. Relevant statistics and data from recent studies</p>
<p>Format as a comprehensive research report with proper citations. Include URLs and publication dates where available.<br />
Always prioritize recent, authoritative sources and provide specific citations for all major claims.</p>
<h1 id="gene-research-for-functional-annotation_1">Gene Research for Functional Annotation</h1>
<h2 id="critical-geneprotein-identification-context_1">‚ö†Ô∏è CRITICAL: Gene/Protein Identification Context</h2>
<p><strong>BEFORE YOU BEGIN RESEARCH:</strong> You MUST verify you are researching the CORRECT gene/protein. Gene symbols can be ambiguous, especially for less well-characterized genes from non-model organisms.</p>
<h3 id="target-geneprotein-identity-from-uniprot_1">Target Gene/Protein Identity (from UniProt):</h3>
<ul>
<li><strong>UniProt Accession:</strong> Q68DU8</li>
<li><strong>Protein Description:</strong> RecName: Full=BTB/POZ domain-containing protein KCTD16; AltName: Full=Potassium channel tetramerization domain-containing protein 16;</li>
<li><strong>Gene Information:</strong> Name=KCTD16; Synonyms=KIAA1317;</li>
<li><strong>Organism (full):</strong> Homo sapiens (Human).</li>
<li><strong>Protein Family:</strong> Not specified in UniProt</li>
<li><strong>Key Domains:</strong> BTB/POZ_dom. (IPR000210); H1_KCTD16. (IPR049903); SKP1/BTB/POZ_sf. (IPR011333); T1-type_BTB. (IPR003131); BTB_2 (PF02214)</li>
</ul>
<h3 id="mandatory-verification-steps_1">MANDATORY VERIFICATION STEPS:</h3>
<ol>
<li><strong>Check if the gene symbol "KCTD16" matches the protein description above</strong></li>
<li><strong>Verify the organism is correct:</strong> Homo sapiens (Human).</li>
<li><strong>Check if protein family/domains align with what you find in literature</strong></li>
<li><strong>If you find literature for a DIFFERENT gene with the same or similar symbol, STOP</strong></li>
</ol>
<h3 id="if-gene-symbol-is-ambiguous-or-you-cannot-find-relevant-literature_1">If Gene Symbol is Ambiguous or You Cannot Find Relevant Literature:</h3>
<p><strong>DO NOT PROCEED WITH RESEARCH ON A DIFFERENT GENE.</strong> Instead:<br />
- State clearly: "The gene symbol 'KCTD16' is ambiguous or literature is limited for this specific protein"<br />
- Explain what you found (e.g., "Found extensive literature on a different gene with the same symbol in a different organism")<br />
- Describe the protein based ONLY on the UniProt information provided above<br />
- Suggest that the protein function can be inferred from domain/family information</p>
<h3 id="research-target_1">Research Target:</h3>
<p>Please provide a comprehensive research report on the gene <strong>KCTD16</strong> (gene ID: KCTD16, UniProt: Q68DU8) in human.</p>
<p>The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.</p>
<p>You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement<br />
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.</p>
<p>We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.</p>
<p>We are interested in where in or outside the cell the gene product carries out its function.</p>
<p>We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.</p>
<p>Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.</p>
<p>Plan<br />
- Verified identity and domains; collected and evaluated recent and foundational sources; synthesized mechanistic function, interactions, signaling context, localization, and clinical relevance; compiled quantitative/statistical data and built an evidence table artifact; composed the final report with citations.</p>
<p>Comprehensive research report: human KCTD16 (UniProt Q68DU8)</p>
<p>1) Key concepts and definitions with current understanding<br />
- Identity, family, domains, organism verification: KCTD16 (gene symbol KCTD16, also known as KIAA1317) is a human potassium channel tetramerization domain-containing protein that belongs to the KCTD family. It contains an N‚Äëterminal BTB/POZ (T1) oligomerization domain and C‚Äëterminal homology regions (H1, and in some members H2). Structural work using human protein fragments confirms that the BTB/T1 forms an open pentamer and binds the distal cytoplasmic tail of the GABAB2 subunit, verifying both the gene symbol and human organism context specified (PDB 6OCP; PNAS 2019). The BTB/POZ and T1‚Äëtype BTB domain annotations align with the literature (BTB/POZ/T1 oligomerization module; H1 module for GŒ≤Œ≥ engagement in paralogs) (https://doi.org/10.1073/pnas.1903024116; https://doi.org/10.1038/s41586-019-0990-0) (zuo2019structuralbasisfor pages 1-1, zheng2019structuralbasisfor pages 1-2, zuo2019structuralbasisfor pages 7-7, zheng2019structuralbasisfor pages 2-4).<br />
- Functional class: KCTD16 is an auxiliary subunit of metabotropic GABAB receptors (GBRs). Native GBR complexes comprise principal subunits GABAB1 and GABAB2 plus auxiliary KCTDs (notably KCTD8, KCTD12/12b, KCTD16). KCTD16 modulates GBR signaling kinetics and amplitude, particularly in coupling to G protein-gated inwardly rectifying K+ channels (GIRK) (https://doi.org/10.1073/pnas.1903024116; https://doi.org/10.1038/s41586-019-0990-0) (zuo2019structuralbasisfor pages 1-1, zheng2019structuralbasisfor pages 1-2).</p>
<p>2) Mechanism, interactions, pathways, and localization<br />
- Direct molecular interfaces and stoichiometry: The KCTD16 BTB/T1 domain forms an open pentamer that wraps around one copy of the GABAB2 C-terminal peptide, establishing a 1:5 GB2 peptide:KCTD16 stoichiometry. Key interfacial residues include KCTD16 Q34, F80, P101, E102 and GABAB2 I898, Y903, L904; mutating these residues disrupts both biochemical association and functional modulation of GBR‚ÜíGIRK currents (https://doi.org/10.1073/pnas.1903024116) (zuo2019structuralbasisfor pages 1-3, zuo2019structuralbasisfor pages 7-7, zuo2019structuralbasisfor pages 9-10).<br />
- H1‚ÄìGŒ≤Œ≥ engagement and desensitization paradigm: KCTD family H1 domains can oligomerize to bind multiple GŒ≤Œ≥ heterodimers cooperatively in a 5:5 complex, enabling rapid desensitization of GBR‚ÜíGIRK signaling by stripping GŒ≤Œ≥ from GIRK after initial activation. Quantitative measures for KCTD12 show H1‚ÄìGŒ≤Œ≥ KD ~185 nM and cooperative 5:5 assembly; analogous architecture and receptor tethering is proposed to underlie KCTD effects broadly, including KCTD16 (https://doi.org/10.1038/s41586-019-0990-0) (zheng2019structuralbasisfor pages 2-4, zheng2019structuralbasisfor pages 12-16).<br />
- Kinetic specialization among KCTDs: KCTD12/12b enforce rapid desensitization of GABAB‚Äëevoked GIRK currents by GŒ≤Œ≥ sequestration, whereas KCTD8 and KCTD16 generally confer primarily non‚Äëdesensitizing/sustained responses; KCTD8/16 possess additional C‚Äëterminal features (including H2) that oppose desensitization (https://doi.org/10.1073/pnas.1903024116) (zuo2019structuralbasisfor pages 1-3, zuo2019structuralbasisfor pages 1-1).<br />
- Pathway context: KCTD16 operates within the canonical GBR pathway (GABAB‚ÜíGi/o‚ÜíGŒ≤Œ≥‚ÜíGIRK; and presynaptically GŒ≤Œ≥‚ÜíVGCC inhibition), shaping postsynaptic inhibitory K+ currents and presynaptic release probability. Allosteric and G protein readouts show KCTD-dependent modulation of G protein conformations and cAMP pathway efficacy across KCTD paralogs; KCTD8/12/16 redundantly sustain the efficacy of inhibitory GPCR signals to cAMP in neurons (https://doi.org/10.1016/j.neuropharm.2014.08.020; https://doi.org/10.1073/pnas.2119237119) (rajalu2015pharmacologicalcharacterizationof pages 5-7, muntean2022membersofthe pages 3-5).<br />
- Subcellular localization and brain distribution: In mouse brain, KCTD16 mRNA and protein are broadly expressed with prominent enrichment across thalamic nuclei, hippocampal CA1, dentate gyrus (somata/neuropil bands), amygdala (lateral and basolateral nuclei), olfactory regions, claustrum, and septum. In the adult thalamus, GABAB receptors predominantly incorporate KCTD16 based on subtype distributions. Immunolocalization shows KCTD16 at granule cell somata and neuropil in dentate gyrus and colocalization with GABAB2 in specific layers, supporting a postsynaptic role, with additional presence in interneuron-rich layers (https://doi.org/10.1002/cne.22610) (metz2011distributionofthe pages 7-10).</p>
<p>3) Recent developments and latest research (prioritizing 2023‚Äì2024)<br />
- GPCR regulation reviews: Recent Trends in Neurosciences review emphasizes constitutive binding of KCTD16 (and KCTD8/12) to GABAB2 C‚Äëterminus as a paradigm for auxiliary control of neuromodulatory GPCRs and highlights diverse GPCR‚ÄìGPCR crosstalk and effector competition (2024; https://doi.org/10.1016/j.tins.2024.05.008) (gonzalezhernandez2024emergingmodesof pages 7-9).<br />
- KCTD‚ÄìCullin3 recognition landscape: A 2024 IJMS structural analysis using AlphaFold indicates that KCTD subcluster harboring GABAB-binding proteins (including KCTD16) shows no structural propensity for Cul3 binding via BTB, in contrast to other KCTDs that serve as Cul3 adaptors. This suggests that KCTD16‚Äôs BTB evolved primarily to assemble GBR complexes rather than Cul3 E3 ligase scaffolds (2024; https://doi.org/10.3390/ijms25031881) (balasco2024acomprehensiveanalysis pages 8-9).<br />
- Proteomic context at synapses: A 2023 cerebellar proteomics study cataloging mGlu1 interactomes discussed KCTD family members as part of synaptic protein networks, highlighting complex, region‚Äëspecific assemblies and the possibility of indirect cross‚Äëcomplex interactions in native tissue (2023; https://doi.org/10.3390/cells12091325) (mansouri2023proteinnetworksassociated pages 13-15).<br />
- System-level physiology: A 2023 review of GABAB signaling in auditory circuits details presynaptic and postsynaptic mechanisms (GIRK, VGCC) and plasticity that are shaped by GBR auxiliary components, consistent with regional roles where KCTD16 is enriched (2023; https://doi.org/10.3389/fendo.2023.1195038) (turecek2023theroleof pages 6-7).</p>
<p>4) Current applications and real-world implementations<br />
- Structural biology and mechanistic dissection: KCTD16 has enabled high-resolution determination of the GBR‚Äìauxiliary subunit interface and underpins mechanistic models for temporal control of GIRK signaling; these coordinates and models are used to guide mutational and pharmacological experiments (2019; PDB 6OCP; https://doi.org/10.1073/pnas.1903024116; 2019; https://doi.org/10.1038/s41586-019-0990-0) (zuo2019structuralbasisfor pages 1-1, zuo2019structuralbasisfor pages 9-10, zheng2019structuralbasisfor pages 2-4, zheng2019structuralbasisfor pages 12-16).<br />
- Electrophysiology and pharmacology: Heterologous and neuronal systems employ KCTD16 co-expression to measure baclofen-evoked GIRK currents, kinetic modulation, and G protein conformational BRET assays, often comparing with KCTD8/12/12b to parse desensitization versus sustained responses (2015; https://doi.org/10.1016/j.neuropharm.2014.08.020) (rajalu2015pharmacologicalcharacterizationof pages 5-7).<br />
- Clinical diagnostics: Incorporation of KCTD16 into GABABR cell-based assays increases sensitivity of autoantibody detection for anti-GABABR encephalitis without loss of specificity, aiding earlier diagnosis and tumor screening (2019; https://doi.org/10.1093/brain/awz094) (coevordenhameete2019theexpandedclinical pages 1-2).</p>
<p>5) Expert opinions and analysis from authoritative sources<br />
- Structural consensus: Nature and PNAS structural studies converge on a bipartite mechanism: BTB/T1 mediates a 1:5 tethering of KCTD to GABAB2, while H1 pentamers engage multiple GŒ≤Œ≥ to sculpt signal kinetics; cooperative GŒ≤Œ≥ engagement explains rapid desensitization in KCTD12 and the more sustained modulation seen for KCTD16 lacking the canonical desensitization motif (2019; https://doi.org/10.1038/s41586-019-0990-0; https://doi.org/10.1073/pnas.1903024116) (zheng2019structuralbasisfor pages 2-4, zheng2019structuralbasisfor pages 1-2, zuo2019structuralbasisfor pages 1-3).<br />
- Family-level specialization: 2024 IJMS analysis suggests that the GABAB‚Äëbinding KCTD clade (including KCTD16) does not structurally favor Cul3 binding, reinforcing the view that not all BTB-containing KCTDs are ubiquitin ligase adaptors; instead, KCTD16‚Äôs BTB is specialized for receptor complex assembly (2024; https://doi.org/10.3390/ijms25031881) (balasco2024acomprehensiveanalysis pages 8-9).<br />
- Systems neuroscience perspective: 2024 Trends review frames KCTD16 as a key determinant of synaptic GPCR signaling nanoscale organization and crosstalk restraint, through constitutive receptor association and effector competition paradigms in neurons (2024; https://doi.org/10.1016/j.tins.2024.05.008) (gonzalezhernandez2024emergingmodesof pages 7-9).</p>
<p>6) Relevant statistics and data from recent studies<br />
- Structural stoichiometry: 1 GABAB2 C‚Äëterminal peptide per KCTD16 BTB/T1 pentamer (1:5), supported by crystal structure (PDB 6OCP) and mutational validation (2019; https://doi.org/10.1073/pnas.1903024116) (zuo2019structuralbasisfor pages 1-3, zuo2019structuralbasisfor pages 9-10).<br />
- GŒ≤Œ≥ binding/desensitization parameters (family paradigm): KCTD12 H1‚ÄìGŒ≤Œ≥ KD ~185 nM; cooperative assembly into 5:5 complexes; H1 mutants (R232D/R257D) abolish GŒ≤Œ≥ binding and prevent desensitization (2019; https://doi.org/10.1038/s41586-019-0990-0) (zheng2019structuralbasisfor pages 2-4, zheng2019structuralbasisfor pages 12-16).<br />
- Brain distribution: In adult mouse thalamus, KCTD16 is highly expressed across many nuclei, supporting the inference that many thalamic GBRs incorporate KCTD16; hippocampal CA1 enrichment and dentate gyrus somatic/neuropil labeling are prominent (2011; https://doi.org/10.1002/cne.22610) (metz2011distributionofthe pages 7-10).<br />
- Clinical autoantibodies: In a cohort of 32 anti‚ÄëGABABR encephalitis patients, KCTD16 autoantibodies were present in 23/32; tumor association was 18/19 (95%) in KCTD16‚ÄëAb+ vs 3/9 (33%) in KCTD16‚ÄëAb‚àí (P = 0.001). Adding KCTD16 to the GABABR cell-based assay increased sensitivity without loss of specificity (2019; https://doi.org/10.1093/brain/awz094) (coevordenhameete2019theexpandedclinical pages 1-2).</p>
<p>7) Subcellular site of action and role in defined signaling circuits<br />
- Postsynaptic inhibition: By tethering to GABAB2 and shaping GŒ≤Œ≥ availability and GIRK channel interactions, KCTD16 contributes to the amplitude and temporal profile of postsynaptic inhibitory currents, particularly in dendritic compartments where GABABRs are enriched (https://doi.org/10.1073/pnas.1903024116; https://doi.org/10.1002/cne.22610) (zuo2019structuralbasisfor pages 1-1, metz2011distributionofthe pages 7-10).<br />
- Presynaptic modulation: Within the GBR‚ÜíGi/o framework, KCTD16-containing complexes likely modulate presynaptic GŒ≤Œ≥ signaling to VGCCs and release probability in regions where it is abundant, consistent with physiological reviews of auditory pathways (2023; https://doi.org/10.3389/fendo.2023.1195038) (turecek2023theroleof pages 6-7).</p>
<p>Key evidence summary table<br />
| Category | Key finding | Primary source (journal) | Year | URL |<br />
|---|---|---:|---:|---|<br />
| Identity &amp; domains | KCTD16 is a BTB/POZ-containing KCTD family protein with an N-terminal T1/BTB oligomerization domain and C‚Äëterminal H1 (and H2) homology regions; the T1/BTB mediates pentamer formation. (zuo2019structuralbasisfor pages 1-1, zheng2019structuralbasisfor pages 1-2) | PNAS | 2019 | https://doi.org/10.1073/pnas.1903024116 |<br />
| Primary function | Functions as an auxiliary subunit of neuronal GABAB receptors, modulating receptor expression and the amplitude/kinetics of GIRK-mediated K+ currents. (zuo2019structuralbasisfor pages 1-1, zheng2019structuralbasisfor pages 1-2) | PNAS | 2019 | https://doi.org/10.1073/pnas.1903024116 |<br />
| Structural mechanism ‚Äî T1/BTB | The KCTD16 T1/BTB domain forms an open pentamer that binds one GABAB2 C‚Äëterminal peptide (1:5 stoichiometry; structure deposited PDB 6OCP); interfacial residues (e.g., F80, Q34) are required for binding. (zuo2019structuralbasisfor pages 1-1, zuo2019structuralbasisfor pages 9-10) | PNAS | 2019 | https://doi.org/10.1073/pnas.1903024116 |<br />
| Structural mechanism ‚Äî H1/GŒ≤Œ≥ | KCTD family H1 domains assemble symmetrically to engage multiple GŒ≤Œ≥ subunits cooperatively (5:5 assemblies demonstrated for KCTD12), a mechanism proposed to strip GŒ≤Œ≥ from GIRK and drive desensitization. (zheng2019structuralbasisfor pages 1-2, zheng2019structuralbasisfor pages 2-4) | Nature | 2019 | https://doi.org/10.1038/s41586-019-0990-0 |<br />
| Key interaction partners | Direct/functional partners include the GABAB2 C‚Äëterminal tail, GŒ≤Œ≥ heterodimers, and GIRK channels; mutations at the interfaces disrupt biochemical binding and GIRK modulation. (zheng2019structuralbasisfor pages 1-2, zuo2019structuralbasisfor pages 1-1, zuo2019structuralbasisfor pages 9-10) | Nature / PNAS | 2019 | https://doi.org/10.1038/s41586-019-0990-0 |<br />
| Signaling pathway context | Operates within the GABAB ‚Üí Gi/o ‚Üí GŒ≤Œ≥ ‚Üí GIRK signaling axis, thereby affecting postsynaptic inhibition and presynaptic release probability; KCTDs also modulate downstream GPCR/G-protein readouts in pharmacological assays. (zheng2019structuralbasisfor pages 1-2, rajalu2015pharmacologicalcharacterizationof pages 5-7, muntean2022membersofthe pages 3-5) | Neuropharmacology / Nature / PNAS | 2015 / 2019 / 2022 | https://doi.org/10.1016/j.neuropharm.2014.08.020 |<br />
| Kinetic effects vs other KCTDs | KCTD12/12b contain H1 motifs that produce rapid desensitization (uncoupling GŒ≤Œ≥ from GIRK); by contrast KCTD8 and KCTD16 typically produce primarily non‚Äëdesensitizing or sustained GABAB‚ÄëGIRK responses. (zuo2019structuralbasisfor pages 9-10, zuo2019structuralbasisfor pages 1-1) | PNAS / Neuropharmacology | 2019 / 2015 | https://doi.org/10.1073/pnas.1903024116 |<br />
| Brain distribution / localization | In mouse brain KCTD16 shows high expression across thalamic nuclei and is enriched in hippocampal CA1, amygdala (lateral/basolateral nuclei) and dentate regions; localization can be somatic/neuropil and region‚Äëspecific. (metz2011distributionofthe pages 7-10, turecek2023theroleof pages 6-7) | Journal of Comparative Neurology | 2011 | https://doi.org/10.1002/cne.22610 |<br />
| Clinical relevance ‚Äî autoantibodies | KCTD16 autoantibodies were detected in 23/32 patients with anti‚ÄëGABABR encephalitis; KCTD16 Ab positivity strongly associated with an underlying tumour (18/19 with KCTD16 Abs vs 3/9 without; P = 0.001). (coevordenhameete2019theexpandedclinical pages 1-2) | Brain | 2019 | https://doi.org/10.1093/brain/awz094 |<br />
| Diagnostic utility | Adding KCTD16 to GABABR cell‚Äëbased assays increased assay sensitivity for anti‚ÄëGABABR encephalitis detection without loss of specificity. (coevordenhameete2019theexpandedclinical pages 1-2) | Brain | 2019 | https://doi.org/10.1093/brain/awz094 |<br />
| Recent developments (2023‚Äì2024) | Recent reviews/analyses (Trends, IJMS, Cells) highlight KCTD16's constitutive GABAB2 binding, roles in GPCR regulatory networks and family‚Äëlevel analyses of Cullin3 partnerships that inform potential ubiquitin‚Äëligase adapter roles across KCTDs. (gonzalezhernandez2024emergingmodesof pages 7-9, balasco2024acomprehensiveanalysis pages 8-9, mansouri2023proteinnetworksassociated pages 13-15) | Trends in Neurosciences / Int. J. Mol. Sci. / Cells | 2024 / 2024 / 2023 | https://doi.org/10.1016/j.tins.2024.05.008 |<br />
| Applications in research | KCTD16 has been used in high‚Äëresolution structural studies (X‚Äëray/cryo‚ÄëEM), electrophysiology (baclofen‚Äëevoked GIRK assays), proteomics and diagnostic assay development for GABAB complexes and encephalitis biomarker work. (zuo2019structuralbasisfor pages 1-1, zheng2019structuralbasisfor pages 1-2, mansouri2023proteinnetworksassociated pages 13-15) | PNAS / Nature / Cells | 2019 / 2019 / 2023 | https://doi.org/10.1073/pnas.1903024116 |</p>
<p><em>Table: Compact, cited summary of major, evidence-backed facts on human KCTD16 (UniProt Q68DU8), covering identity, structure, partners, signaling role, brain distribution, kinetics vs other KCTDs, clinical autoantibody data, and recent (2023‚Äì2024) analyses; useful as a quick reference for research and diagnostics.</em></p>
<p>Ambiguity check and scope note<br />
- Ambiguity: The symbol ‚ÄúKCTD16‚Äù is used consistently in human studies and in mouse distribution studies; no conflicting gene/protein with this symbol was encountered in other organisms within the cited corpus. The functional and structural claims here are specific to Homo sapiens KCTD16 or to conserved mammalian orthologs where explicitly noted (zuo2019structuralbasisfor pages 1-1, zheng2019structuralbasisfor pages 1-2, metz2011distributionofthe pages 7-10).<br />
- Family/function inference boundaries: While many KCTDs can act as Cul3 adaptors, 2024 modeling suggests the GABAB-binding clade (including KCTD16) does not engage Cul3 via BTB, cautioning against overgeneralization of ubiquitin E3 adaptor roles to KCTD16 (https://doi.org/10.3390/ijms25031881) (balasco2024acomprehensiveanalysis pages 8-9).</p>
<p>References (URLs and dates)<br />
- Zuo et al., PNAS 2019. Structural basis for auxiliary subunit KCTD16 regulation of the GABAB receptor. Published Apr 2019. URL: https://doi.org/10.1073/pnas.1903024116 (zuo2019structuralbasisfor pages 1-1, zuo2019structuralbasisfor pages 1-3, zuo2019structuralbasisfor pages 7-7, zuo2019structuralbasisfor pages 9-10).<br />
- Zheng et al., Nature 2019. Structural basis for KCTD-mediated rapid desensitization of GABAB signalling. Published Feb 2019. URL: https://doi.org/10.1038/s41586-019-0990-0 (zheng2019structuralbasisfor pages 2-4, zheng2019structuralbasisfor pages 12-16, zheng2019structuralbasisfor pages 1-2, zheng2019structuralbasisfor pages 18-22).<br />
- Metz et al., J Comp Neurol 2011. Distribution of the auxiliary GABAB receptor subunits KCTD8, 12, 12b, and 16 in the mouse brain. Published Jun 2011. URL: https://doi.org/10.1002/cne.22610 (metz2011distributionofthe pages 7-10).<br />
- Rajalu et al., Neuropharmacology 2015. Pharmacological characterization of GABAB receptor subtypes assembled with auxiliary KCTD subunits. Published Jan 2015. URL: https://doi.org/10.1016/j.neuropharm.2014.08.020 (rajalu2015pharmacologicalcharacterizationof pages 5-7).<br />
- van Coevorden‚ÄëHameete et al., Brain 2019. The expanded clinical spectrum of anti‚ÄëGABABR encephalitis and added value of KCTD16 autoantibodies. Advance Access Apr 22, 2019. URL: https://doi.org/10.1093/brain/awz094 (coevordenhameete2019theexpandedclinical pages 1-2).<br />
- Tureƒçek et al., Frontiers in Endocrinology 2023. The role of GABAB receptors in the subcortical pathways of the mammalian auditory system. Published Aug 2023. URL: https://doi.org/10.3389/fendo.2023.1195038 (turecek2023theroleof pages 6-7).<br />
- Gonzalez‚ÄëHernandez et al., Trends in Neurosciences 2024. Emerging modes of regulation of neuromodulatory GPCRs. Published Aug 2024. URL: https://doi.org/10.1016/j.tins.2024.05.008 (gonzalezhernandez2024emergingmodesof pages 7-9).<br />
- Balasco et al., International Journal of Molecular Sciences 2024. A Comprehensive Analysis of the Structural Recognition between KCTD Proteins and Cullin 3. Published Feb 2024. URL: https://doi.org/10.3390/ijms25031881 (balasco2024acomprehensiveanalysis pages 8-9).<br />
- Muntean et al., PNAS 2022. Members of the KCTD family are major regulators of cAMP signaling. Published Dec 2022. URL: https://doi.org/10.1073/pnas.2119237119 (muntean2022membersofthe pages 3-5).</p>
<p>Conclusion<br />
Human KCTD16 is a BTB/POZ-domain auxiliary protein that constitutively associates with the GABAB2 C‚Äëterminus in a 1:5 pentameric arrangement and sculpts GABAB‚ÜíGŒ≤Œ≥‚ÜíGIRK signaling kinetics. In contrast to KCTD12, KCTD16 generally supports sustained responses, consistent with differences in C‚Äëterminal modules. Regionally enriched expression, particularly in thalamus and hippocampus, implies substantial roles in synaptic inhibition and plasticity. Clinically, KCTD16 autoantibodies are prevalent in anti‚ÄëGABABR encephalitis and improve diagnostic sensitivity, strongly flagging paraneoplastic etiologies. Recent (2023‚Äì2024) analyses refine KCTD16‚Äôs place within GPCR regulatory networks and suggest its BTB domain specializes in receptor complex assembly rather than Cul3 ligase scaffolding (zuo2019structuralbasisfor pages 1-1, zuo2019structuralbasisfor pages 1-3, zheng2019structuralbasisfor pages 2-4, metz2011distributionofthe pages 7-10, coevordenhameete2019theexpandedclinical pages 1-2, gonzalezhernandez2024emergingmodesof pages 7-9, balasco2024acomprehensiveanalysis pages 8-9).</p>
<p>References</p>
<ol>
<li>
<p>(zuo2019structuralbasisfor pages 1-1): Hao Zuo, Ian Glaaser, Yulin Zhao, Igor Kurinov, Lidia Mosyak, Haonan Wang, Jonathan Liu, Jinseo Park, Aurel Frangaj, Emmanuel Sturchler, Ming Zhou, Patricia McDonald, Yong Geng, Paul A. Slesinger, and Qing R. Fan. Structural basis for auxiliary subunit kctd16 regulation of the gabab receptor. Proceedings of the National Academy of Sciences, 116:8370-8379, Apr 2019. URL: https://doi.org/10.1073/pnas.1903024116, doi:10.1073/pnas.1903024116. This article has 54 citations and is from a highest quality peer-reviewed journal.</p>
</li>
<li>
<p>(zheng2019structuralbasisfor pages 1-2): Sanduo Zheng, Nohely Abreu, Joshua Levitz, and Andrew C. Kruse. Structural basis for kctd-mediated rapid desensitization of gabab signalling. Nature, 567:127-131, Feb 2019. URL: https://doi.org/10.1038/s41586-019-0990-0, doi:10.1038/s41586-019-0990-0. This article has 97 citations and is from a highest quality peer-reviewed journal.</p>
</li>
<li>
<p>(zuo2019structuralbasisfor pages 7-7): Hao Zuo, Ian Glaaser, Yulin Zhao, Igor Kurinov, Lidia Mosyak, Haonan Wang, Jonathan Liu, Jinseo Park, Aurel Frangaj, Emmanuel Sturchler, Ming Zhou, Patricia McDonald, Yong Geng, Paul A. Slesinger, and Qing R. Fan. Structural basis for auxiliary subunit kctd16 regulation of the gabab receptor. Proceedings of the National Academy of Sciences, 116:8370-8379, Apr 2019. URL: https://doi.org/10.1073/pnas.1903024116, doi:10.1073/pnas.1903024116. This article has 54 citations and is from a highest quality peer-reviewed journal.</p>
</li>
<li>
<p>(zheng2019structuralbasisfor pages 2-4): Sanduo Zheng, Nohely Abreu, Joshua Levitz, and Andrew C. Kruse. Structural basis for kctd-mediated rapid desensitization of gabab signalling. Nature, 567:127-131, Feb 2019. URL: https://doi.org/10.1038/s41586-019-0990-0, doi:10.1038/s41586-019-0990-0. This article has 97 citations and is from a highest quality peer-reviewed journal.</p>
</li>
<li>
<p>(zuo2019structuralbasisfor pages 1-3): Hao Zuo, Ian Glaaser, Yulin Zhao, Igor Kurinov, Lidia Mosyak, Haonan Wang, Jonathan Liu, Jinseo Park, Aurel Frangaj, Emmanuel Sturchler, Ming Zhou, Patricia McDonald, Yong Geng, Paul A. Slesinger, and Qing R. Fan. Structural basis for auxiliary subunit kctd16 regulation of the gabab receptor. Proceedings of the National Academy of Sciences, 116:8370-8379, Apr 2019. URL: https://doi.org/10.1073/pnas.1903024116, doi:10.1073/pnas.1903024116. This article has 54 citations and is from a highest quality peer-reviewed journal.</p>
</li>
<li>
<p>(zuo2019structuralbasisfor pages 9-10): Hao Zuo, Ian Glaaser, Yulin Zhao, Igor Kurinov, Lidia Mosyak, Haonan Wang, Jonathan Liu, Jinseo Park, Aurel Frangaj, Emmanuel Sturchler, Ming Zhou, Patricia McDonald, Yong Geng, Paul A. Slesinger, and Qing R. Fan. Structural basis for auxiliary subunit kctd16 regulation of the gabab receptor. Proceedings of the National Academy of Sciences, 116:8370-8379, Apr 2019. URL: https://doi.org/10.1073/pnas.1903024116, doi:10.1073/pnas.1903024116. This article has 54 citations and is from a highest quality peer-reviewed journal.</p>
</li>
<li>
<p>(zheng2019structuralbasisfor pages 12-16): Sanduo Zheng, Nohely Abreu, Joshua Levitz, and Andrew C. Kruse. Structural basis for kctd-mediated rapid desensitization of gabab signalling. Nature, 567:127-131, Feb 2019. URL: https://doi.org/10.1038/s41586-019-0990-0, doi:10.1038/s41586-019-0990-0. This article has 97 citations and is from a highest quality peer-reviewed journal.</p>
</li>
<li>
<p>(rajalu2015pharmacologicalcharacterizationof pages 5-7): Mathieu Rajalu, Thorsten Fritzius, Lisa Adelfinger, Valerie Jacquier, Valerie Besseyrias, Martin Gassmann, and Bernhard Bettler. Pharmacological characterization of gabab receptor subtypes assembled with auxiliary kctd subunits. Neuropharmacology, 88:145-154, Jan 2015. URL: https://doi.org/10.1016/j.neuropharm.2014.08.020, doi:10.1016/j.neuropharm.2014.08.020. This article has 45 citations and is from a highest quality peer-reviewed journal.</p>
</li>
<li>
<p>(muntean2022membersofthe pages 3-5): Brian S. Muntean, Subhi Marwari, Xiaona Li, Douglas C. Sloan, Brian D. Young, James A. Wohlschlegel, and Kirill A. Martemyanov. Members of the kctd family are major regulators of camp signaling. Proceedings of the National Academy of Sciences of the United States of America, Dec 2022. URL: https://doi.org/10.1073/pnas.2119237119, doi:10.1073/pnas.2119237119. This article has 36 citations and is from a highest quality peer-reviewed journal.</p>
</li>
<li>
<p>(metz2011distributionofthe pages 7-10): Michaela Metz, Martin Gassmann, Bernd Fakler, Nicole Schaeren‚ÄêWiemers, and Bernhard Bettler. Distribution of the auxiliary gabab receptor subunits kctd8, 12, 12b, and 16 in the mouse brain. Journal of Comparative Neurology, 519:1435-1454, Jun 2011. URL: https://doi.org/10.1002/cne.22610, doi:10.1002/cne.22610. This article has 100 citations and is from a peer-reviewed journal.</p>
</li>
<li>
<p>(gonzalezhernandez2024emergingmodesof pages 7-9): Alberto J. Gonzalez-Hernandez, Hermany Munguba, and Joshua Levitz. Emerging modes of regulation of neuromodulatory g protein-coupled receptors. Trends in Neurosciences, 47:635-650, Aug 2024. URL: https://doi.org/10.1016/j.tins.2024.05.008, doi:10.1016/j.tins.2024.05.008. This article has 23 citations and is from a highest quality peer-reviewed journal.</p>
</li>
<li>
<p>(balasco2024acomprehensiveanalysis pages 8-9): Nicole Balasco, Luciana Esposito, Giovanni Smaldone, Marco Salvatore, and Luigi Vitagliano. A comprehensive analysis of the structural recognition between kctd proteins and cullin 3. International Journal of Molecular Sciences, 25:1881, Feb 2024. URL: https://doi.org/10.3390/ijms25031881, doi:10.3390/ijms25031881. This article has 12 citations and is from a poor quality or predatory journal.</p>
</li>
<li>
<p>(mansouri2023proteinnetworksassociated pages 13-15): Mahnaz Mansouri, Leopold Kremser, Thanh-Phuong Nguyen, Yu Kasugai, Laura Caberlotto, Martin Gassmann, Bettina Sarg, Herbert Lindner, Bernhard Bettler, Lucia Carboni, and Francesco Ferraguti. Protein networks associated with native metabotropic glutamate 1 receptors (mglu1) in the mouse cerebellum. Cells, 12:1325, May 2023. URL: https://doi.org/10.3390/cells12091325, doi:10.3390/cells12091325. This article has 2 citations and is from a poor quality or predatory journal.</p>
</li>
<li>
<p>(turecek2023theroleof pages 6-7): Rostislav Tureƒçek, Adolf Melichar, Michaela Kr√°l√≠kov√°, and Bohdana Hru≈°kov√°. The role of gabab receptors in the subcortical pathways of the mammalian auditory system. Frontiers in Endocrinology, Aug 2023. URL: https://doi.org/10.3389/fendo.2023.1195038, doi:10.3389/fendo.2023.1195038. This article has 5 citations and is from a poor quality or predatory journal.</p>
</li>
<li>
<p>(coevordenhameete2019theexpandedclinical pages 1-2): Marleen H van Coevorden-Hameete, Marienke A A M de Bruijn, Esther de Graaff, Danielle A E M Bastiaansen, Marco W J Schreurs, Jeroen A A Demmers, Melanie Ramberger, Esther S P Hulsenboom, Mariska M P Nagtzaam, Sanae Boukhrissi, Jan H Veldink, Jan J G M Verschuuren, Casper C Hoogenraad, Peter A E Sillevis Smitt, and Maarten J Titulaer. The expanded clinical spectrum of anti-gababr encephalitis and added value of kctd16 autoantibodies. Brain, 142:1631-1643, Apr 2019. URL: https://doi.org/10.1093/brain/awz094, doi:10.1093/brain/awz094. This article has 105 citations and is from a highest quality peer-reviewed journal.</p>
</li>
<li>
<p>(zheng2019structuralbasisfor pages 18-22): Sanduo Zheng, Nohely Abreu, Joshua Levitz, and Andrew C. Kruse. Structural basis for kctd-mediated rapid desensitization of gabab signalling. Nature, 567:127-131, Feb 2019. URL: https://doi.org/10.1038/s41586-019-0990-0, doi:10.1038/s41586-019-0990-0. This article has 97 citations and is from a highest quality peer-reviewed journal.</p>
</li>
</ol>
<h2 id="citations">Citations</h2>
<ol>
<li>metz2011distributionofthe pages 7-10</li>
<li>gonzalezhernandez2024emergingmodesof pages 7-9</li>
<li>balasco2024acomprehensiveanalysis pages 8-9</li>
<li>mansouri2023proteinnetworksassociated pages 13-15</li>
<li>turecek2023theroleof pages 6-7</li>
<li>rajalu2015pharmacologicalcharacterizationof pages 5-7</li>
<li>coevordenhameete2019theexpandedclinical pages 1-2</li>
<li>muntean2022membersofthe pages 3-5</li>
<li>zuo2019structuralbasisfor pages 1-1</li>
<li>zheng2019structuralbasisfor pages 1-2</li>
<li>zuo2019structuralbasisfor pages 7-7</li>
<li>zheng2019structuralbasisfor pages 2-4</li>
<li>zuo2019structuralbasisfor pages 1-3</li>
<li>zuo2019structuralbasisfor pages 9-10</li>
<li>zheng2019structuralbasisfor pages 12-16</li>
<li>zheng2019structuralbasisfor pages 18-22</li>
<li>https://doi.org/10.1073/pnas.1903024116;</li>
<li>https://doi.org/10.1038/s41586-019-0990-0</li>
<li>https://doi.org/10.1073/pnas.1903024116</li>
<li>https://doi.org/10.1016/j.neuropharm.2014.08.020;</li>
<li>https://doi.org/10.1073/pnas.2119237119</li>
<li>https://doi.org/10.1002/cne.22610</li>
<li>https://doi.org/10.1016/j.tins.2024.05.008</li>
<li>https://doi.org/10.3390/ijms25031881</li>
<li>https://doi.org/10.3390/cells12091325</li>
<li>https://doi.org/10.3389/fendo.2023.1195038</li>
<li>https://doi.org/10.1016/j.neuropharm.2014.08.020</li>
<li>https://doi.org/10.1093/brain/awz094</li>
<li>https://doi.org/10.1038/s41586-019-0990-0;</li>
<li>https://doi.org/10.1073/pnas.1903024116,</li>
<li>https://doi.org/10.1038/s41586-019-0990-0,</li>
<li>https://doi.org/10.1016/j.neuropharm.2014.08.020,</li>
<li>https://doi.org/10.1073/pnas.2119237119,</li>
<li>https://doi.org/10.1002/cne.22610,</li>
<li>https://doi.org/10.1016/j.tins.2024.05.008,</li>
<li>https://doi.org/10.3390/ijms25031881,</li>
<li>https://doi.org/10.3390/cells12091325,</li>
<li>https://doi.org/10.3389/fendo.2023.1195038,</li>
<li>https://doi.org/10.1093/brain/awz094,</li>
</ol>
            </div>
        </details>
        
        <details class="markdown-section">
            <summary style="display: flex; justify-content: space-between; align-items: center; cursor: pointer;">
                <div style="flex: 1;">
                    <h3 style="display: inline;">Deep Research Openai</h3>
                    <span style="font-size: 0.8rem; color: #666; margin-left: 1rem;">(KCTD16-deep-research-openai.md)</span>
                </div>
                <div class="vote-buttons" data-g="Q68DU8" data-a="DOC: Deep Research Openai" data-r="" data-act="DOCUMENTATION" style="display: flex; gap: 0.25rem;">
                    <button class="vote-btn" data-v="up" title="This documentation is helpful">üëç</button>
                    <button class="vote-btn" data-v="down" title="This documentation needs improvement">üëé</button>
                </div>
            </summary>
            <div class="markdown-content">
                <hr />
<p>provider: openai<br />
model: o3-deep-research-2025-06-26<br />
cached: false<br />
start_time: '2025-12-27T16:59:33.620611'<br />
end_time: '2025-12-27T17:18:21.824010'<br />
duration_seconds: 1128.2<br />
template_file: templates/gene_research_go_focused.md<br />
template_variables:<br />
  organism: human<br />
  gene_id: KCTD16<br />
  gene_symbol: KCTD16<br />
  uniprot_accession: Q68DU8<br />
  protein_description: 'RecName: Full=BTB/POZ domain-containing protein KCTD16; AltName:<br />
    Full=Potassium channel tetramerization domain-containing protein 16;'<br />
  gene_info: Name=KCTD16; Synonyms=KIAA1317;<br />
  organism_full: Homo sapiens (Human).<br />
  protein_family: Not specified in UniProt<br />
  protein_domains: BTB/POZ_dom. (IPR000210); H1_KCTD16. (IPR049903); SKP1/BTB/POZ_sf.<br />
    (IPR011333); T1-type_BTB. (IPR003131); BTB_2 (PF02214)<br />
provider_config:<br />
  timeout: 600<br />
  max_retries: 3<br />
  parameters:<br />
    allowed_domains: []<br />
    temperature: 0.1<br />
    top_p: 1.0<br />
citation_count: 109</p>
<hr />
<h2 id="question">Question</h2>
<h1 id="gene-research-for-functional-annotation">Gene Research for Functional Annotation</h1>
<h2 id="critical-geneprotein-identification-context">‚ö†Ô∏è CRITICAL: Gene/Protein Identification Context</h2>
<p><strong>BEFORE YOU BEGIN RESEARCH:</strong> You MUST verify you are researching the CORRECT gene/protein. Gene symbols can be ambiguous, especially for less well-characterized genes from non-model organisms.</p>
<h3 id="target-geneprotein-identity-from-uniprot">Target Gene/Protein Identity (from UniProt):</h3>
<ul>
<li><strong>UniProt Accession:</strong> Q68DU8</li>
<li><strong>Protein Description:</strong> RecName: Full=BTB/POZ domain-containing protein KCTD16; AltName: Full=Potassium channel tetramerization domain-containing protein 16;</li>
<li><strong>Gene Information:</strong> Name=KCTD16; Synonyms=KIAA1317;</li>
<li><strong>Organism (full):</strong> Homo sapiens (Human).</li>
<li><strong>Protein Family:</strong> Not specified in UniProt</li>
<li><strong>Key Domains:</strong> BTB/POZ_dom. (IPR000210); H1_KCTD16. (IPR049903); SKP1/BTB/POZ_sf. (IPR011333); T1-type_BTB. (IPR003131); BTB_2 (PF02214)</li>
</ul>
<h3 id="mandatory-verification-steps">MANDATORY VERIFICATION STEPS:</h3>
<ol>
<li><strong>Check if the gene symbol "KCTD16" matches the protein description above</strong></li>
<li><strong>Verify the organism is correct:</strong> Homo sapiens (Human).</li>
<li><strong>Check if protein family/domains align with what you find in literature</strong></li>
<li><strong>If you find literature for a DIFFERENT gene with the same or similar symbol, STOP</strong></li>
</ol>
<h3 id="if-gene-symbol-is-ambiguous-or-you-cannot-find-relevant-literature">If Gene Symbol is Ambiguous or You Cannot Find Relevant Literature:</h3>
<p><strong>DO NOT PROCEED WITH RESEARCH ON A DIFFERENT GENE.</strong> Instead:<br />
- State clearly: "The gene symbol 'KCTD16' is ambiguous or literature is limited for this specific protein"<br />
- Explain what you found (e.g., "Found extensive literature on a different gene with the same symbol in a different organism")<br />
- Describe the protein based ONLY on the UniProt information provided above<br />
- Suggest that the protein function can be inferred from domain/family information</p>
<h3 id="research-target">Research Target:</h3>
<p>Please provide a comprehensive research report on the gene <strong>KCTD16</strong> (gene ID: KCTD16, UniProt: Q68DU8) in human.</p>
<p>The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.</p>
<p>You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement<br />
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.</p>
<p>We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.</p>
<p>We are interested in where in or outside the cell the gene product carries out its function.</p>
<p>We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.</p>
<p>Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.</p>
<h2 id="output">Output</h2>
<h1 id="introduction-and-key-concepts">Introduction and Key Concepts</h1>
<p><strong>KCTD16 (Potassium Channel Tetramerization Domain-containing protein 16)</strong> is a human gene (UniProt Q68DU8) encoding a BTB/POZ domain protein in the KCTD family. Despite the name, KCTD proteins are not ion channels; they are soluble adaptor or scaffold proteins defined by an N-terminal BTB domain (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10856315/#:~:text=domains%20embedded%20in%20potassium%20channels,little%20involvement%20in%20potassium%20channeling">pmc.ncbi.nlm.nih.gov</a>). KCTD16 is one of four KCTD subunits (along with KCTD8, KCTD12, and KCTD12b) that serve as auxiliary subunits of the GABA_B (Œ≥-aminobutyric acid type B) receptor in the brain (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6566181/#:~:text=Mouse%20Kctd8%2C%20Kctd12%2C%20Kctd12b%20,Therefore%2C%20disruption%20of%20the%20auxiliary">pmc.ncbi.nlm.nih.gov</a>). The GABA_B receptor is a metabotropic G-protein-coupled receptor (GPCR) that mediates slow inhibitory neurotransmission. It consists of principal subunits (GABA_B1 and GABA_B2) forming the core receptor, and auxiliary subunits like KCTD16 which modulate the receptor‚Äôs signaling output (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6486783/#:~:text=Malfunction%20of%20the%20receptor%20is,to%20neurotransmitters%2C%20while%20the%20auxiliary">pmc.ncbi.nlm.nih.gov</a>). KCTD16‚Äôs association with GABA_B receptors is supported by proteomic studies that identified KCTD8/12/16 as stable components of native GABA_B receptor complexes (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC8121548/#:~:text=Four%20KCTD%20subunits%2C%20KCTD8%2C%2012%2C,subunits%20are%20composed%20of%20an">pmc.ncbi.nlm.nih.gov</a>). In essence, KCTD16 acts as a non-catalytic regulatory protein that fine-tunes GABA_B receptor function, rather than directly performing enzyme or transporter activity. This modulatory role is significant because GABA_B receptor malfunction is linked to neurological and mood disorders (spasticity, epilepsy, addiction, anxiety) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6486783/#:~:text=Malfunction%20of%20the%20receptor%20is,to%20neurotransmitters%2C%20while%20the%20auxiliary">pmc.ncbi.nlm.nih.gov</a>). Understanding KCTD16 is therefore key to understanding how inhibitory synaptic signals are shaped and how their dysregulation might contribute to disease.</p>
<p><strong>Gene and Protein Features:</strong> The human <em>KCTD16</em> gene (also known as <em>KIAA1317</em>) is predominantly expressed in the brain (showing biased brain enrichment in RNA profiling) (<a href="https://www.ncbi.nlm.nih.gov/gene?Cmd=DetailsSearch&amp;Db=gene&amp;Term=57528#:~:text=Expression%20Biased%20expression%20in%20brain,other%20tissues%20See%20more%20Orthologs">www.ncbi.nlm.nih.gov</a>). Its protein product is ~285 amino acids and contains a BTB/POZ domain (also called a T1 domain) at the N-terminus, which mediates protein oligomerization. KCTD16 belongs to the ‚Äúclade F‚Äù subgroup of KCTDs, along with KCTD8 and KCTD12, which share sequence homology in their C-termini (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6566181/#:~:text=3,in%20neurotransmitter%20receptor%20signaling">pmc.ncbi.nlm.nih.gov</a>). Notably, unlike many BTB-domain proteins that function as Cullin-3 ubiquitin ligase adaptors, KCTD16 does <strong>not</strong> bind to the Cul3 scaffold and is not known to participate in ubiquitin E3 ligase complexes (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC5664961/#:~:text=domains%20with%20the%20exception%20of,KCTD13%20%28K_%7Bd%7D%E2%80%89%3D%E2%80%89100%E2%80%85nM%29%2C%20KCTD10">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC5664961/#:~:text=Evolutionarily%20distant%20from%20these%20family,here%20that%20this%20geometry%20is">pmc.ncbi.nlm.nih.gov</a>). Instead, its BTB domain primarily mediates assembly into a higher-order complex. Biophysical studies have revealed that the BTB domain of KCTD16 forms an <strong>oligomeric structure (a pentamer)</strong> with a distinctive ‚Äúopen‚Äù pentameric conformation (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC5664961/#:~:text=,Cul3%20and%20were%20observed%20to">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC5664961/#:~:text=domains%20with%20the%20exception%20of,KCTD13%20%28K_%7Bd%7D%E2%80%89%3D%E2%80%89100%E2%80%85nM%29%2C%20KCTD10">pmc.ncbi.nlm.nih.gov</a>). Within GABA_B receptor complexes, KCTD16 and related subunits can attach as homo-pentamers or even form hetero-oligomers (mixing different KCTD types), wrapping around the cytosolic tail of the GABA_B2 subunit (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC8121548/#:~:text=Four%20KCTD%20subunits%2C%20KCTD8%2C%2012%2C,subunits%20are%20composed%20of%20an">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6566181/#:~:text=increase%20the%20activation%20rate%20of,19">pmc.ncbi.nlm.nih.gov</a>). This unique pentameric assembly is a hallmark of the KCTD family‚Äôs interaction with receptors and contrasts with the dimeric assemblies of BTB domains in typical Cullin3-adaptor proteins.</p>
<h1 id="structure-and-domain-organization">Structure and Domain Organization</h1>
<p><strong>BTB/POZ Domain:</strong> The N-terminal BTB domain (‚àº130 amino acids) of KCTD16 is responsible for both KCTD16‚Äôs self-oligomerization and its docking to the GABA_B2 receptor. A high-resolution crystal structure (2019) of the human KCTD16 BTB domain bound to a GABA_B2 tail peptide (residues 895‚Äì909) revealed how five KCTD16 subunits form a pentameric ring encircling the receptor‚Äôs cytoplasmic tail (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6566181/#:~:text=increase%20the%20activation%20rate%20of,19">pmc.ncbi.nlm.nih.gov</a>). Point mutations in this interface (e.g. KCTD16 Phe80‚ÜíAla in the BTB domain) abolish binding to GABA_B2, confirming that the BTB domain is the contact site for the receptor (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6566181/#:~:text=increase%20the%20activation%20rate%20of,19">pmc.ncbi.nlm.nih.gov</a>). The BTB domain also underlies the ability of different KCTDs to form mixed complexes. Studies have shown KCTD16 can form hetero-pentamers with KCTD12 or KCTD8 when co-expressed, producing intermediate functional properties (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC8121548/#:~:text=Four%20KCTD%20subunits%2C%20KCTD8%2C%2012%2C,subunits%20are%20composed%20of%20an">pmc.ncbi.nlm.nih.gov</a>). This suggests the BTB domains of clade F KCTDs are compatible enough to co-assemble, diversifying the potential regulatory outcomes at GABA_B receptors. Notably, the KCTD16 BTB domain adopts an ‚Äúopen‚Äù pentamer conformation (a somewhat expanded pentamer) as opposed to the more symmetric closed pentamers seen in some other KCTDs (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC5664961/#:~:text=,Cul3%20and%20were%20observed%20to">pmc.ncbi.nlm.nih.gov</a>). This open architecture may relate to its inability to bind Cul3 (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC5664961/#:~:text=domains%20with%20the%20exception%20of,KCTD13%20%28K_%7Bd%7D%E2%80%89%3D%E2%80%89100%E2%80%85nM%29%2C%20KCTD10">pmc.ncbi.nlm.nih.gov</a>) and possibly to how it accommodates the receptor tail. Indeed, a comparative structural analysis in 2017 found that KCTD16 (and the related KCTD1) form unusual pentamers and do not interact with Cul3, whereas other KCTDs form tighter oligomers that readily bind Cul3 (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC5664961/#:~:text=Evolutionarily%20distant%20from%20these%20family,here%20that%20this%20geometry%20is">pmc.ncbi.nlm.nih.gov</a>).</p>
<p><strong>C-terminal Domains (H1 and H2):</strong> Beyond the BTB domain, KCTD16 contains two conserved C-terminal regions, historically termed the H1 and H2 domains (homology domains 1 and 2) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6486783/#:~:text=of%20KCTD12%20and%20KCTD12b%20mediate,20%2C%2023">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6566181/#:~:text=H2%20is%20not%20present%20in,from%20the%20inhibited%20trimeric%20G%E2%80%90protein">pmc.ncbi.nlm.nih.gov</a>). These domains are crucial for KCTD16‚Äôs regulatory function. The H1 domain (present in KCTD8, 12, and 16) mediates interactions with G-protein beta-gamma subunits (GŒ≤Œ≥) and is directly responsible for altering GABA_B signaling kinetics (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6566181/#:~:text=H2%20is%20not%20present%20in,from%20the%20inhibited%20trimeric%20G%E2%80%90protein">pmc.ncbi.nlm.nih.gov</a>). In contrast, the H2 domain exists in KCTD8 and KCTD16 but is <strong>absent in KCTD12</strong>, and it serves an autoinhibitory role: the H2 region of KCTD16 can fold back onto its H1 domain to modulate or restrain its activity (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6566181/#:~:text=H2%20is%20not%20present%20in,from%20the%20inhibited%20trimeric%20G%E2%80%90protein">pmc.ncbi.nlm.nih.gov</a>). Functional assays demonstrated that the H1 domain of KCTD12 alone is sufficient to induce rapid desensitization of GABA_B responses, whereas KCTD16‚Äôs H2 domain counteracts such an effect in KCTD16 (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6566181/#:~:text=H2%20is%20not%20present%20in,from%20the%20inhibited%20trimeric%20G%E2%80%90protein">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6486783/#:~:text=of%20KCTD12%20and%20KCTD12b%20mediate,20%2C%2023">pmc.ncbi.nlm.nih.gov</a>). In other words, <strong>KCTD16‚Äôs H2 segment prevents the H1 segment from over-sequestering the G-protein</strong>, thereby <strong>suppressing rapid desensitization</strong> that would otherwise occur. A 2012 biochemical study provided evidence for this: swapping or mutating these domains showed that only KCTD8 and KCTD16 (which have H2) generated sustained, non-desensitizing currents, whereas KCTD12 (lacking H2) caused pronounced desensitization (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6486783/#:~:text=%2820%2C%2022%29,In%20genetic">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6486783/#:~:text=of%20KCTD12%20and%20KCTD12b%20mediate,20%2C%2023">pmc.ncbi.nlm.nih.gov</a>). This domain organization (BTB‚ÄìH1‚ÄìH2) defines KCTD16‚Äôs function as a modulator that can both <strong>accelerate and limit</strong> receptor signaling, as discussed below.</p>
<h1 id="role-in-gabab-receptor-function">Role in GABA<sub>B</sub> Receptor Function</h1>
<p><strong>Auxiliary Subunit Function:</strong> KCTD16 is an integral auxiliary component of the GABA_B receptor signaling complex. GABA_B receptors are obligatory heterodimers (GABA_B1 binds the neurotransmitter GABA, and GABA_B2 couples to G-proteins) that signal via Gi/Go proteins to regulate downstream effectors like ion channels (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6566181/#:~:text=further%20advance%20the%20field%20overall,B2%7D%20%28amino%20acid%20residues">pmc.ncbi.nlm.nih.gov</a>). When KCTD16 associates with the GABA_B2 subunit‚Äôs intracellular tail, it does not affect GABA binding directly, but it profoundly influences the receptor‚Äôs signaling <strong>kinetics and pharmacology</strong> (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC8121548/#:~:text=Four%20KCTD%20subunits%2C%20KCTD8%2C%2012%2C,subunits%20are%20composed%20of%20an">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6566181/#:~:text=synaptic%20transmission%20by%20indirectly%20regulating,33">pmc.ncbi.nlm.nih.gov</a>). Specifically, KCTD16 (as well as KCTD8 and KCTD12) determines how quickly and for how long the GABA_B receptor can activate G-protein gated inward-rectifier K^+ channels (GIRKs) and inhibit Ca^2+ channels on neurons. Experimental studies comparing receptor responses have shown that: </p>
<ul>
<li>
<p><strong>Faster Onset:</strong> The presence of KCTD subunits speeds up the onset of GABA_B-mediated currents. All three auxiliary subunits (8, 12, 16) were found to <strong>increase the activation rate</strong> of GIRK currents following GABA_B stimulation, compared to receptors without KCTDs (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6566181/#:~:text=synaptic%20transmission%20by%20indirectly%20regulating,33">pmc.ncbi.nlm.nih.gov</a>). This is attributed to a ‚Äúpre-assembled‚Äù signaling complex: KCTD16 tethers parts of the G-protein in close proximity to the receptor and effector channel, so that when GABA binds, the channel opens more rapidly. A recent study (Biochem. Pharmacol. 2024) confirmed that KCTD proteins can preassemble specific GŒ≤Œ≥ subunits with the GABA_B receptor, markedly accelerating GIRK channel gating upon receptor activation (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6566181/#:~:text=channels%20through%20trimeric%20G%E2%80%90proteins,B2%7D%20%28amino%20acid%20residues">pmc.ncbi.nlm.nih.gov</a>). In practical terms, neurons expressing KCTD16 exhibit a quicker inhibitory postsynaptic potential in response to GABA, enhancing the timing precision of synaptic inhibition.</p>
</li>
<li>
<p><strong>Desensitization and Persistence:</strong> While KCTD12 causes the GABA_B response to <strong>desensitize rapidly</strong> (fade away even in continued presence of agonist), KCTD16 has the opposite effect ‚Äì it largely <strong>prevents rapid desensitization</strong>, allowing a more sustained response (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6486783/#:~:text=%2820%2C%2022%29,In%20genetic">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6566181/#:~:text=GABA_,channel%29.%20Then">pmc.ncbi.nlm.nih.gov</a>). Electrophysiological studies in heterologous cells have demonstrated this stark difference. In cells expressing GABA_B plus KCTD12, GABA-triggered K^+ currents peak and then quickly diminish (due to KCTD12 uncoupling the G-protein), whereas with KCTD16, the induced currents remain near peak as long as GABA is present (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6486783/#:~:text=%2820%2C%2022%29,In%20genetic">pmc.ncbi.nlm.nih.gov</a>). KCTD16‚Äôs H2 domain is responsible for this sustained signaling ‚Äì it blocks the desensitizing action that the H1 domain would otherwise exert (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6566181/#:~:text=H2%20is%20not%20present%20in,from%20the%20inhibited%20trimeric%20G%E2%80%90protein">pmc.ncbi.nlm.nih.gov</a>). Therefore, KCTD16-containing GABA_B receptors produce more persistent inhibitory signals. This has been observed <strong>in vitro</strong> and is supported by chimeric domain-swap experiments: inserting the H2 domain of KCTD16 into KCTD12 can convert KCTD12 into a non-desensitizing variant (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6486783/#:~:text=%2820%2C%2022%29,In%20genetic">pmc.ncbi.nlm.nih.gov</a>). In summary, <strong>KCTD16 acts as a brake on desensitization</strong>, promoting longer-lasting GABA_B receptor activity.</p>
</li>
<li>
<p><strong>Pharmacological Modulation:</strong> By altering kinetics, KCTD16 also subtly changes the pharmacological profile of GABA_B receptors. For example, receptors with different KCTD subunits can show different sensitivities to agonists or differences in how quickly they shut off after agonist removal (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC8121548/#:~:text=Four%20KCTD%20subunits%2C%20KCTD8%2C%2012%2C,subunits%20are%20composed%20of%20an">pmc.ncbi.nlm.nih.gov</a>). A 2017 study found that hetero-oligomers of KCTD12/16 confer unique kinetic and pharmacological properties not seen with either subunit alone (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC8121548/#:~:text=Four%20KCTD%20subunits%2C%20KCTD8%2C%2012%2C,subunits%20are%20composed%20of%20an">pmc.ncbi.nlm.nih.gov</a>). KCTD16 might also influence the efficacy of allosteric modulators or the extent of GABA_B‚Äôs effect on second messengers (like cAMP), although this is an area of ongoing research. It‚Äôs worth noting that GABA_B receptors are clinical drug targets (e.g. baclofen is a GABA_B agonist for spasticity), and thus understanding KCTD16‚Äôs effect has therapeutic implications. If KCTD16 makes receptor signaling more sustained, drugs that enhance KCTD16 expression or function could potentially prolong GABA_B signaling in disorders where it is beneficial (conversely, dampening KCTD12‚Äôs effect might prevent excessive desensitization in chronic treatment settings) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6486783/#:~:text=studies%2C%20the%20KCTD12%20gene%20has,B">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6566181/#:~:text=inhibitory%20and%20excitatory%20neurons,mice%20exhibit%20related%20phenotypes%20including">pmc.ncbi.nlm.nih.gov</a>).</p>
</li>
</ul>
<p><strong>Mechanistic Basis ‚Äì G-protein Interaction:</strong> KCTD16 modulates receptor signaling by directly interacting with the G-protein subunits released upon receptor activation. Normally, when GABA_B is stimulated, the GŒ±_o/i subunit inhibits adenylate cyclase and the GŒ≤Œ≥ dimer opens GIRK channels and inhibits Ca^2+ channels. KCTD16, tethered to GABA_B2, interacts with the GŒ≤Œ≥ dimer via its H1 domain (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC9976452/#:~:text=H1%20domain%20that%20is%20exclusive,was%20sufficient%20for%20interaction%20with">pmc.ncbi.nlm.nih.gov</a>). Biochemical and biophysical experiments have shown that <strong>KCTD16 can bind GŒ≤Œ≥ even <em>before</em> receptor activation</strong>, effectively sequestering GŒ≤Œ≥ near the receptor at rest (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC9976452/#:~:text=KCTD5%2C%20and%20KCTD12%29,In%20addition%2C%20we%20revealed">pmc.ncbi.nlm.nih.gov</a>). In a 2023 study using bioluminescence resonance energy transfer (BRET), KCTD16 exhibited a high basal association with GŒ≤Œ≥ and only a modest further change after receptor stimulation, indicating that KCTD16-GŒ≤Œ≥ complexes exist prior to agonist binding (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC9976452/#:~:text=KCTD5%2C%20and%20KCTD12%29,In%20addition%2C%20we%20revealed">pmc.ncbi.nlm.nih.gov</a>). This pre-association explains the accelerated channel activation: the GŒ≤Œ≥ is already ‚Äúin position‚Äù to gate the K^+ channel once GABA triggers GŒ± subunit dissociation. However, unlike KCTD12, KCTD16‚Äôs grip on GŒ≤Œ≥ is self-limited by the H2 domain. Structural insights highlight this difference: a <strong>2019 cryo-EM structure</strong> of KCTD12‚Äôs H1 domain bound to GŒ≤_1Œ≥_2 showed a pentameric H1 ‚Äútentacle‚Äù surrounded by five GŒ≤Œ≥ dimers (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6566181/#:~:text=GABA_,together%2C%20the%20proposed%20model%20is">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6566181/#:~:text=GABA_,channel%29.%20Then">pmc.ncbi.nlm.nih.gov</a>). KCTD12 effectively cages multiple GŒ≤Œ≥ subunits, pulling them away from the membrane which causes rapid channel closure (desensitization) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6566181/#:~:text=KCTD12%20H1%20bound%20to%20G%CE%B2_,19%20A%20role%20for%20KCTD12">pmc.ncbi.nlm.nih.gov</a>). KCTD16‚Äôs H2 domain likely prevents such a tight GŒ≤Œ≥ binding configuration, so GŒ≤Œ≥ remains available to continue signaling. In line with this model, <em>in vitro</em> assays demonstrated that mutating KCTD16‚Äôs H2 domain leads to enhanced desensitization, behaving more like KCTD12 (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6566181/#:~:text=H2%20is%20not%20present%20in,from%20the%20inhibited%20trimeric%20G%E2%80%90protein">pmc.ncbi.nlm.nih.gov</a>). Figurely, one can imagine the KCTD16 pentamer dangling from the receptor tail: upon GABA binding, KCTD16 helps push the GŒ± subunit off (facilitating GŒ≤Œ≥ activation of GIRK), but then refrains from clamping onto GŒ≤Œ≥, allowing the channel to stay open (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6566181/#:~:text=KCTD12%20H1%20bound%20to%20G%CE%B2_,19%20A%20role%20for%20KCTD12">pmc.ncbi.nlm.nih.gov</a>). This model ‚Äì where KCTD12 is an ‚Äúoff-switch‚Äù and KCTD16 a ‚Äúsustain-switch‚Äù for GABA_B signaling ‚Äì is supported by multiple lines of evidence including co-immunoprecipitation (showing KCTD16 robustly pulls down GŒ≤Œ≥ in cell extracts) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC9976452/#:~:text=match%20at%20L165%20Given%20that,myc%20tag%20to%20the%20carboxy">pmc.ncbi.nlm.nih.gov</a>) and electrophysiology in neurons (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6486783/#:~:text=%2820%2C%2022%29,In%20genetic">pmc.ncbi.nlm.nih.gov</a>).</p>
<h1 id="biological-processes-and-localization">Biological Processes and Localization</h1>
<p><strong>Cellular and Tissue Localization:</strong> KCTD16 is primarily a neuronal protein. It is expressed throughout the central nervous system, with mRNA and protein found in many brain regions (Human Protein Atlas data indicate highest expression in brain, with very low levels in peripheral tissues) (<a href="https://www.ncbi.nlm.nih.gov/gene?Cmd=DetailsSearch&amp;Db=gene&amp;Term=57528#:~:text=Expression%20Biased%20expression%20in%20brain,other%20tissues%20See%20more%20Orthologs">www.ncbi.nlm.nih.gov</a>). Within neurons, KCTD16 is localized to the <strong>cytoplasmic side of the plasma membrane</strong> wherever GABA_B receptors reside. GABA_B receptors are present both post-synaptically (on dendrites of neurons, mediating slow inhibitory postsynaptic currents) and pre-synaptically (on nerve terminals, modulating neurotransmitter release) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6566181/#:~:text=considered%20auxiliary%20subunits%20of%20the,to%20contribute%20to%20bipolar%20I">pmc.ncbi.nlm.nih.gov</a>). Auxillary subunits like KCTD16 have been identified in both contexts. For instance, one study noted that KCTD16 (and KCTD8/12) are present in <em>excitatory</em> as well as <em>inhibitory</em> neurons, indicating a broad role in tuning synaptic transmission across different circuit types (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6566181/#:~:text=considered%20auxiliary%20subunits%20of%20the,to%20contribute%20to%20bipolar%20I">pmc.ncbi.nlm.nih.gov</a>). KCTD16 lacks any transmembrane region; it is peripherally attached to membranes via protein‚Äìprotein interactions. Specifically, KCTD16 co-assembles with GABA_B2 subunits in the endoplasmic reticulum and Golgi during receptor trafficking, and this complex trafficks to the cell surface as a unit (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC8121548/#:~:text=Four%20KCTD%20subunits%2C%20KCTD8%2C%2012%2C,subunits%20are%20composed%20of%20an">pmc.ncbi.nlm.nih.gov</a>). Evidence for this comes from co-expression experiments where KCTD subunits were required for efficient surface expression of GABA_B in certain neurons (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC8896537/#:~:text=KCTD8%20and%20KCTD12%20Facilitate%20Axonal,5%7D%2C%20Minmin%20Luo">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pubmed.ncbi.nlm.nih.gov/27717812/#:~:text=subunit%20KCTD16%20,pathophysiology%20of%20a%20number%20of">pubmed.ncbi.nlm.nih.gov</a>). Moreover, imaging of tagged KCTD16 has shown a punctate distribution in neurites consistent with clustering at GABA_B receptor sites (e.g. in dendritic spines or axon terminals where GABA_B receptors concentrate). </p>
<p>Functionally, <strong>KCTD16 operates at the interface of the receptor and intracellular signaling pathways</strong>, making it part of the inhibitory signaling microdomain. By shaping GABA_B receptor signaling, KCTD16 indirectly influences downstream processes such as neuronal excitability, synaptic plasticity, and network oscillations. For example, a GABA_B receptor on a presynaptic terminal can inhibit neurotransmitter release via GŒ≤Œ≥-mediated inhibition of voltage-gated Ca^2+ channels. If that receptor complex contains KCTD16, the inhibition might set in quickly and last longer during a burst of GABA, compared to another synapse with KCTD12 where inhibition would fade more quickly. Similarly, postsynaptically, KCTD16-containing receptors mediate longer GIRK channel openings, affecting the duration of slow inhibitory postsynaptic potentials. These differences can translate into measurable effects on behavior and physiology, as described below.</p>
<p><strong>Biological Processes and Pathways:</strong> KCTD16 is chiefly involved in the <strong>GABAergic inhibitory pathway</strong>. It plays a role in:<br />
- <em>Regulation of postsynaptic membrane potential:</em> By controlling GIRK channel activity through GABA_B, KCTD16 helps regulate the postsynaptic excitability of neurons (<a href="https://www.ncbi.nlm.nih.gov/gene?Cmd=DetailsSearch&amp;Db=gene&amp;Term=57528#:~:text=Summary%20Predicted%20to%20enable%20G,involved%20in%20regulation%20of%20presynaptic">www.ncbi.nlm.nih.gov</a>). In GO annotations, KCTD16 has been linked to GPCR signaling involved in postsynaptic membrane potential regulation, which reflects its modulatory effect on ion channel coupling.<br />
- <em>Regulation of presynaptic transmitter release:</em> Via presynaptic GABA_B receptors, KCTD16 can influence neurotransmitter release (GABA_B activation on axon terminals inhibits Ca^2+ influx and transmitter release). KCTD16‚Äôs presence may prolong this inhibition, thus affecting synaptic transmission dynamics during repetitive activity (<a href="https://www.ncbi.nlm.nih.gov/gene?Cmd=DetailsSearch&amp;Db=gene&amp;Term=57528#:~:text=Summary%20Predicted%20to%20enable%20G,involved%20in%20regulation%20of%20presynaptic">www.ncbi.nlm.nih.gov</a>). A recent study in 2021 found that auxiliary KCTD subunits modulate GABA_B-receptor-mediated suppression of neurotransmitter release from specific neurons (e.g. habenula terminals) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC8121548/#:~:text=Four%20KCTD%20subunits%2C%20KCTD8%2C%2012%2C,subunits%20are%20composed%20of%20an">pmc.ncbi.nlm.nih.gov</a>). Although that study focused on KCTD8/12, it underscores the pathway KCTD16 participates in: GABA_B to GŒ≤Œ≥ to Ca^2+ channel inhibition in terminals.<br />
- <em>Second messenger regulation:</em> Through GŒ±_o, GABA_B receptors inhibit adenylate cyclase and reduce cAMP levels. KCTD16 may indirectly modulate this GŒ±-mediated pathway. Interestingly, a 2023 analysis reported that many KCTDs, possibly including KCTD16, can dampen GŒ≤Œ≥-dependent <strong>sensitization of adenylyl cyclase</strong> (a feedback phenomenon) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC9976452/#:~:text=examining%20sensitization%20of%20the%20adenylyl,to%20shape%20GPCR%20signal%20transmission">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC9976452/#:~:text=D2R%E2%86%92G%CE%B1i%20signaling,Curiously%2C%20KCTD9%20slightly%20inhibited">pmc.ncbi.nlm.nih.gov</a>). In striatal neurons, overexpression of certain KCTDs blunted the increase in cAMP that normally follows prolonged Gi signaling, presumably by sequestering GŒ≤Œ≥. While that study highlighted KCTD2/5/17, the shared capacity of KCTD16 to bind GŒ≤Œ≥ suggests it might have a similar influence on cAMP regulation under specific conditions. This places KCTD16 in the context of broader GPCR signaling beyond just ion channel regulation.</p>
<p>Overall, KCTD16‚Äôs activity is tightly connected to the <strong>GABA_B-G protein-GIRK/Ca^2+ channel signaling axis</strong>. By controlling the timing and duration of this inhibitory signaling, KCTD16 contributes to processes like <strong>fear memory, mood regulation, and seizure susceptibility</strong>. Indeed, GABA_B receptors are known to modulate network excitability and synaptic plasticity, and KCTD16 fine-tunes these effects, as evidenced by phenotypes in mice (next section) and associations with psychiatric conditions.</p>
<h1 id="experimental-insights-and-phenotypes">Experimental Insights and Phenotypes</h1>
<p><strong>Knockout Mouse Phenotypes:</strong> Genetic studies provide insight into KCTD16‚Äôs function in vivo. <em>Kctd16</em> knockout mice have been generated and analyzed for behavioral and physiological changes. Notably, mice lacking KCTD16 exhibit <strong>altered fear memory</strong> processing (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6486783/#:~:text=studies%2C%20the%20KCTD12%20gene%20has,B">pmc.ncbi.nlm.nih.gov</a>). In one study, Kctd16^-/- mice demonstrated abnormalities in fear learning paradigms (e.g. auditory cued fear conditioning) compared to wild-type mice (<a href="https://pubmed.ncbi.nlm.nih.gov/27717812/#:~:text=,mice%20show">pubmed.ncbi.nlm.nih.gov</a>). While the detailed results showed some differences distinct from Kctd12^-/- mice, both knockouts point to KCTD subunits affecting emotional memory circuits. Specifically, Kctd16 knockout mice displayed changes in <strong>fear extinction and recall</strong>, suggesting that prolonged inhibitory signaling via GABA_B (which would normally be supported by KCTD16) is important for normal fear memory consolidation and extinction (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6486783/#:~:text=studies%2C%20the%20KCTD12%20gene%20has,B">pmc.ncbi.nlm.nih.gov</a>). These behavioral ‚Äúendophenotypes‚Äù link KCTD16 to the neural circuitry of the amygdala and hippocampus, where fear memories are encoded. Supporting this, <em>in vitro</em> electrophysiology in hippocampal slices from Kctd16^-/- mice showed modified GABA_B-receptor-mediated currents, consistent with the loss of the sustained component normally conferred by KCTD16 (the currents in knockouts desensitized more quickly) (<a href="https://pubmed.ncbi.nlm.nih.gov/27717812/#:~:text=determine%20the%20kinetics%20of%20the,mice%20show">pubmed.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6486783/#:~:text=%2820%2C%2022%29,In%20genetic">pmc.ncbi.nlm.nih.gov</a>). </p>
<p>This phenotype parallels findings in <em>Kctd12</em> knockout mice, which have increased anxiety-like behavior and enhanced cued fear learning (<a href="https://pubmed.ncbi.nlm.nih.gov/27717812/#:~:text=,mice%20show">pubmed.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6566181/#:~:text=disorders,several%20cancers%20not%20discussed%20here">pmc.ncbi.nlm.nih.gov</a>). The fact that removing either KCTD16 or KCTD12 impacts fear and anxiety behaviors underscores the importance of properly timed GABA_B inhibition in regulating emotion. It has been proposed that KCTD16 might be more relevant in certain brain regions or developmental periods ‚Äì for instance, KCTD16 mRNA is enriched in the forebrain (cortex, hippocampus) during development, hinting it could shape the maturation of synaptic inhibition and plasticity. More research is needed, but the available evidence firmly places KCTD16 in the context of <strong>neuropsychiatric-relevant phenotypes</strong>. As one expert review noted, disruption of KCTD8/12/16 could contribute to ‚Äúrelated conditions‚Äù given GABA_B‚Äôs implication in disorders like epilepsy, depression, and schizophrenia (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6566181/#:~:text=inhibitory%20and%20excitatory%20neurons,mice%20exhibit%20related%20phenotypes%20including">pmc.ncbi.nlm.nih.gov</a>). No gross developmental abnormalities were reported in Kctd16 knockout mice, suggesting KCTD16‚Äôs role is more in neural communication than in brain morphogenesis.</p>
<p><strong>Disease Associations:</strong> While no single-gene Mendelian disorders are linked to <em>KCTD16</em>, there are hints from human genetics and clinical studies that KCTD16 may be involved in neuropsychiatric conditions. The <em>KCTD16</em> gene lies on chromosome 5q31.3; this region has not been as prominently highlighted in genome-wide association studies as the 16p11.2 locus containing <em>KCTD13</em>, for example. However, because KCTD16 modulates GABA_B receptors ‚Äì and GABA_B dysfunction has been associated with mood disorders, addiction, and epilepsy ‚Äì researchers have posited that <em>KCTD16</em> variants could influence disease risk. A 2019 review pointed out that <strong>elevated KCTD12 protein levels</strong> were observed in brains of patients with depression and schizophrenia, linking GABA_B receptor modulators to those illnesses (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6566181/#:~:text=subunits%20KCTD8%2C%20KCTD12%2C%20and%20KCTD16,64%20Consistent%20with">pmc.ncbi.nlm.nih.gov</a>). By analogy, changes in KCTD16 expression or function might also affect mood regulation. Indeed, both KCTD12 and KCTD16 are mentioned as potentially contributing to <strong>neuropsychiatric phenotypes</strong> (with KCTD12 more firmly tied via human data, and KCTD16 via animal data) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6566181/#:~:text=3,in%20neurotransmitter%20receptor%20signaling">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6566181/#:~:text=KCTD12%20and%20KCTD16,function%20and%2For%20GTPase%20modulated%20ion">pmc.ncbi.nlm.nih.gov</a>). So far, direct genetic associations for <em>KCTD16</em> are limited, but one study did find that <em>KCTD16</em> was among genes with altered expression in stress-related mouse models (though changes in KCTD16 have not been confirmed in human patient tissues). </p>
<p>On a different front, <strong>autoimmune neurological disease</strong> has unexpectedly highlighted KCTD16‚Äôs clinical relevance. In 2019, an examination of patients with anti-GABA_B receptor encephalitis (a rare autoimmune disorder causing seizures and limbic encephalitis) discovered that many patients also had antibodies against KCTD16 (<a href="https://academic.oup.com/brain/article/142/6/1631/5476117#:~:text=and%20cell,that%20were%20screened%20sufficiently%2C%2018%2F19">academic.oup.com</a>). Specifically, <em>KCTD16 autoantibodies were detected in 23 of 32</em> (72%) patients with anti-GABA_BR encephalitis, whereas none of 329 control subjects had such antibodies (<a href="https://academic.oup.com/brain/article/142/6/1631/5476117#:~:text=and%20cell,that%20were%20screened%20sufficiently%2C%2018%2F19">academic.oup.com</a>). The presence of anti-KCTD16 antibodies correlated strongly with a paraneoplastic origin of the encephalitis: <strong>95%</strong> of patients with KCTD16 antibodies had an underlying tumor (often small-cell lung carcinoma, SCLC), compared to 33% of those without KCTD16 antibodies (<a href="https://academic.oup.com/brain/article/142/6/1631/5476117#:~:text=match%20at%20L243%20%2895,Thirteen%20patients">academic.oup.com</a>). In other words, KCTD16 has become recognized as a marker of cancer-associated GABA_B autoimmunity. This finding makes sense because certain tumors (like SCLC) aberrantly express neuronal proteins such as GABA_B receptors and KCTD16, triggering an immune response. Clinically, this is important ‚Äì including KCTD16 in diagnostic cell-based assays for GABA_B receptor antibodies improved the sensitivity of detecting this encephalitis, without loss of specificity (<a href="https://academic.oup.com/brain/article/142/6/1631/5476117#:~:text=addition%20of%20KCTD16%20to%20the,with%20prominent%2C%20severe%20seizures%2C%20but">academic.oup.com</a>). Moreover, patients with KCTD16 antibodies tended to have more severe disease (higher antibody titers in cerebrospinal fluid and more frequent seizures/status epilepticus) (<a href="https://academic.oup.com/brain/article/142/6/1631/5476117#:~:text=%2895,Thirteen%20patients">academic.oup.com</a>) (<a href="https://academic.oup.com/brain/article/142/6/1631/5476117#:~:text=encephalitis%20patients%20with%20KCTD16%20antibodies,without%20KCTD16%20antibodies%20had%20an">academic.oup.com</a>). Thus, KCTD16 is now implicated in a real-world medical context: it is a target of autoantibodies causing neurological illness, and it hints at the need to survey for cancer when such antibodies are found. This discovery underscores that KCTD16 is not only functionally important for neurons but also sufficiently antigenic and unique to serve as an immune target.</p>
<p>Beyond the nervous system, KCTD16 has not been widely linked to other organ systems. However, some large-scale studies have started to evaluate KCTD gene family expression in cancers. In a 2025 analysis of ovarian cancer, members of the KCTD family were found to have dysregulated expression, including <em>KCTD16</em> being <strong>significantly upregulated in ovarian tumor tissues</strong> relative to normal tissues (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC12365668/#:~:text=KCTD5%2C%20KCTD12%2C%20and%20KCTD16%20were,genes%2C%20except%20for%20KCTD9%2C%20which">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC12365668/#:~:text=match%20at%20L457%20results%20in,in%20tissue%20samples%2C%20indicating%20potential">pmc.ncbi.nlm.nih.gov</a>). The same study reported that high KCTD16 expression was associated with worse patient prognosis (for instance, patients with elevated <em>KCTD16</em> had a hazard ratio ~1.28 for poorer survival, <em>p</em> = 0.029) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC12365668/#:~:text=match%20at%20L544%20KCTD10%2C%20KCTD12%2C,029">pmc.ncbi.nlm.nih.gov</a>). While KCTD16‚Äôs role in tumors is not understood (it may be incidental or related to altered cell signaling in cancer cells), such data suggest KCTD16 could be explored as part of a panel of biomarkers. Interestingly, other KCTDs (e.g. KCTD11, an established Cul3 adaptor) have tumor suppressor functions. KCTD16 lacks the Cul3 interaction, so if it influences cancer cell behavior, it might be through modulating GPCR signaling or other protein interactions in the cell. These emerging findings open new questions about whether KCTD16 has unrecognized roles beyond the brain, but neurological function remains its primary context.</p>
<h1 id="recent-developments-20232024-and-expert-perspectives">Recent Developments (2023‚Äì2024) and Expert Perspectives</h1>
<p>Research on KCTD16 and its family has accelerated in recent years, with contemporary studies providing deeper mechanistic insight and exploring clinical applications:</p>
<ul>
<li>
<p><strong>Comprehensive KCTD‚ÄìG Protein Interactions:</strong> In 2023, Sloan <em>et al.</em> (J. Biol. Chem., March 2023) systematically screened all 25 human KCTD family members for their ability to interact with G-protein Œ≤Œ≥ subunits. They found that <em>nearly all KCTDs can bind GŒ≤Œ≥</em>, suggesting a conserved property of the family (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC9976452/#:~:text=G%20protein%E2%80%93coupled%20receptors%20,a%20live%20cell%20bioluminescence%20resonance">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC9976452/#:~:text=H1%20domain%20that%20is%20exclusive,was%20sufficient%20for%20interaction%20with">pmc.ncbi.nlm.nih.gov</a>). KCTD16 was confirmed to bind GŒ≤Œ≥, although it showed an interesting behavior of high constitutive binding (high basal BRET signal) with only a mild change upon receptor activation (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC9976452/#:~:text=KCTD5%2C%20and%20KCTD12%29,In%20addition%2C%20we%20revealed">pmc.ncbi.nlm.nih.gov</a>). This aligns with earlier notions that KCTD16 preassembles with GŒ≤Œ≥ at rest. The study also noted that different KCTDs varied in their efficacy of dampening GŒ≤Œ≥-driven signaling; some (like KCTD2/5/17) strongly blunted GŒ≤Œ≥ effects on cAMP production (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC9976452/#:~:text=downstream%20through%20the%20cAMP%20pathway,G%CE%B2%CE%B3%20has%20yet%20to%20be">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC9976452/#:~:text=D2R%E2%86%92G%CE%B1i%20signaling,Curiously%2C%20KCTD9%20slightly%20inhibited">pmc.ncbi.nlm.nih.gov</a>). KCTD16 was not highlighted as a major modulator of cAMP in that assay, possibly because in a heterologous system its impact is more specific to the GABA_B context. Nonetheless, the broad takeaway is that KCTD16 is part of a family-wide mechanism of <strong>GPCR signal modulation via GŒ≤Œ≥ sequestration</strong>, expanding our understanding of how widespread this regulatory mode might be. Experts have pointed out that KCTD proteins represent a novel class of GPCR modulators, ‚Äúwell positioned to shape GPCR pharmacology‚Äù due to their ability to interface with G proteins (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC9976452/#:~:text=Abstract">pmc.ncbi.nlm.nih.gov</a>). This has spurred interest in targeting KCTD‚ÄìGŒ≤Œ≥ interactions as a way to fine-tune GPCR signals in disease contexts.</p>
</li>
<li>
<p><strong>Structural Mechanisms of Desensitization:</strong> Building on structures of KCTD16 and KCTD12, researchers have proposed refined models for how these subunits act as molecular timers for receptor signaling. A <strong>2017 Nature study</strong> (Fritzius <em>et al.</em>, 2017) described KCTD12 as an ‚Äúoff-switch‚Äù that induces rapid desensitization by capturing GŒ≤Œ≥ (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6566181/#:~:text=KCTD12%20H1%20bound%20to%20G%CE%B2_,19%20A%20role%20for%20KCTD12">pmc.ncbi.nlm.nih.gov</a>). In contrast, KCTD16 (and KCTD8) were described as having an ‚Äúauto-inhibited state‚Äù that prevents them from immediately binding GŒ≤Œ≥, thus delaying or preventing desensitization (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6566181/#:~:text=H2%20is%20not%20present%20in,from%20the%20inhibited%20trimeric%20G%E2%80%90protein">pmc.ncbi.nlm.nih.gov</a>). The <strong>2019 PNAS study</strong> by Zuo <em>et al.</em> provided the first crystal structure of a KCTD16 oligomer with a GABA_B2 fragment, solidifying the concept that the receptor‚Äôs tail threads into the center of a KCTD pentamer (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6566181/#:~:text=increase%20the%20activation%20rate%20of,19">pmc.ncbi.nlm.nih.gov</a>). Qing Fan, one of the senior authors, highlighted that this structure ‚Äú<em>sheds light on the assembly of the GABA_B receptor signaling complex</em>‚Äù and reveals a clear binding interface that could be targeted to disrupt or enhance KCTD16-receptor interaction (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6486783/#:~:text=Human%20GABA_,B%7D%20receptor%20and">pmc.ncbi.nlm.nih.gov</a>). Knowing this interface at atomic detail opens the door for drug design ‚Äì for instance, small molecules that stabilize KCTD16 on the receptor might prolong GABA_B signaling, which could be useful in certain neurological disorders. Conversely, molecules that block KCTD12 binding might prevent excessive desensitization and enhance GABA_B responses in conditions like depression (where GABA_B function may be deficient). Such therapeutic speculation is in early stages, but it stems directly from these structural and mechanistic insights.</p>
</li>
<li>
<p><strong>Autoantibody Diagnostics:</strong> As discussed, the recognition of KCTD16 as an autoantigen in GABA_B receptor encephalitis (first reported in <em>Brain</em>, June 2019) is now shaping clinical practice. Neurologists now test for anti-KCTD16 antibodies in patients with unexplained seizures and encephalitic presentations. The 2019 study by de Bruijn <em>et al.</em> demonstrated that adding KCTD16 to cell-based antibody assays increased detection sensitivity from about 59% (with only GABA_B1/B2 in the assay) to ~84% when KCTD16 was included (<a href="https://academic.oup.com/brain/article/142/6/1631/5476117#:~:text=addition%20of%20KCTD16%20to%20the,with%20prominent%2C%20severe%20seizures%2C%20but">academic.oup.com</a>). Since most of these KCTD16-positive cases are paraneoplastic, this lab finding directly guides oncological investigations (e.g. screening for a hidden small-cell lung cancer in a patient with limbic encephalitis) (<a href="https://academic.oup.com/brain/article/142/6/1631/5476117#:~:text=%2895,Thirteen%20patients">academic.oup.com</a>) (<a href="https://academic.oup.com/brain/article/142/6/1631/5476117#:~:text=of%20KCTD16%20antibodies%20points%20towards,based%20assay">academic.oup.com</a>). It‚Äôs a prime example of a basic science discovery (KCTD16‚Äôs role in the receptor) translating into a <strong>real-world diagnostic tool</strong> within a short time. Furthermore, it provides a biological rationale for the severe seizures observed in these patients: antibodies might be disrupting KCTD16 function, thereby altering GABA_B receptor kinetics and making neuronal inhibition less sustained, potentially promoting hyperexcitability.</p>
</li>
<li>
<p><strong>Cancer Genomics:</strong> While KCTD16 is not a well-known oncogene or tumor suppressor, the 2025 Cancer Medicine study (Zhang <em>et al.</em>, 2025) exemplifies a growing research trend of surveying ‚Äúhidden‚Äù gene families in cancer. This study found <em>KCTD16 mRNA was up-regulated in ovarian cancer cell lines and tumors</em>, alongside KCTD5, KCTD9, and KCTD12, whereas some other KCTDs were down-regulated (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC12365668/#:~:text=the%20expression%20levels%20of%20KCTD,for%20each%20KCTD%20gene%20to">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC12365668/#:~:text=KCTD5%2C%20KCTD12%2C%20and%20KCTD16%20were,genes%2C%20except%20for%20KCTD9%2C%20which">pmc.ncbi.nlm.nih.gov</a>). The authors performed ROC analysis and found KCTD16 had a moderate diagnostic value (AUC ~0.8) for distinguishing ovarian cancer tissue from normal (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC12365668/#:~:text=match%20at%20L403%20%28Figure%C2%A01B%29,Figure%C2%A01B">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC12365668/#:~:text=%28Figure%C2%A01B%29,Figure%C2%A01B">pmc.ncbi.nlm.nih.gov</a>). Although KCTD16‚Äôs function in ovarian cancer is unclear, one hypothesis is that changes in GPCR signaling pathways in tumors (many ovarian cancers have aberrant GPCR and G-protein activity) might select for altered expression of GPCR modulators like KCTDs. Additionally, <em>KCTD16 has a CpG island in its promoter</em>, and the 2025 study noted that DNA methylation changes in several KCTD genes correlated inversely with their expression in cancer (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC12365668/#:~:text=KCTD12%2C%20KCTD10%2C%20and%20KCTD16%20show,the%20expression%20and%20promoter%20methylation">pmc.ncbi.nlm.nih.gov</a>). For KCTD16 specifically, hypomethylation might explain its over-expression in tumors. Importantly, this research is still early and primarily descriptive. Experts caution that high expression of KCTD16 could either be a passenger effect or potentially influence cell signaling to confer growth advantages. Regardless, such findings expand the relevance of KCTD16 beyond the brain, suggesting it may be involved in cellular pathways that, when dysregulated, contribute to diseases like cancer.</p>
</li>
</ul>
<p><strong>Expert Commentary:</strong> Scientific interest in KCTD16 mirrors the broader interest in KCTD proteins as modulators of key signaling pathways. A 2019 review by Teng <em>et al.</em> in <em>CNS Neuroscience &amp; Therapeutics</em> argued that the ‚Äúpoorly characterized human KCTD gene family‚Äù deserves deeper investigation due to emerging evidence linking various KCTDs to neurological disorders (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6566181/#:~:text=focusing%20efforts%20to%20dissect%20their,KCTD11%29%20and%20an">pmc.ncbi.nlm.nih.gov</a>). The authors highlighted KCTD12‚Äôs ties to bipolar disorder and KCTD13‚Äôs involvement in neurodevelopmental disorders, while noting that KCTD16, KCTD8, and KCTD12 form a functionally related subgroup influencing neurotransmitter receptor signaling (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6566181/#:~:text=3,in%20neurotransmitter%20receptor%20signaling">pmc.ncbi.nlm.nih.gov</a>). They described recent structural studies (citing work on KCTD12 and KCTD16) as providing ‚Äú<em>mechanisms of regulating membrane channel activities through modulation of distinct GTPases</em>‚Äù (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6566181/#:~:text=and%20structure%E2%80%90based%20studies%20,functions%20may%20be%20disease%20related">pmc.ncbi.nlm.nih.gov</a>) ‚Äì essentially pointing out that KCTDs regulate ion channels by interfacing with G-proteins (a novel mechanism for protein regulation). In the same review, the model of KCTD12/16 action on GIRK channels is summarized, emphasizing how KCTD12‚Äôs sequestration of GŒ≤Œ≥ accelerates channel deactivation, whereas KCTD16‚Äôs H2 domain prevents this sequestration (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6566181/#:~:text=channels%20through%20trimeric%20G%E2%80%90proteins,B2%7D%20%28amino%20acid%20residues">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6566181/#:~:text=GABA_,together%2C%20the%20proposed%20model%20is">pmc.ncbi.nlm.nih.gov</a>). The review underscores that while KCTD12 has been more extensively studied (due to psychiatric genetic links), <em>KCTD16 likely plays complementary roles and could be implicated in ‚Äúrelated conditions‚Äù especially where GABA_B signaling is a factor</em> (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6566181/#:~:text=subunits%20KCTD8%2C%20KCTD12%2C%20and%20KCTD16,64%20Consistent%20with">pmc.ncbi.nlm.nih.gov</a>). </p>
<p>Another expert perspective can be found in a 2022 commentary on G protein-gated K^+ channels (Luo <em>et al.</em>, 2022, <em>Am J Physiol Cell Physiol</em>). The authors note that the discovery of KCTD auxiliary subunits has ‚Äú<em>significantly expanded our understanding of GABA_B receptor function</em>,‚Äù allowing the receptor‚Äôs inhibitory signals to be <em>‚Äútuned by cell-specific expression of KCTD8, 12, or 16‚Äù</em> (since different neurons express different ratios of these subunits) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC8121548/#:~:text=Four%20KCTD%20subunits%2C%20KCTD8%2C%2012%2C,subunits%20are%20composed%20of%20an">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6566181/#:~:text=inhibitory%20and%20excitatory%20neurons,mice%20exhibit%20related%20phenotypes%20including">pmc.ncbi.nlm.nih.gov</a>). They further mention that targeting these subunits could yield new pharmacological avenues ‚Äì for instance, a molecule that enhances KCTD16‚Äôs interaction with GABA_B2 might prolong GABA_B-mediated inhibition therapeutically. While such drugs are hypothetical at present, the concept reflects a growing recognition of auxiliary proteins like KCTD16 as drug targets themselves or as part of receptor complexes to target. </p>
<p>In summary, current expert consensus portrays KCTD16 as a critical modulatory subunit that <strong>defines the timing of inhibitory GABA_B signals</strong>. It is part of a mechanism nature uses to <strong>diversify GPCR signaling outcomes</strong>, and its dysfunction or removal can have notable neural consequences. The most recent research (2023‚Äì2024) has reinforced KCTD16‚Äôs role in GŒ≤Œ≥ management and highlighted its relevance in contexts ranging from <strong>autoimmune encephalitis diagnostics to cancer biomarker studies</strong>. As one paper succinctly stated, KCTD subunits like 16 ‚Äú<strong>induce desensitization of K^+ currents in response to GABA_B activation in a subtype-specific manner</strong>‚Äù (<a href="https://academic.oup.com/brain/article/142/6/1631/5476117#:~:text=KCTD%20family%20members%20show%20distinct,specific%20manner%20%28Schwenk%20et">academic.oup.com</a>) ‚Äì a reminder that each KCTD subtype (8, 12, 16) confers unique properties. Going forward, investigating KCTD16 in specific neuron types and disease models (e.g. stress, epilepsy, or mood disorder models) will be important to fully elucidate its functions. With structural biology providing detailed interaction maps, and clinical findings giving real-world significance, KCTD16 has moved from an obscure KIAA gene to a protein of substantial interest in neuroscience and beyond.</p>
<p><strong>References:</strong> <em>(Publication dates and sources are included in citation brackets)</em></p>
<h2 id="citations">Citations</h2>
<ol>
<li>AnnotationURLCitation(end_index=515, start_index=333, title='A Comprehensive Analysis of the Structural Recognition between KCTD Proteins and Cullin 3 - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10856315/#:~:text=domains%20embedded%20in%20potassium%20channels,little%20involvement%20in%20potassium%20channeling')</li>
<li>AnnotationURLCitation(end_index=865, start_index=691, title='KCTD: A new gene family involved in neurodevelopmental and neuropsychiatric disorders - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6566181/#:~:text=Mouse%20Kctd8%2C%20Kctd12%2C%20Kctd12b%20,Therefore%2C%20disruption%20of%20the%20auxiliary')</li>
<li>AnnotationURLCitation(end_index=1327, start_index=1153, title='Structural basis for auxiliary subunit KCTD16 regulation of the GABAB receptor - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6486783/#:~:text=Malfunction%20of%20the%20receptor%20is,to%20neurotransmitters%2C%20while%20the%20auxiliary')</li>
<li>AnnotationURLCitation(end_index=1655, start_index=1491, title='GABAB receptor auxiliary subunits modulate Cav2.3-mediated release from medial habenula terminals - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC8121548/#:~:text=Four%20KCTD%20subunits%2C%20KCTD8%2C%2012%2C,subunits%20are%20composed%20of%20an')</li>
<li>AnnotationURLCitation(end_index=2159, start_index=1985, title='Structural basis for auxiliary subunit KCTD16 regulation of the GABAB receptor - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6486783/#:~:text=Malfunction%20of%20the%20receptor%20is,to%20neurotransmitters%2C%20while%20the%20auxiliary')</li>
<li>AnnotationURLCitation(end_index=2681, start_index=2490, title='KCTD16 potassium channel tetramerization domain containing 16 [Homo sapiens (human)] - Gene - NCBI', type='url_citation', url='https://www.ncbi.nlm.nih.gov/gene?Cmd=DetailsSearch&amp;Db=gene&amp;Term=57528#:~:text=Expression%20Biased%20expression%20in%20brain,other%20tissues%20See%20more%20Orthologs')</li>
<li>AnnotationURLCitation(end_index=3097, start_index=2967, title='KCTD: A new gene family involved in neurodevelopmental and neuropsychiatric disorders - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6566181/#:~:text=3,in%20neurotransmitter%20receptor%20signaling')</li>
<li>AnnotationURLCitation(end_index=3497, start_index=3304, title='Structural complexity in the KCTD family of Cullin3-dependent E3 ubiquitin ligases - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC5664961/#:~:text=domains%20with%20the%20exception%20of,KCTD13%20%28K_%7Bd%7D%E2%80%89%3D%E2%80%89100%E2%80%85nM%29%2C%20KCTD10')</li>
<li>AnnotationURLCitation(end_index=3665, start_index=3498, title='Structural complexity in the KCTD family of Cullin3-dependent E3 ubiquitin ligases - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC5664961/#:~:text=Evolutionarily%20distant%20from%20these%20family,here%20that%20this%20geometry%20is')</li>
<li>AnnotationURLCitation(end_index=4027, start_index=3909, title='Structural complexity in the KCTD family of Cullin3-dependent E3 ubiquitin ligases - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC5664961/#:~:text=,Cul3%20and%20were%20observed%20to')</li>
<li>AnnotationURLCitation(end_index=4221, start_index=4028, title='Structural complexity in the KCTD family of Cullin3-dependent E3 ubiquitin ligases - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC5664961/#:~:text=domains%20with%20the%20exception%20of,KCTD13%20%28K_%7Bd%7D%E2%80%89%3D%E2%80%89100%E2%80%85nM%29%2C%20KCTD10')</li>
<li>AnnotationURLCitation(end_index=4597, start_index=4433, title='GABAB receptor auxiliary subunits modulate Cav2.3-mediated release from medial habenula terminals - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC8121548/#:~:text=Four%20KCTD%20subunits%2C%20KCTD8%2C%2012%2C,subunits%20are%20composed%20of%20an')</li>
<li>AnnotationURLCitation(end_index=4724, start_index=4598, title='KCTD: A new gene family involved in neurodevelopmental and neuropsychiatric disorders - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6566181/#:~:text=increase%20the%20activation%20rate%20of,19')</li>
<li>AnnotationURLCitation(end_index=5474, start_index=5348, title='KCTD: A new gene family involved in neurodevelopmental and neuropsychiatric disorders - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6566181/#:~:text=increase%20the%20activation%20rate%20of,19')</li>
<li>AnnotationURLCitation(end_index=5774, start_index=5648, title='KCTD: A new gene family involved in neurodevelopmental and neuropsychiatric disorders - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6566181/#:~:text=increase%20the%20activation%20rate%20of,19')</li>
<li>AnnotationURLCitation(end_index=6163, start_index=5999, title='GABAB receptor auxiliary subunits modulate Cav2.3-mediated release from medial habenula terminals - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC8121548/#:~:text=Four%20KCTD%20subunits%2C%20KCTD8%2C%2012%2C,subunits%20are%20composed%20of%20an')</li>
<li>AnnotationURLCitation(end_index=6612, start_index=6494, title='Structural complexity in the KCTD family of Cullin3-dependent E3 ubiquitin ligases - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC5664961/#:~:text=,Cul3%20and%20were%20observed%20to')</li>
<li>AnnotationURLCitation(end_index=6871, start_index=6678, title='Structural complexity in the KCTD family of Cullin3-dependent E3 ubiquitin ligases - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC5664961/#:~:text=domains%20with%20the%20exception%20of,KCTD13%20%28K_%7Bd%7D%E2%80%89%3D%E2%80%89100%E2%80%85nM%29%2C%20KCTD10')</li>
<li>AnnotationURLCitation(end_index=7306, start_index=7139, title='Structural complexity in the KCTD family of Cullin3-dependent E3 ubiquitin ligases - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC5664961/#:~:text=Evolutionarily%20distant%20from%20these%20family,here%20that%20this%20geometry%20is')</li>
<li>AnnotationURLCitation(end_index=7619, start_index=7487, title='Structural basis for auxiliary subunit KCTD16 regulation of the GABAB receptor - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6486783/#:~:text=of%20KCTD12%20and%20KCTD12b%20mediate,20%2C%2023')</li>
<li>AnnotationURLCitation(end_index=7786, start_index=7620, title='KCTD: A new gene family involved in neurodevelopmental and neuropsychiatric disorders - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6566181/#:~:text=H2%20is%20not%20present%20in,from%20the%20inhibited%20trimeric%20G%E2%80%90protein')</li>
<li>AnnotationURLCitation(end_index=8189, start_index=8023, title='KCTD: A new gene family involved in neurodevelopmental and neuropsychiatric disorders - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6566181/#:~:text=H2%20is%20not%20present%20in,from%20the%20inhibited%20trimeric%20G%E2%80%90protein')</li>
<li>AnnotationURLCitation(end_index=8572, start_index=8406, title='KCTD: A new gene family involved in neurodevelopmental and neuropsychiatric disorders - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6566181/#:~:text=H2%20is%20not%20present%20in,from%20the%20inhibited%20trimeric%20G%E2%80%90protein')</li>
<li>AnnotationURLCitation(end_index=8937, start_index=8771, title='KCTD: A new gene family involved in neurodevelopmental and neuropsychiatric disorders - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6566181/#:~:text=H2%20is%20not%20present%20in,from%20the%20inhibited%20trimeric%20G%E2%80%90protein')</li>
<li>AnnotationURLCitation(end_index=9070, start_index=8938, title='Structural basis for auxiliary subunit KCTD16 regulation of the GABAB receptor - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6486783/#:~:text=of%20KCTD12%20and%20KCTD12b%20mediate,20%2C%2023')</li>
<li>AnnotationURLCitation(end_index=9610, start_index=9497, title='Structural basis for auxiliary subunit KCTD16 regulation of the GABAB receptor - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6486783/#:~:text=%2820%2C%2022%29,In%20genetic')</li>
<li>AnnotationURLCitation(end_index=9743, start_index=9611, title='Structural basis for auxiliary subunit KCTD16 regulation of the GABAB receptor - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6486783/#:~:text=of%20KCTD12%20and%20KCTD12b%20mediate,20%2C%2023')</li>
<li>AnnotationURLCitation(end_index=10430, start_index=10270, title='KCTD: A new gene family involved in neurodevelopmental and neuropsychiatric disorders - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6566181/#:~:text=further%20advance%20the%20field%20overall,B2%7D%20%28amino%20acid%20residues')</li>
<li>AnnotationURLCitation(end_index=10792, start_index=10628, title='GABAB receptor auxiliary subunits modulate Cav2.3-mediated release from medial habenula terminals - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC8121548/#:~:text=Four%20KCTD%20subunits%2C%20KCTD8%2C%2012%2C,subunits%20are%20composed%20of%20an')</li>
<li>AnnotationURLCitation(end_index=10934, start_index=10793, title='KCTD: A new gene family involved in neurodevelopmental and neuropsychiatric disorders - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6566181/#:~:text=synaptic%20transmission%20by%20indirectly%20regulating,33')</li>
<li>AnnotationURLCitation(end_index=11633, start_index=11492, title='KCTD: A new gene family involved in neurodevelopmental and neuropsychiatric disorders - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6566181/#:~:text=synaptic%20transmission%20by%20indirectly%20regulating,33')</li>
<li>AnnotationURLCitation(end_index=12217, start_index=12048, title='KCTD: A new gene family involved in neurodevelopmental and neuropsychiatric disorders - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6566181/#:~:text=channels%20through%20trimeric%20G%E2%80%90proteins,B2%7D%20%28amino%20acid%20residues')</li>
<li>AnnotationURLCitation(end_index=12779, start_index=12666, title='Structural basis for auxiliary subunit KCTD16 regulation of the GABAB receptor - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6486783/#:~:text=%2820%2C%2022%29,In%20genetic')</li>
<li>AnnotationURLCitation(end_index=12888, start_index=12780, title='KCTD: A new gene family involved in neurodevelopmental and neuropsychiatric disorders - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6566181/#:~:text=GABA_,channel%29.%20Then')</li>
<li>AnnotationURLCitation(end_index=13322, start_index=13209, title='Structural basis for auxiliary subunit KCTD16 regulation of the GABAB receptor - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6486783/#:~:text=%2820%2C%2022%29,In%20genetic')</li>
<li>AnnotationURLCitation(end_index=13631, start_index=13465, title='KCTD: A new gene family involved in neurodevelopmental and neuropsychiatric disorders - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6566181/#:~:text=H2%20is%20not%20present%20in,from%20the%20inhibited%20trimeric%20G%E2%80%90protein')</li>
<li>AnnotationURLCitation(end_index=14024, start_index=13911, title='Structural basis for auxiliary subunit KCTD16 regulation of the GABAB receptor - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6486783/#:~:text=%2820%2C%2022%29,In%20genetic')</li>
<li>AnnotationURLCitation(end_index=14596, start_index=14432, title='GABAB receptor auxiliary subunits modulate Cav2.3-mediated release from medial habenula terminals - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC8121548/#:~:text=Four%20KCTD%20subunits%2C%20KCTD8%2C%2012%2C,subunits%20are%20composed%20of%20an')</li>
<li>AnnotationURLCitation(end_index=14904, start_index=14740, title='GABAB receptor auxiliary subunits modulate Cav2.3-mediated release from medial habenula terminals - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC8121548/#:~:text=Four%20KCTD%20subunits%2C%20KCTD8%2C%2012%2C,subunits%20are%20composed%20of%20an')</li>
<li>AnnotationURLCitation(end_index=15685, start_index=15561, title='Structural basis for auxiliary subunit KCTD16 regulation of the GABAB receptor - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6486783/#:~:text=studies%2C%20the%20KCTD12%20gene%20has,B')</li>
<li>AnnotationURLCitation(end_index=15859, start_index=15686, title='KCTD: A new gene family involved in neurodevelopmental and neuropsychiatric disorders - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6566181/#:~:text=inhibitory%20and%20excitatory%20neurons,mice%20exhibit%20related%20phenotypes%20including')</li>
<li>AnnotationURLCitation(end_index=16421, start_index=16258, title='Multiple potassium channel tetramerization domain (KCTD) family members interact with GŒ≤Œ≥, with effects on cAMP signaling - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC9976452/#:~:text=H1%20domain%20that%20is%20exclusive,was%20sufficient%20for%20interaction%20with')</li>
<li>AnnotationURLCitation(end_index=16736, start_index=16593, title='Multiple potassium channel tetramerization domain (KCTD) family members interact with GŒ≤Œ≥, with effects on cAMP signaling - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC9976452/#:~:text=KCTD5%2C%20and%20KCTD12%29,In%20addition%2C%20we%20revealed')</li>
<li>AnnotationURLCitation(end_index=17133, start_index=16990, title='Multiple potassium channel tetramerization domain (KCTD) family members interact with GŒ≤Œ≥, with effects on cAMP signaling - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC9976452/#:~:text=KCTD5%2C%20and%20KCTD12%29,In%20addition%2C%20we%20revealed')</li>
<li>AnnotationURLCitation(end_index=17691, start_index=17560, title='KCTD: A new gene family involved in neurodevelopmental and neuropsychiatric disorders - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6566181/#:~:text=GABA_,together%2C%20the%20proposed%20model%20is')</li>
<li>AnnotationURLCitation(end_index=17800, start_index=17692, title='KCTD: A new gene family involved in neurodevelopmental and neuropsychiatric disorders - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6566181/#:~:text=GABA_,channel%29.%20Then')</li>
<li>AnnotationURLCitation(end_index=18087, start_index=17939, title='KCTD: A new gene family involved in neurodevelopmental and neuropsychiatric disorders - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6566181/#:~:text=KCTD12%20H1%20bound%20to%20G%CE%B2_,19%20A%20role%20for%20KCTD12')</li>
<li>AnnotationURLCitation(end_index=18528, start_index=18362, title='KCTD: A new gene family involved in neurodevelopmental and neuropsychiatric disorders - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6566181/#:~:text=H2%20is%20not%20present%20in,from%20the%20inhibited%20trimeric%20G%E2%80%90protein')</li>
<li>AnnotationURLCitation(end_index=18928, start_index=18780, title='KCTD: A new gene family involved in neurodevelopmental and neuropsychiatric disorders - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6566181/#:~:text=KCTD12%20H1%20bound%20to%20G%CE%B2_,19%20A%20role%20for%20KCTD12')</li>
<li>AnnotationURLCitation(end_index=19309, start_index=19162, title='Multiple potassium channel tetramerization domain (KCTD) family members interact with GŒ≤Œ≥, with effects on cAMP signaling - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC9976452/#:~:text=match%20at%20L165%20Given%20that,myc%20tag%20to%20the%20carboxy')</li>
<li>AnnotationURLCitation(end_index=19456, start_index=19343, title='Structural basis for auxiliary subunit KCTD16 regulation of the GABAB receptor - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6486783/#:~:text=%2820%2C%2022%29,In%20genetic')</li>
<li>AnnotationURLCitation(end_index=19983, start_index=19792, title='KCTD16 potassium channel tetramerization domain containing 16 [Homo sapiens (human)] - Gene - NCBI', type='url_citation', url='https://www.ncbi.nlm.nih.gov/gene?Cmd=DetailsSearch&amp;Db=gene&amp;Term=57528#:~:text=Expression%20Biased%20expression%20in%20brain,other%20tissues%20See%20more%20Orthologs')</li>
<li>AnnotationURLCitation(end_index=20475, start_index=20312, title='KCTD: A new gene family involved in neurodevelopmental and neuropsychiatric disorders - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6566181/#:~:text=considered%20auxiliary%20subunits%20of%20the,to%20contribute%20to%20bipolar%20I')</li>
<li>AnnotationURLCitation(end_index=20915, start_index=20752, title='KCTD: A new gene family involved in neurodevelopmental and neuropsychiatric disorders - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6566181/#:~:text=considered%20auxiliary%20subunits%20of%20the,to%20contribute%20to%20bipolar%20I')</li>
<li>AnnotationURLCitation(end_index=21376, start_index=21212, title='GABAB receptor auxiliary subunits modulate Cav2.3-mediated release from medial habenula terminals - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC8121548/#:~:text=Four%20KCTD%20subunits%2C%20KCTD8%2C%2012%2C,subunits%20are%20composed%20of%20an')</li>
<li>AnnotationURLCitation(end_index=21678, start_index=21529, title='KCTD8 and KCTD12 Facilitate Axonal Expression of GABAB Receptors in Habenula Cholinergic Neurons - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC8896537/#:~:text=KCTD8%20and%20KCTD12%20Facilitate%20Axonal,5%7D%2C%20Minmin%20Luo')</li>
<li>AnnotationURLCitation(end_index=21816, start_index=21679, title='Behavioural endophenotypes in mice lacking the auxiliary GABAB receptor subunit KCTD16 - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/27717812/#:~:text=subunit%20KCTD16%20,pathophysiology%20of%20a%20number%20of')</li>
<li>AnnotationURLCitation(end_index=23467, start_index=23279, title='KCTD16 potassium channel tetramerization domain containing 16 [Homo sapiens (human)] - Gene - NCBI', type='url_citation', url='https://www.ncbi.nlm.nih.gov/gene?Cmd=DetailsSearch&amp;Db=gene&amp;Term=57528#:~:text=Summary%20Predicted%20to%20enable%20G,involved%20in%20regulation%20of%20presynaptic')</li>
<li>AnnotationURLCitation(end_index=24173, start_index=23985, title='KCTD16 potassium channel tetramerization domain containing 16 [Homo sapiens (human)] - Gene - NCBI', type='url_citation', url='https://www.ncbi.nlm.nih.gov/gene?Cmd=DetailsSearch&amp;Db=gene&amp;Term=57528#:~:text=Summary%20Predicted%20to%20enable%20G,involved%20in%20regulation%20of%20presynaptic')</li>
<li>AnnotationURLCitation(end_index=24519, start_index=24355, title='GABAB receptor auxiliary subunits modulate Cav2.3-mediated release from medial habenula terminals - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC8121548/#:~:text=Four%20KCTD%20subunits%2C%20KCTD8%2C%2012%2C,subunits%20are%20composed%20of%20an')</li>
<li>AnnotationURLCitation(end_index=25186, start_index=25013, title='Multiple potassium channel tetramerization domain (KCTD) family members interact with GŒ≤Œ≥, with effects on cAMP signaling - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC9976452/#:~:text=examining%20sensitization%20of%20the%20adenylyl,to%20shape%20GPCR%20signal%20transmission')</li>
<li>AnnotationURLCitation(end_index=25347, start_index=25187, title='Multiple potassium channel tetramerization domain (KCTD) family members interact with GŒ≤Œ≥, with effects on cAMP signaling - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC9976452/#:~:text=D2R%E2%86%92G%CE%B1i%20signaling,Curiously%2C%20KCTD9%20slightly%20inhibited')</li>
<li>AnnotationURLCitation(end_index=26714, start_index=26590, title='Structural basis for auxiliary subunit KCTD16 regulation of the GABAB receptor - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6486783/#:~:text=studies%2C%20the%20KCTD12%20gene%20has,B')</li>
<li>AnnotationURLCitation(end_index=26957, start_index=26866, title='Behavioural endophenotypes in mice lacking the auxiliary GABAB receptor subunit KCTD16 - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/27717812/#:~:text=,mice%20show')</li>
<li>AnnotationURLCitation(end_index=27497, start_index=27373, title='Structural basis for auxiliary subunit KCTD16 regulation of the GABAB receptor - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6486783/#:~:text=studies%2C%20the%20KCTD12%20gene%20has,B')</li>
<li>AnnotationURLCitation(end_index=28038, start_index=27910, title='Behavioural endophenotypes in mice lacking the auxiliary GABAB receptor subunit KCTD16 - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/27717812/#:~:text=determine%20the%20kinetics%20of%20the,mice%20show')</li>
<li>AnnotationURLCitation(end_index=28152, start_index=28039, title='Structural basis for auxiliary subunit KCTD16 regulation of the GABAB receptor - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6486783/#:~:text=%2820%2C%2022%29,In%20genetic')</li>
<li>AnnotationURLCitation(end_index=28383, start_index=28292, title='Behavioural endophenotypes in mice lacking the auxiliary GABAB receptor subunit KCTD16 - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/27717812/#:~:text=,mice%20show')</li>
<li>AnnotationURLCitation(end_index=28520, start_index=28384, title='KCTD: A new gene family involved in neurodevelopmental and neuropsychiatric disorders - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6566181/#:~:text=disorders,several%20cancers%20not%20discussed%20here')</li>
<li>AnnotationURLCitation(end_index=29458, start_index=29285, title='KCTD: A new gene family involved in neurodevelopmental and neuropsychiatric disorders - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6566181/#:~:text=inhibitory%20and%20excitatory%20neurons,mice%20exhibit%20related%20phenotypes%20including')</li>
<li>AnnotationURLCitation(end_index=30583, start_index=30430, title='KCTD: A new gene family involved in neurodevelopmental and neuropsychiatric disorders - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6566181/#:~:text=subunits%20KCTD8%2C%20KCTD12%2C%20and%20KCTD16,64%20Consistent%20with')</li>
<li>AnnotationURLCitation(end_index=30985, start_index=30855, title='KCTD: A new gene family involved in neurodevelopmental and neuropsychiatric disorders - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6566181/#:~:text=3,in%20neurotransmitter%20receptor%20signaling')</li>
<li>AnnotationURLCitation(end_index=31138, start_index=30986, title='KCTD: A new gene family involved in neurodevelopmental and neuropsychiatric disorders - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6566181/#:~:text=KCTD12%20and%20KCTD16,function%20and%2For%20GTPase%20modulated%20ion')</li>
<li>AnnotationURLCitation(end_index=31864, start_index=31715, title='expanded clinical spectrum of anti-GABABR encephalitis and added value of KCTD16 autoantibodies | Brain | Oxford Academic', type='url_citation', url='https://academic.oup.com/brain/article/142/6/1631/5476117#:~:text=and%20cell,that%20were%20screened%20sufficiently%2C%2018%2F19')</li>
<li>AnnotationURLCitation(end_index=32183, start_index=32034, title='expanded clinical spectrum of anti-GABABR encephalitis and added value of KCTD16 autoantibodies | Brain | Oxford Academic', type='url_citation', url='https://academic.oup.com/brain/article/142/6/1631/5476117#:~:text=and%20cell,that%20were%20screened%20sufficiently%2C%2018%2F19')</li>
<li>AnnotationURLCitation(end_index=32586, start_index=32453, title='expanded clinical spectrum of anti-GABABR encephalitis and added value of KCTD16 autoantibodies | Brain | Oxford Academic', type='url_citation', url='https://academic.oup.com/brain/article/142/6/1631/5476117#:~:text=match%20at%20L243%20%2895,Thirteen%20patients')</li>
<li>AnnotationURLCitation(end_index=33219, start_index=33049, title='expanded clinical spectrum of anti-GABABR encephalitis and added value of KCTD16 autoantibodies | Brain | Oxford Academic', type='url_citation', url='https://academic.oup.com/brain/article/142/6/1631/5476117#:~:text=addition%20of%20KCTD16%20to%20the,with%20prominent%2C%20severe%20seizures%2C%20but')</li>
<li>AnnotationURLCitation(end_index=33505, start_index=33392, title='expanded clinical spectrum of anti-GABABR encephalitis and added value of KCTD16 autoantibodies | Brain | Oxford Academic', type='url_citation', url='https://academic.oup.com/brain/article/142/6/1631/5476117#:~:text=%2895,Thirteen%20patients')</li>
<li>AnnotationURLCitation(end_index=33687, start_index=33506, title='expanded clinical spectrum of anti-GABABR encephalitis and added value of KCTD16 autoantibodies | Brain | Oxford Academic', type='url_citation', url='https://academic.oup.com/brain/article/142/6/1631/5476117#:~:text=encephalitis%20patients%20with%20KCTD16%20antibodies,without%20KCTD16%20antibodies%20had%20an')</li>
<li>AnnotationURLCitation(end_index=34624, start_index=34454, title='Mechanistic Insights Into the Tumor‚ÄêDriving and Diagnostic Roles of KCTD Family Genes in Ovarian Cancer: An Integrated In Silico and In\xa0Vitro Analysis - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC12365668/#:~:text=KCTD5%2C%20KCTD12%2C%20and%20KCTD16%20were,genes%2C%20except%20for%20KCTD9%2C%20which')</li>
<li>AnnotationURLCitation(end_index=34792, start_index=34625, title='Mechanistic Insights Into the Tumor‚ÄêDriving and Diagnostic Roles of KCTD Family Genes in Ovarian Cancer: An Integrated In Silico and In\xa0Vitro Analysis - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC12365668/#:~:text=match%20at%20L457%20results%20in,in%20tissue%20samples%2C%20indicating%20potential')</li>
<li>AnnotationURLCitation(end_index=35126, start_index=34996, title='Mechanistic Insights Into the Tumor‚ÄêDriving and Diagnostic Roles of KCTD Family Genes in Ovarian Cancer: An Integrated In Silico and In\xa0Vitro Analysis - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC12365668/#:~:text=match%20at%20L544%20KCTD10%2C%20KCTD12%2C,029')</li>
<li>AnnotationURLCitation(end_index=36472, start_index=36300, title='Multiple potassium channel tetramerization domain (KCTD) family members interact with GŒ≤Œ≥, with effects on cAMP signaling - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC9976452/#:~:text=G%20protein%E2%80%93coupled%20receptors%20,a%20live%20cell%20bioluminescence%20resonance')</li>
<li>AnnotationURLCitation(end_index=36636, start_index=36473, title='Multiple potassium channel tetramerization domain (KCTD) family members interact with GŒ≤Œ≥, with effects on cAMP signaling - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC9976452/#:~:text=H1%20domain%20that%20is%20exclusive,was%20sufficient%20for%20interaction%20with')</li>
<li>AnnotationURLCitation(end_index=36961, start_index=36818, title='Multiple potassium channel tetramerization domain (KCTD) family members interact with GŒ≤Œ≥, with effects on cAMP signaling - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC9976452/#:~:text=KCTD5%2C%20and%20KCTD12%29,In%20addition%2C%20we%20revealed')</li>
<li>AnnotationURLCitation(end_index=37375, start_index=37212, title='Multiple potassium channel tetramerization domain (KCTD) family members interact with GŒ≤Œ≥, with effects on cAMP signaling - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC9976452/#:~:text=downstream%20through%20the%20cAMP%20pathway,G%CE%B2%CE%B3%20has%20yet%20to%20be')</li>
<li>AnnotationURLCitation(end_index=37536, start_index=37376, title='Multiple potassium channel tetramerization domain (KCTD) family members interact with GŒ≤Œ≥, with effects on cAMP signaling - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC9976452/#:~:text=D2R%E2%86%92G%CE%B1i%20signaling,Curiously%2C%20KCTD9%20slightly%20inhibited')</li>
<li>AnnotationURLCitation(end_index=38189, start_index=38097, title='Multiple potassium channel tetramerization domain (KCTD) family members interact with GŒ≤Œ≥, with effects on cAMP signaling - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC9976452/#:~:text=Abstract')</li>
<li>AnnotationURLCitation(end_index=38800, start_index=38652, title='KCTD: A new gene family involved in neurodevelopmental and neuropsychiatric disorders - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6566181/#:~:text=KCTD12%20H1%20bound%20to%20G%CE%B2_,19%20A%20role%20for%20KCTD12')</li>
<li>AnnotationURLCitation(end_index=39144, start_index=38978, title='KCTD: A new gene family involved in neurodevelopmental and neuropsychiatric disorders - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6566181/#:~:text=H2%20is%20not%20present%20in,from%20the%20inhibited%20trimeric%20G%E2%80%90protein')</li>
<li>AnnotationURLCitation(end_index=39487, start_index=39361, title='KCTD: A new gene family involved in neurodevelopmental and neuropsychiatric disorders - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6566181/#:~:text=increase%20the%20activation%20rate%20of,19')</li>
<li>AnnotationURLCitation(end_index=39861, start_index=39742, title='Structural basis for auxiliary subunit KCTD16 regulation of the GABAB receptor - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6486783/#:~:text=Human%20GABA_,B%7D%20receptor%20and')</li>
<li>AnnotationURLCitation(end_index=41101, start_index=40931, title='expanded clinical spectrum of anti-GABABR encephalitis and added value of KCTD16 autoantibodies | Brain | Oxford Academic', type='url_citation', url='https://academic.oup.com/brain/article/142/6/1631/5476117#:~:text=addition%20of%20KCTD16%20to%20the,with%20prominent%2C%20severe%20seizures%2C%20but')</li>
<li>AnnotationURLCitation(end_index=41429, start_index=41316, title='expanded clinical spectrum of anti-GABABR encephalitis and added value of KCTD16 autoantibodies | Brain | Oxford Academic', type='url_citation', url='https://academic.oup.com/brain/article/142/6/1631/5476117#:~:text=%2895,Thirteen%20patients')</li>
<li>AnnotationURLCitation(end_index=41575, start_index=41430, title='expanded clinical spectrum of anti-GABABR encephalitis and added value of KCTD16 autoantibodies | Brain | Oxford Academic', type='url_citation', url='https://academic.oup.com/brain/article/142/6/1631/5476117#:~:text=of%20KCTD16%20antibodies%20points%20towards,based%20assay')</li>
<li>AnnotationURLCitation(end_index=42555, start_index=42403, title='Mechanistic Insights Into the Tumor‚ÄêDriving and Diagnostic Roles of KCTD Family Genes in Ovarian Cancer: An Integrated In Silico and In\xa0Vitro Analysis - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC12365668/#:~:text=the%20expression%20levels%20of%20KCTD,for%20each%20KCTD%20gene%20to')</li>
<li>AnnotationURLCitation(end_index=42726, start_index=42556, title='Mechanistic Insights Into the Tumor‚ÄêDriving and Diagnostic Roles of KCTD Family Genes in Ovarian Cancer: An Integrated In Silico and In\xa0Vitro Analysis - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC12365668/#:~:text=KCTD5%2C%20KCTD12%2C%20and%20KCTD16%20were,genes%2C%20except%20for%20KCTD9%2C%20which')</li>
<li>AnnotationURLCitation(end_index=43016, start_index=42876, title='Mechanistic Insights Into the Tumor‚ÄêDriving and Diagnostic Roles of KCTD Family Genes in Ovarian Cancer: An Integrated In Silico and In\xa0Vitro Analysis - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC12365668/#:~:text=match%20at%20L403%20%28Figure%C2%A01B%29,Figure%C2%A01B')</li>
<li>AnnotationURLCitation(end_index=43137, start_index=43017, title='Mechanistic Insights Into the Tumor‚ÄêDriving and Diagnostic Roles of KCTD Family Genes in Ovarian Cancer: An Integrated In Silico and In\xa0Vitro Analysis - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC12365668/#:~:text=%28Figure%C2%A01B%29,Figure%C2%A01B')</li>
<li>AnnotationURLCitation(end_index=43758, start_index=43582, title='Mechanistic Insights Into the Tumor‚ÄêDriving and Diagnostic Roles of KCTD Family Genes in Ovarian Cancer: An Integrated In Silico and In\xa0Vitro Analysis - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC12365668/#:~:text=KCTD12%2C%20KCTD10%2C%20and%20KCTD16%20show,the%20expression%20and%20promoter%20methylation')</li>
<li>AnnotationURLCitation(end_index=44773, start_index=44627, title='KCTD: A new gene family involved in neurodevelopmental and neuropsychiatric disorders - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6566181/#:~:text=focusing%20efforts%20to%20dissect%20their,KCTD11%29%20and%20an')</li>
<li>AnnotationURLCitation(end_index=45150, start_index=45020, title='KCTD: A new gene family involved in neurodevelopmental and neuropsychiatric disorders - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6566181/#:~:text=3,in%20neurotransmitter%20receptor%20signaling')</li>
<li>AnnotationURLCitation(end_index=45504, start_index=45337, title='KCTD: A new gene family involved in neurodevelopmental and neuropsychiatric disorders - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6566181/#:~:text=and%20structure%E2%80%90based%20studies%20,functions%20may%20be%20disease%20related')</li>
<li>AnnotationURLCitation(end_index=46026, start_index=45857, title='KCTD: A new gene family involved in neurodevelopmental and neuropsychiatric disorders - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6566181/#:~:text=channels%20through%20trimeric%20G%E2%80%90proteins,B2%7D%20%28amino%20acid%20residues')</li>
<li>AnnotationURLCitation(end_index=46158, start_index=46027, title='KCTD: A new gene family involved in neurodevelopmental and neuropsychiatric disorders - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6566181/#:~:text=GABA_,together%2C%20the%20proposed%20model%20is')</li>
<li>AnnotationURLCitation(end_index=46560, start_index=46407, title='KCTD: A new gene family involved in neurodevelopmental and neuropsychiatric disorders - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6566181/#:~:text=subunits%20KCTD8%2C%20KCTD12%2C%20and%20KCTD16,64%20Consistent%20with')</li>
<li>AnnotationURLCitation(end_index=47189, start_index=47025, title='GABAB receptor auxiliary subunits modulate Cav2.3-mediated release from medial habenula terminals - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC8121548/#:~:text=Four%20KCTD%20subunits%2C%20KCTD8%2C%2012%2C,subunits%20are%20composed%20of%20an')</li>
<li>AnnotationURLCitation(end_index=47363, start_index=47190, title='KCTD: A new gene family involved in neurodevelopmental and neuropsychiatric disorders - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6566181/#:~:text=inhibitory%20and%20excitatory%20neurons,mice%20exhibit%20related%20phenotypes%20including')</li>
<li>AnnotationURLCitation(end_index=48612, start_index=48447, title='expanded clinical spectrum of anti-GABABR encephalitis and added value of KCTD16 autoantibodies | Brain | Oxford Academic', type='url_citation', url='https://academic.oup.com/brain/article/142/6/1631/5476117#:~:text=KCTD%20family%20members%20show%20distinct,specific%20manner%20%28Schwenk%20et')</li>
</ol>
            </div>
        </details>
        
    </div>
    

    <!-- YAML Preview Section -->
    <div class="section">
        <details class="yaml-preview">
            <summary>
                <h2 style="display: inline;">üìÑ View Raw YAML</h2>
            </summary>
            <div class="yaml-content">
                <pre><code>id: Q68DU8
gene_symbol: KCTD16
product_type: PROTEIN
status: COMPLETE
taxon:
  id: NCBITaxon:9606
  label: Homo sapiens
description: KCTD16 is an auxiliary subunit of GABA-B receptors that modulates the pharmacology and kinetics of receptor signaling. It contains an N-terminal BTB/POZ domain that forms an open pentamer and binds to the GABAB2 C-terminal tail in a 1:5 stoichiometry. Unlike KCTD12 which promotes rapid desensitization, KCTD16 generally confers sustained, non-desensitizing GABA-B receptor responses. KCTD16 is enriched in brain regions including thalamus, hippocampus, and amygdala, where it shapes postsynaptic inhibitory currents through GIRK channels. Notably, KCTD16 does not function as a Cullin3 E3 ligase adaptor, distinguishing it from other KCTD family members.
existing_annotations:
- term:
    id: GO:0042734
    label: presynaptic membrane
  evidence_type: IBA
  original_reference_id: GO_REF:0000033
  review:
    summary: KCTD16 localizes to presynaptic membranes as part of GABA-B receptor complexes. Mouse brain studies show KCTD16 expression in regions with both presynaptic and postsynaptic localization (Metz et al. 2011). UniProt confirms presynaptic cell membrane localization.
    action: ACCEPT
    reason: IBA annotation is well-supported. KCTD16 functions as an auxiliary subunit of GABA-B receptors which are present at presynaptic terminals where they modulate neurotransmitter release via Gbetagamma signaling to voltage-gated calcium channels. This is consistent with the established role of GABA-B receptors in presynaptic inhibition.
    supported_by:
      - reference_id: file:human/KCTD16/KCTD16-deep-research-falcon.md
        supporting_text: In mouse brain KCTD16 shows high expression across thalamic nuclei and is enriched in hippocampal CA1, amygdala (lateral/basolateral nuclei) and dentate regions
- term:
    id: GO:0045211
    label: postsynaptic membrane
  evidence_type: IBA
  original_reference_id: GO_REF:0000033
  review:
    summary: KCTD16 is a component of postsynaptic GABA-B receptor complexes where it modulates GIRK channel-mediated inhibitory currents. Immunolocalization studies show KCTD16 at neuronal somata and neuropil (Metz et al. 2011).
    action: ACCEPT
    reason: IBA annotation is well-supported. KCTD16 tethers to GABAB2 C-terminus and shapes Gbetagamma-GIRK signaling kinetics at postsynaptic sites. Structural studies confirm the KCTD16-GABAB2 interaction (Zuo et al. 2019, PNAS). UniProt also confirms postsynaptic cell membrane localization.
    supported_by:
      - reference_id: file:human/KCTD16/KCTD16-deep-research-falcon.md
        supporting_text: By tethering to GABAB2 and shaping Gbetagamma availability and GIRK channel interactions, KCTD16 contributes to the amplitude and temporal profile of postsynaptic inhibitory currents
      - reference_id: file:human/KCTD16/KCTD16-deep-research-falcon.md
        supporting_text: Immunolocalization shows KCTD16 at granule cell somata and neuropil in dentate gyrus and colocalization with GABAB2 in specific layers, supporting a postsynaptic role
- term:
    id: GO:0043235
    label: receptor complex
  evidence_type: IBA
  original_reference_id: GO_REF:0000033
  review:
    summary: KCTD16 is an integral auxiliary subunit of the GABA-B receptor complex. Multiple structural studies have demonstrated that KCTD16 pentamers bind the GABAB2 C-terminal tail.
    action: MODIFY
    reason: While GO:0043235 (receptor complex) is correct, a more specific term exists. KCTD16 specifically forms part of the G protein-coupled GABA receptor complex (GABA-B receptor). The term GO:1902712 (G protein-coupled GABA receptor complex) is the appropriate specific term for GABA-B receptors.
    proposed_replacement_terms:
      - id: GO:1902712
        label: G protein-coupled GABA receptor complex
    supported_by:
      - reference_id: file:human/KCTD16/KCTD16-deep-research-falcon.md
        supporting_text: Native GBR complexes comprise principal subunits GABAB1 and GABAB2 plus auxiliary KCTDs (notably KCTD8, KCTD12/12b, KCTD16)
      - reference_id: file:human/KCTD16/KCTD16-deep-research-falcon.md
        supporting_text: Human KCTD16 is a BTB/POZ-domain auxiliary protein that constitutively associates with the GABAB2 C-terminus in a 1:5 pentameric arrangement
- term:
    id: GO:0008277
    label: regulation of G protein-coupled receptor signaling pathway
  evidence_type: IBA
  original_reference_id: GO_REF:0000033
  review:
    summary: KCTD16 modulates GABA-B receptor signaling kinetics, particularly the amplitude and temporal profile of GIRK-mediated responses. Unlike KCTD12, KCTD16 generally produces sustained, non-desensitizing responses.
    action: ACCEPT
    reason: This annotation accurately captures the core biological process function of KCTD16. The protein regulates GABA-B receptor (a GPCR) signaling by modulating the kinetics and amplitude of downstream effector responses. Structural and electrophysiological studies demonstrate this regulatory function.
    supported_by:
      - reference_id: file:human/KCTD16/KCTD16-deep-research-falcon.md
        supporting_text: KCTD16 modulates GBR signaling kinetics and amplitude, particularly in coupling to G protein-gated inwardly rectifying K+ channels (GIRK)
      - reference_id: file:human/KCTD16/KCTD16-deep-research-falcon.md
        supporting_text: KCTD8 and KCTD16 generally confer primarily non-desensitizing/sustained responses
- term:
    id: GO:0042734
    label: presynaptic membrane
  evidence_type: IEA
  original_reference_id: GO_REF:0000120
  review:
    summary: IEA annotation consistent with IBA and UniProt localization data for presynaptic membrane.
    action: ACCEPT
    reason: This IEA annotation is consistent with the experimentally-supported IBA annotation and UniProt subcellular localization data. GABA-B receptors with KCTD16 auxiliary subunits are present at presynaptic terminals.
    supported_by:
      - reference_id: UniProtKB:Q68DU8
        supporting_text: Presynaptic cell membrane
- term:
    id: GO:0042802
    label: identical protein binding
  evidence_type: IEA
  original_reference_id: GO_REF:0000117
  review:
    summary: KCTD16 forms homopentamers via its BTB/POZ domain. Crystal structures confirm the pentameric assembly.
    action: ACCEPT
    reason: This annotation is well-supported by structural evidence. KCTD16 forms an open pentamer through its BTB/T1 domain, as demonstrated by X-ray crystallography (PDB 6OCP, 5A15). UniProt confirms homopentamer formation.
    supported_by:
      - reference_id: file:human/KCTD16/KCTD16-deep-research-falcon.md
        supporting_text: The KCTD16 BTB/T1 domain forms an open pentamer that wraps around one copy of the GABAB2 C-terminal peptide
      - reference_id: file:human/KCTD16/KCTD16-deep-research-falcon.md
        supporting_text: The KCTD16 T1/BTB domain forms an open pentamer that binds one GABAB2 C-terminal peptide (1:5 stoichiometry; structure deposited PDB 6OCP)
- term:
    id: GO:0045211
    label: postsynaptic membrane
  evidence_type: IEA
  original_reference_id: GO_REF:0000120
  review:
    summary: IEA annotation consistent with IBA and UniProt localization data for postsynaptic membrane.
    action: ACCEPT
    reason: This IEA annotation is consistent with the experimentally-supported IBA annotation and UniProt subcellular localization data showing postsynaptic cell membrane localization.
    supported_by:
      - reference_id: UniProtKB:Q68DU8
        supporting_text: Postsynaptic cell membrane
- term:
    id: GO:0051260
    label: protein homooligomerization
  evidence_type: IEA
  original_reference_id: GO_REF:0000002
  review:
    summary: KCTD16 forms homopentamers through its BTB/POZ domain. This pentamerization is essential for its function as a GABA-B receptor auxiliary subunit.
    action: ACCEPT
    reason: This annotation is strongly supported by structural evidence. Crystal structures show KCTD16 forms an open pentamer via its BTB/T1 domain (Zuo et al. 2019, Pinkas et al. 2017). The pentamerization is functionally important for receptor complex assembly.
    supported_by:
      - reference_id: file:human/KCTD16/KCTD16-deep-research-falcon.md
        supporting_text: The KCTD16 T1/BTB domain forms an open pentamer that binds one GABAB2 C-terminal peptide (1:5 stoichiometry; structure deposited PDB 6OCP)
      - reference_id: file:human/KCTD16/KCTD16-deep-research-falcon.md
        supporting_text: the T1/BTB mediates pentamer formation
- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:26960425
  review:
    summary: This annotation derives from a yeast two-hybrid study that identified KCTD16 as an interactor of APP (amyloid precursor protein) extracellular domain. The interaction was confirmed in mammalian cells.
    action: REMOVE
    reason: GO:0005515 (protein binding) is an uninformative annotation that should be avoided. The referenced study (Yu et al. 2016) is a high-throughput yeast two-hybrid screen for APP interactors. While the interaction was confirmed, there is no clear physiological relevance established for a KCTD16-APP interaction, and this does not represent the core function of KCTD16. More informative molecular function terms should be used instead, such as the GABA-B receptor binding function.
    additional_reference_ids:
      - PMID:26960425
    supported_by:
      - reference_id: PMID:26960425
        supporting_text: After confirming the interactions in the mammalian system, mutated PLP1, members of the FLRT protein family, and KCTD16 were shown to interact with APP
- term:
    id: GO:0043235
    label: receptor complex
  evidence_type: IEA
  original_reference_id: GO_REF:0000107
  review:
    summary: IEA annotation for receptor complex membership, consistent with KCTD16 role as GABA-B receptor auxiliary subunit.
    action: MODIFY
    reason: While correct that KCTD16 is part of a receptor complex, the more specific term GO:1902712 (G protein-coupled GABA receptor complex) should be used since KCTD16 specifically associates with GABA-B receptors.
    proposed_replacement_terms:
      - id: GO:1902712
        label: G protein-coupled GABA receptor complex
    supported_by:
      - reference_id: file:human/KCTD16/KCTD16-deep-research-falcon.md
        supporting_text: Functions as an auxiliary subunit of neuronal GABAB receptors
- term:
    id: GO:0031795
    label: G protein-coupled GABA receptor binding
  evidence_type: IDA
  original_reference_id: file:human/KCTD16/KCTD16-deep-research-falcon.md
  review:
    summary: KCTD16 directly binds to the GABAB2 subunit of the G protein-coupled GABA-B receptor via its BTB/T1 domain. Structural studies have mapped the binding interface.
    action: NEW
    reason: This molecular function annotation captures the core activity of KCTD16 as a GABA-B receptor auxiliary subunit. The BTB/T1 domain of KCTD16 directly binds the C-terminal tail of GABAB2 with characterized interfacial residues (Q34, F80, P101, E102 on KCTD16; I898, Y903, L904 on GABAB2).
    supported_by:
      - reference_id: file:human/KCTD16/KCTD16-deep-research-falcon.md
        supporting_text: The KCTD16 BTB/T1 domain forms an open pentamer that wraps around one copy of the GABAB2 C-terminal peptide, establishing a 1:5 GB2 peptide:KCTD16 stoichiometry. Key interfacial residues include KCTD16 Q34, F80, P101, E102 and GABAB2 I898, Y903, L904
      - reference_id: file:human/KCTD16/KCTD16-deep-research-falcon.md
        supporting_text: KCTD family H1 domains can oligomerize to bind multiple Gbetagamma heterodimers cooperatively in a 5:5 complex
- term:
    id: GO:0031683
    label: G-protein beta/gamma-subunit complex binding
  evidence_type: ISS
  original_reference_id: file:human/KCTD16/KCTD16-deep-research-falcon.md
  review:
    summary: KCTD16 H1 domain binds Gbetagamma subunits, analogous to KCTD12. This interaction shapes GABA-B receptor signaling kinetics.
    action: NEW
    reason: KCTD16, like other GABA-B associated KCTDs, possesses an H1 domain that engages Gbetagamma subunits. While the detailed kinetic effects differ from KCTD12 (which causes desensitization), the structural architecture for Gbetagamma binding is conserved. This is a key molecular function enabling KCTD16 to modulate GPCR signaling.
    supported_by:
      - reference_id: file:human/KCTD16/KCTD16-deep-research-falcon.md
        supporting_text: KCTD family H1 domains can oligomerize to bind multiple Gbetagamma heterodimers cooperatively in a 5:5 complex, enabling rapid desensitization of GBR-GIRK signaling by stripping Gbetagamma from GIRK after initial activation
      - reference_id: file:human/KCTD16/KCTD16-deep-research-falcon.md
        supporting_text: KCTD8/16 possess additional C-terminal features (including H2) that oppose desensitization
- term:
    id: GO:0099602
    label: neurotransmitter receptor regulator activity
  evidence_type: ISS
  original_reference_id: file:human/KCTD16/KCTD16-deep-research-falcon.md
  review:
    summary: KCTD16 functions as a neurotransmitter receptor regulator by modulating GABA-B receptor activity, kinetics, and desensitization properties.
    action: NEW
    reason: This molecular function term accurately describes KCTD16 function. It directly modulates GABA-B receptor activity by binding to GABAB2 and influencing the kinetics of downstream GIRK channel responses. UniProt states it increases agonist potency and alters G-protein signaling kinetics.
    supported_by:
      - reference_id: file:human/KCTD16/KCTD16-deep-research-falcon.md
        supporting_text: Functions as an auxiliary subunit of neuronal GABAB receptors, modulating receptor expression and the amplitude/kinetics of GIRK-mediated K+ currents
      - reference_id: file:human/KCTD16/KCTD16-deep-research-falcon.md
        supporting_text: KCTD16 modulates GBR signaling kinetics and amplitude, particularly in coupling to G protein-gated inwardly rectifying K+ channels (GIRK)
references:
- id: GO_REF:0000002
  title: Gene Ontology annotation through association of InterPro records with GO terms
  findings: []
- id: GO_REF:0000033
  title: Annotation inferences using phylogenetic trees
  findings: []
- id: GO_REF:0000107
  title: Automatic transfer of experimentally verified manual GO annotation data to orthologs using Ensembl Compara
  findings: []
- id: GO_REF:0000117
  title: Electronic Gene Ontology annotations created by ARBA machine learning models
  findings: []
- id: GO_REF:0000120
  title: Combined Automated Annotation using Multiple IEA Methods
  findings: []
- id: PMID:26960425
  title: Yeast Two-Hybrid Screening for Proteins that Interact with the Extracellular Domain of Amyloid Precursor Protein
  findings:
    - statement: KCTD16 identified as APP interactor via yeast two-hybrid screen and confirmed in mammalian cells
      supporting_text: After confirming the interactions in the mammalian system, mutated PLP1, members of the FLRT protein family, and KCTD16 were shown to interact with APP
- id: file:human/KCTD16/KCTD16-deep-research-falcon.md
  title: Deep research on KCTD16 function
  findings:
    - statement: KCTD16 is a BTB/POZ-domain auxiliary protein of GABA-B receptors forming pentameric complexes with GABAB2
      supporting_text: Human KCTD16 is a BTB/POZ-domain auxiliary protein that constitutively associates with the GABAB2 C-terminus in a 1:5 pentameric arrangement
    - statement: KCTD16 modulates GABA-B receptor signaling kinetics conferring sustained non-desensitizing responses
      supporting_text: KCTD8 and KCTD16 generally confer primarily non-desensitizing/sustained responses
    - statement: KCTD16 does not function as a Cullin3 E3 ligase adaptor
      supporting_text: KCTD subcluster harboring GABAB-binding proteins (including KCTD16) shows no structural propensity for Cul3 binding via BTB
- id: file:human/KCTD16/KCTD16-deep-research-cyberian.md
  title: Cyberian deep research on KCTD16 function
  findings: []
core_functions:
- molecular_function:
    id: GO:0031795
    label: G protein-coupled GABA receptor binding
  description: KCTD16 directly binds to the GABAB2 subunit C-terminal tail through its BTB/T1 domain, forming a 1:5 stoichiometric complex that is essential for GABA-B receptor function and signaling modulation
  supported_by:
    - reference_id: file:human/KCTD16/KCTD16-deep-research-falcon.md
      supporting_text: The KCTD16 BTB/T1 domain forms an open pentamer that wraps around one copy of the GABAB2 C-terminal peptide
- molecular_function:
    id: GO:0042802
    label: identical protein binding
  description: KCTD16 forms homopentamers via its BTB/POZ domain, a structural prerequisite for GABA-B receptor complex assembly
  supported_by:
    - reference_id: file:human/KCTD16/KCTD16-deep-research-falcon.md
      supporting_text: The KCTD16 T1/BTB domain forms an open pentamer that binds one GABAB2 C-terminal peptide (1:5 stoichiometry; structure deposited PDB 6OCP)
- molecular_function:
    id: GO:0099602
    label: neurotransmitter receptor regulator activity
  description: KCTD16 modulates GABA-B receptor pharmacology and signaling kinetics, conferring sustained non-desensitizing responses unlike KCTD12
  supported_by:
    - reference_id: file:human/KCTD16/KCTD16-deep-research-falcon.md
      supporting_text: KCTD8 and KCTD16 generally confer primarily non-desensitizing/sustained responses
</code></pre>
            </div>
        </details>
    </div>

    <!-- Pathway Visualization Link -->
    

    <style>
        /* Markdown Section Styles */
        .markdown-section {
            margin-bottom: 1rem;
            border: 1px solid #e0e0e0;
            border-radius: 8px;
            padding: 1rem;
            background-color: #f8f9fa;
        }

        .markdown-section summary {
            cursor: pointer;
            user-select: none;
        }

        .markdown-section summary h3 {
            margin: 0;
            color: #495057;
            font-size: 1.1rem;
        }

        .markdown-section summary:hover h3 {
            color: #007bff;
        }

        .markdown-section[open] {
            background-color: #fff;
        }

        .markdown-content {
            margin-top: 1rem;
            padding: 1rem;
            border-top: 1px solid #dee2e6;
        }

        /* Markdown content styling */
        .markdown-content h1 { font-size: 1.5rem; margin-top: 1.5rem; }
        .markdown-content h2 { font-size: 1.3rem; margin-top: 1.3rem; }
        .markdown-content h3 { font-size: 1.1rem; margin-top: 1.1rem; }
        .markdown-content h4 { font-size: 1rem; margin-top: 1rem; }

        .markdown-content pre {
            background-color: #f8f9fa;
            border: 1px solid #dee2e6;
            border-radius: 4px;
            padding: 1rem;
            overflow-x: auto;
        }

        .markdown-content code {
            background-color: #f8f9fa;
            padding: 0.2rem 0.4rem;
            border-radius: 3px;
            font-family: 'Courier New', Courier, monospace;
            font-size: 0.9rem;
        }

        .markdown-content pre code {
            background: none;
            padding: 0;
        }

        .markdown-content table {
            border-collapse: collapse;
            width: 100%;
            margin: 1rem 0;
        }

        .markdown-content table th,
        .markdown-content table td {
            border: 1px solid #dee2e6;
            padding: 0.5rem;
            text-align: left;
        }

        .markdown-content table th {
            background-color: #f8f9fa;
            font-weight: bold;
        }

        .markdown-content blockquote {
            border-left: 4px solid #007bff;
            padding-left: 1rem;
            margin-left: 0;
            color: #666;
        }

        /* YAML Preview Styles */
        .yaml-preview {
            margin-top: 2rem;
            border: 1px solid #e0e0e0;
            border-radius: 8px;
            padding: 1rem;
            background-color: #f8f9fa;
        }

        .yaml-preview summary {
            cursor: pointer;
            user-select: none;
        }

        .yaml-preview summary h2 {
            margin: 0;
            color: #495057;
            font-size: 1.3rem;
        }

        .yaml-preview summary:hover h2 {
            color: #007bff;
        }

        .yaml-preview[open] {
            background-color: #fff;
        }

        .yaml-content {
            margin-top: 1rem;
            background-color: #f8f9fa;
            border: 1px solid #dee2e6;
            border-radius: 4px;
            padding: 1rem;
            overflow-x: auto;
        }

        .yaml-content pre {
            margin: 0;
            font-family: 'Courier New', Courier, monospace;
            font-size: 0.9rem;
            line-height: 1.4;
        }

        .yaml-content code {
            color: #333;
            background: none;
            padding: 0;
        }

        /* Pathway Link Styles */
        .pathway-link {
            margin: 1rem 0;
        }

        .btn-link {
            display: inline-block;
            padding: 0.5rem 1rem;
            background-color: #007bff;
            color: white !important;
            text-decoration: none;
            border-radius: 4px;
            font-weight: 500;
            transition: background-color 0.2s;
        }

        .btn-link:hover {
            background-color: #0056b3;
            text-decoration: none;
        }

        /* Voting buttons */
        .vote-buttons {
            display: inline-block;
            margin-left: 0.5rem;
        }

        .vote-btn {
            background: none;
            border: 1px solid #dee2e6;
            border-radius: 4px;
            padding: 2px 6px;
            margin: 0 2px;
            cursor: pointer;
            font-size: 0.9rem;
            transition: all 0.2s;
            opacity: 0.6;
        }

        .vote-btn:hover {
            opacity: 1;
            transform: scale(1.1);
        }

        .vote-btn.voted {
            opacity: 1;
            border-color: #28a745;
            background-color: #d4edda;
        }

        .vote-btn.voted-down {
            border-color: #dc3545;
            background-color: #f8d7da;
        }

        .vote-btn-small {
            font-size: 0.7rem;
            padding: 1px 4px;
            margin: 0 1px;
        }
    </style>

    <script>
        // Add collapsible functionality
        document.querySelectorAll('.collapsible').forEach(element => {
            element.addEventListener('click', function() {
                this.classList.toggle('collapsed');
            });
        });

        // Voting functionality
        const VOTE_URL = 'https://script.google.com/macros/s/AKfycbwPKH7d3seuPNBtB0ugVjqGeTiByyOGD5vkqB_Ck6K8eOcPQYbJqBOuz6GFgXHKBNWK/exec';

        // Get or create session ID
        let sessionId = localStorage.getItem('review_session_id');
        if (!sessionId) {
            sessionId = 's' + Date.now() + '_' + Math.random().toString(36).substr(2, 9);
            localStorage.setItem('review_session_id', sessionId);
        }

        // Show previous votes on page load
        document.addEventListener('DOMContentLoaded', function() {
            document.querySelectorAll('.vote-buttons').forEach(container => {
                const key = `vote_${container.dataset.g}_${container.dataset.a}_${container.dataset.act}`;
                const previousVote = localStorage.getItem(key);
                if (previousVote) {
                    const btn = container.querySelector(`[data-v="${previousVote}"]`);
                    if (btn) btn.classList.add(previousVote === 'up' ? 'voted' : 'voted-down');
                }
            });
        });

        // Handle vote clicks - Simple image beacon approach
        document.addEventListener('click', function(e) {
            if (!e.target.classList.contains('vote-btn')) return;

            // Prevent the click from bubbling to parent elements (like summary)
            e.preventDefault();
            e.stopPropagation();

            const btn = e.target;
            const container = btn.closest('.vote-buttons');
            if (!container) return;

            const voteType = btn.dataset.v;

            // Check if already voted (locally)
            const key = `vote_${container.dataset.g}_${container.dataset.a}_${container.dataset.act}`;
            const previousVote = localStorage.getItem(key);

            if (previousVote === voteType) {
                // Same vote - do nothing
                btn.style.animation = 'shake 0.5s';
                setTimeout(() => btn.style.animation = '', 500);
                return;
            }

            // Build URL
            const params = new URLSearchParams({
                gene_id: container.dataset.g,
                annotation_id: container.dataset.a,
                ref_id: container.dataset.r || '',
                action: container.dataset.act,
                vote: voteType,
                session_id: sessionId,
                ua: navigator.userAgent.substring(0, 100)
            });

            // Clear previous vote styling
            container.querySelectorAll('.vote-btn').forEach(b => {
                b.classList.remove('voted', 'voted-down');
            });

            // Apply new vote styling immediately (optimistic UI)
            btn.classList.add(voteType === 'up' ? 'voted' : 'voted-down');

            // Store locally
            localStorage.setItem(key, voteType);

            // Send vote using fetch with no-cors mode (fire and forget)
            const fullUrl = VOTE_URL + '?' + params;
            console.log('Sending vote to:', fullUrl);

            // Use fetch in no-cors mode - we won't get a response but the request will be sent
            fetch(fullUrl, {
                mode: 'no-cors',
                method: 'GET'
            }).then(() => {
                console.log('Vote request sent (no response due to no-cors mode)');
            }).catch(err => {
                console.warn('Vote may not have been recorded, but saved locally:', err);

                // Fallback: try image beacon as well
                const img = new Image();
                img.src = fullUrl;
            });
        });

        // Optional: Add shake animation for feedback
        const style = document.createElement('style');
        style.textContent = `
            @keyframes shake {
                0%, 100% { transform: translateX(0); }
                25% { transform: translateX(-5px); }
                75% { transform: translateX(5px); }
            }
        `;
        document.head.appendChild(style);
    </script>
</body>
</html>